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Abstract 
Morbidity following hip and knee arthroplasty has previously been poorly 
recorded.  This is the first time the Post-Operative Morbidity Survey (POMS) 
has been used for this purpose.  The POMS identifies clinically significant 
morbidity using indicators of organ system dysfunction rather than traditional 
diagnostic categories.  
 
The most common types of morbidity following hip and knee arthroplasty are 
infection and renal morbidity.  Pulmonary, pain and gastro-intestinal morbidity 
are less common.  Cardiovascular, wound, neurological and haematological 
morbidity are least common.  
 
Many arthroplasty patients remain in hospital without morbidity.  The POMS 
identifies these patients and thus has potential as a prospective bed utilisation 
tool.  To be used for this purpose, the POMS must identify all clinically 
significant morbidity.  Mobility is an important factor for safe discharge of 
arthroplasty patients.  Addition of a ‘mobility’ domain could improve the utility of 
POMS as a bed utilisation tool following orthopaedic surgery.  
 
This study showed no association between post-operative morbidity defined by 
the POMS and longer-term patient-reported outcome measures (PROMs).  This 
study does not support the POMS as an early surrogate marker of long-term 
PROMs in orthopaedic patients.  
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The wound domain of the POMS has a high specificity, reasonable sensitivity, 
high negative predictive value and low positive predictive value compared to the 
inpatient ASEPSIS (Additional treatment, Serous discharge, Erythema, Purulent 
exudate, Separation of deep tissues, Isolation of bacteria, inpatient Stay over 14 
days) score.  The wound domain of POMS could be replaced with a validated 
definition of wound infection such as ASEPSIS.  
 
On the same series of orthopaedic patients, surgical site infection (SSI) rate 
according to the Centres for Disease Control (CDC) definition was 15.45%, 
according to the Nosocomial Infection National Surveillance Scheme (NINSS) 
definition was 11.32% and according to the ASEPSIS definition was 8.79%.  
This highlights the need for a consistent definition of SSI. 
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Chapter 1: Background 
 
1.1 Introduction 
 
In this chapter I will describe how surgical outcome is measured for 
interventions on the hip and knee.  I will start by explaining why surgical 
outcome is measured and I will describe the introduction of outcome measures 
in the United Kingdom.  I will proceed to explain how these measures have 
evolved with time. 
 
I will then discuss how the quality of surgery can be measured.  I will describe 
how quality can be categorised and the advantages and disadvantages of 
reporting each category.   
 
Following this I will discuss how outcome measures are adjusted to allow for 
patient factors.  I will describe two risk classification systems that are commonly 
used in orthopaedic studies. 
 
Next I will describe outcome measures used to assess orthopaedic surgery.  I 
will focus on hip and knee arthroplasty.  I will discuss mortality rates, hospital 
length of stay, post-operative morbidity and quality of life measures.  In the 
morbidity discussion I will pay particular attention to surgical site infection.  I will 
divide quality of life measures into generic outcomes, disease-specific 
outcomes and joint-specific outcomes.  The joint-specific tools will be further 
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divided into surgeon-reported and patient-reported measures. 
 
Following this I will discuss the possibility of using post-operative outcome 
measures as bed utilisation tools.  Finally I will discuss the ways in which 
outcome measures are evaluated and validated. 
1.2 Why measure the outcome of orthopaedic 
interventions? 
The World Health Organisation (WHO) estimates that over 234.2 million 
surgical procedures are performed worldwide each year1. Due to high morbidity 
and mortality rates, the WHO recommended that surgical safety should be a 
global public health concern and surveillance of all types of surgery should be 
established. 
 
The aim of surgery is either to increase quality of life or to prolong life.  A small 
proportion of elective orthopaedic surgery aims to prolong life e.g. excision of 
primary bone tumours.  However, the aim of most elective orthopaedic surgery 
is to improve quality of life.  For example, lower limb arthroplasty (e.g. total hip 
replacement) aims to improve joint pain and mobility. 
 
All surgery carries risk and can have a significant impact on a patient’s life. 
There are physical (e.g. pain, fatigue), psychological (e.g. anxiety, depression) 
and social (e.g. loss of income due to work absence) implications of surgery.  
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Mortality is a risk of all surgery but is low in most elective orthopaedic 
procedures.  
 
There are both moral and economic reasons to continually strive to improve 
surgical outcome.  Morally, a surgical procedure should offer a patient benefit 
with the lowest possible risk.  From an economic point of view, in order to 
maximise the cost-effectiveness of surgery, the maximum benefit must be 
achieved whilst minimising risk.  The risk of surgery comes from the operation 
itself and from peri-operative interventions.   
 
Measures of outcome are required to monitor the effectiveness of surgical 
interventions.  These measures need to evaluate both the benefits and risks of 
surgery.  They have several purposes.  Firstly, they are used in clinical trials to 
compare different interventions.  In orthopaedic surgery, they can be used to 
compare joint prostheses, different methods of prosthesis fixation and varying 
surgical techniques.  Outcome measures are also used to assess peri-operative 
care including the use of prophylactic antibiotics, the effect of increased 
physiotherapy input and alternate regimes of post-operative analgesia.  
Secondly, outcome measures are used for audit purposes to compare 
individuals, departments, hospitals and regions.  In this way outliers can be 
identified.   This enables good practice to be highlighted and propagated and 
remedial action to be initiated where practice is sub-standard.  Thirdly, regular 
feedback of outcome measures to surgeons makes them more aware of their 
own performance, and has been shown to improve results2.  Fourthly, 
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outcome measure results can be used to guide the distribution of resources.  In 
departments with poor results, increased training or new equipment may be 
needed.  Finally, results from outcome measures can be used to guide patients 
and purchasers in their choice of surgeon and institution.  Some studies show 
that patients are reluctant to use healthcare performance indicators3 and that 
they are more concerned about other factors (such as the proximity of a hospital 
to their home) than outcome results4.  However, a more recent study indicates 
that patients do wish to make an informed choice regarding their healthcare 
based on outcome data5.  The ‘NHS Choices’ website now provides the general 
public with information regarding hip and knee arthroplasty procedures at 
different hospitals. Information such as average length of hospital stay, waiting 
time for surgery and surgical site infection rates is available to view. 
1.3 The use of performance indicators in the UK 
 
The National Health Service (NHS) was formed in the UK in 1948.  This service 
provides free universal healthcare at the point of contact, paid for by general 
taxation.  Until recently healthcare delivery was mainly self-regulated.  However, 
due to budget restrictions and recent gross failures in the self-regulatory system 
(such as the Harold Shipman case), accountability has become an integral part 
of the NHS. 
 
The push for accountability started in 2000 when the government announced an 
increase in NHS spending.  In an attempt to ensure that extra spending resulted 
in a better service, hospitals were required to publish performance indicators.  
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Initially, most of the data published by the Healthcare Commission was process 
focused and a large emphasis was put on the prompt delivery of services.  
There was little initial focus on the outcome of services.  
 
In 2003 the Department of Health introduced ‘Payment by Results’6.  Prior to 
this, hospitals were paid a fixed annual sum for providing a service.  This sum 
did not reward efficiency or activity.  ‘Payment by Results’ aimed to change this 
by paying a fixed ‘tariff’ for each procedure performed.  This encouraged 
increased activity with increased payment but it did not incentivise higher 
‘quality’.  
 
In 2008, the Department of Health published a report entitled ‘High Quality Care 
For All’7.  This report stipulated that all hospitals must collect and publish 
surgical outcome data by 2010.  This data covers three domains: safety (e.g. 
surgical site infection rates), clinical effectiveness (e.g. patient-centred quality-
of-life assessments) and personal experience (e.g. respectful treatment of 
patients).  The payment for each procedure is now modified based on outcome 
data.  Thus, the government is now rewarding ‘quality’ of healthcare, as well as 
‘quantity’. 
1.4 How is the quality of orthopaedic surgery 
measured? 
 
 
Performance indicators include information regarding the ‘structure’ of a service, 
the ‘process’ by which a service is delivered and the ‘outcome’ of a service. 
  
 
 
 
 
 
 
20 
Data regarding the ‘structure’ of a service provides information about the place 
where the service is delivered.  Examples in orthopaedic surgery include the 
number of operating theatres, the ‘quality’ of surgical equipment and the ‘quality’ 
of the operating theatres e.g. whether a laminar airflow system is present.  
‘Process’ data provides information about how efficiently a service is delivered.  
In orthopaedic surgery, examples include the waiting time for a surgical 
intervention and the level of physiotherapy provision following surgery.  
‘Outcome’ data provides information about the risks and benefits of surgery.  
Outcome indicators used in orthopaedic surgery include surgical site infection 
rates and patient-centred outcome measures (both of which are now reported 
on the NHS Choices website). 
 
The Department of Health introduced ‘High Quality of Care for All’7 to improve 
the ‘quality’ of medical services but there was considerable debate over which 
of the quality measurements (structure, process or outcome) should be used.  
‘Structural’ factors remain relatively stable over time.  They allow for the 
provision of high quality care but do not directly result in high quality care.  For 
these two reasons ‘structural’ factors are not deemed a fair way to reward 
quality. 
 
‘Process’ measures are easy to record and have been used in the NHS as 
measures of ‘quality’ with financial implications.  For example, hospitals used to 
receive a financial penalty for any patient in the Accident and Emergency 
Department who did not receive treatment within 4 hours.  However ‘process’ 
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measures have their limitations.  There is no sense in rewarding a process if it 
does not result in a better outcome.  A better outcome with poor processing is 
preferable to a poor outcome with efficient processing.  Rewarding ‘process’ 
measures alone can lead to a decline in quality of care.  This is seen when 
managers are rewarded for ‘processing’ increased numbers of operative 
interventions.   Patients may be operated on by less experienced surgeons, 
there may be less time for safety checks, older equipment may be used since 
there is insufficient time to sterilise newer equipment, and non-orthopaedic 
theatres may be used.  All these factors can lead to a poorer outcome.  If 
‘process’ factors are to be rewarded, a link to ‘outcome’ must be proven. 
 
‘Outcome’ measures are generally accepted as a good way of measuring 
‘quality’.  However the data is often not readily available and requires resources 
to collect it.   ‘Process’ data may be used until ‘outcome’ data is available, but 
‘outcome’ data should be the ultimate way to assess any intervention.  
‘Outcome’ measures must be continually validated to ensure that they provide a 
true representation of the benefits or failings of a surgical intervention. 
    
 The Department of Health splits ‘quality’ into three main categories: safety, 
clinical effectiveness and personal experience.  Safety is not clearly defined but 
can be surmised to mean ‘do as least harm as possible’ i.e. reduce risks to a 
minimum.  In orthopaedic surgery, there are certain events or risks that should 
never happen.  These are known as ‘never events’ e.g. wrong side surgery.  
There are other risks that can never be completely eradicated e.g. deep vein 
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thrombosis and surgical site infection.  The incidence of these risks should be 
continually audited and regular action taken in an attempt to reduce rates 
further.   
 
Clinical effectiveness looks at the ‘success’ of a procedure.  Such outcomes 
include mortality and morbidity rates.  Effectiveness can be reported by the 
surgeon (e.g. the range of motion in a replaced joint) or the patient (e.g. quality 
of life outcome measures).  Personal experience investigates what the patient 
thought about their treatment.  Did they feel that they were treated with dignity 
and respect?  Did they feel that medical staff communicated well with them?   
 
From the three different ways of classifying ‘quality’, a matrix can be formed 
(table 1).  The matrix includes examples of quality indicators used in 
orthopaedic surgery.  The rest of this thesis will concentrate on ‘outcome’ 
measures.  There will be no further discussion about ‘structure’ and ‘processes’, 
except where they act as a representative marker for an ‘outcome’ e.g. length of 
hospital stay. 
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Table 1. Matrix showing different ways to measure ‘quality’ in  
healthcare with orthopaedic examples 
 
 Structure Process Outcome 
Safety Laminar flow 
theatre 
Thoroughness of 
theatre cleaning 
Surgical site 
infection rates 
 
Effectiveness Type of operating 
equipment 
Turn-around time 
in theatre 
Post-operative 
morbidity survey 
(POMS) 
 
Expectation Quality of food 
provision 
Waiting time for 
surgery 
Patient-centred 
outcome 
measures 
 
 
In order for ‘quality’ data to be meaningful, it must be accurate.  Some 
institutions may deliberately ‘improve’ their figures for both financial purposes 
and to maintain a good reputation.  This is fraud.  Other institutions may ‘select’ 
their patients to improve their overall outcome data.  This is known as ‘gaming’.  
For example, high-risk patients (e.g. diabetics) may be discouraged from having 
lower limb arthroplasty surgery due to a higher surgical site infection rate.  This 
change in patient population undergoing surgery was seen in New York when 
the outcome of cardiac surgery was first published8.  
1.5 Risk adjustment for surgical outcome  
Measures 
 
 
The outcome of surgery is not simply a result of the effectiveness of care (both 
structure and process).  Patient factors and random variation also play a role9.  
In order to adjust for confounding patient factors, risk adjustment tools have 
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been established.  These tools aim to eliminate patient factors, making outcome 
a measure of the effectiveness of care and random variation alone. However, in 
practice not all patient factors can be excluded since some factors cannot be 
taken into account.  Random variation cannot be excluded.   
 
Several risk adjustment tools have been developed.  They aim to predict which 
patients are at risk of higher morbidity and mortality.  Most also aim to quantify 
this risk.  Two tools commonly used to adjust for risk in orthopaedic surgery are 
the American Society of Anesthesiologists (ASA) Physical Status Classification 
and the Physiological and Operative Severity Score for the Enumeration of 
Mortality and Morbidity (POSSUM).   
 
The American Society of Anesthesiologists Physical Status Classification (ASA-
PS) was first published in 194110 and has been modified several times since.  
The ASA-PS divides patients into one of six groups (table 2).  
Table 2. American Society of Anesthesiologists Physical Status Score  
(ASA 2008) 
 
ASA grade Criteria 
I Normal healthy patient 
II Patient with mild systemic disease 
III Patient with severe systemic disease 
IV Patient with severe systemic disease that is a constant threat to life 
V Moribund patient who is not expected to survive without the operation 
VI Declared brain-dead patient whose organs are being removed for donation 
  
 
 
 
 
 
 
25 
The ASA grade has been shown to correlate with morbidity in patients 
undergoing hip fracture surgery11.  ASA-PS was originally devised as a 
predictor of anaesthetic risk for epidemiological studies and not as a predictor of 
outcome.  ASA-PS is not suitable for predicting outcome on an individual basis.  
 
 
First described in 1992, the POSSUM score is composed of eighteen 
components12.  Twelve of the components relate to pre-operative physiological 
status and six relate to the severity of surgery.  The scores for these two groups 
of components are entered into logistic regression equations to calculate the 
overall risk of morbidity and mortality.  POSSUM is useful at predicting ‘high 
risk’ patients.  It should not be used in isolation to suggest that an operation on 
a ‘high-risk’ individual is not worth performing.  Other factors must be taken into 
account in this situation and it must be remembered that the figures for the 
POSSUM score are derived from population statistics, not individuals.  
 
The lowest possible POSSUM mortality score for any intervention is 1.08%.  It 
is well known that many surgical procedures have mortality rates lower than 
this13.  It has been shown that POSSUM over-predicts the mortality rate by up to 
6-fold in all patients with a predicted mortality rate of less than 10%14.  For this 
reason, a new model of POSSUM, known as P-POSSUM was developed15.  
This predicts mortality rates more accurately than POSSUM15.  A predictor of 
morbidity for P-POSSUM was not developed due to poor recording of post-
operative morbidity.   A further version of POSSUM has been produced 
specifically for orthopaedic patients16. 
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1.6 Orthopaedic post-operative outcome  
Measures 
 
1.6.1 Introduction 
 
 
Describing the overall clinical impact of orthopaedic interventions can be done 
in a variety of ways, all of which have their limitations.  Outcome measures aim 
to detect physiological (e.g. level of fitness), pathological (e.g. joint fixed flexion 
deformity), psychological (e.g. depression) and/or social (e.g. inability to work) 
factors.  Outcomes may be measured in the short-term and long-term.  There is 
no clear universal definition of ‘short-term’. For the purpose of this thesis ‘short-
term’ will refer to the duration of the inpatient stay.      
1.6.2 Death 
 
Surgical mortality has strengths as an outcome measure: it is easy to define 
and diagnose, accurate records of death are kept and it is a very important 
measure of outcome to both surgeons and patients alike.  When considering 
death rates over longer time scales, it is important to compare this to the 
‘background’ death rate of a similar population.  
 
A National Joint Registry in England and Wales was established in 2003.  It is 
now mandatory that data from all arthroplasty procedures be submitted to this 
registry. Mortality rates following primary hip arthroplasty according to the 2013 
report are 0.25% at 30 days (95% CI 0.24% - 0.26%), 0.51% at 90 days (95% 
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CI 0.50% - 0.53%) and 1.52% at 1 year (95% CI 1.49% - 1.56%).  Mortality 
rates following knee arthroplasty are 0.20% at 30 days (95% CI 0.19% - 0.21%), 
0.36% at 90 days (95% CI 0.34% - 0.37%) and 1.15% at 1 year (95% CI 1.12% 
- 1.17%). 
 
One drawback of mortality as a measure of outcome in comparative trials is its 
relative infrequency.   For most types of orthopaedic surgery it is not a useful 
comparative index: the event rate is so low that very large numbers of 
operations would have to be compared to demonstrate a meaningful difference 
in outcome.   
1.6.3 Length of hospital stay 
 
 
Length of hospital stay is sometimes used as a surrogate for clinical outcome.  
It is easy to define and is recorded accurately by most hospital systems.  The 
use of this measure as a surrogate marker of outcome is based on two 
assumptions: firstly, that all patients are discharged at same ‘point’ of recovery 
i.e. at a standard level of well-being; and secondly, that all patients who have 
reached this level of well-being are discharged.  It is well known that these two 
assumptions are not true and length of hospital stay is influenced by many 
factors other than the health status of the patient17,18. 
1.6.4 Post-operative morbidity 
 
Post-operative complications and morbidity following surgery are poorly 
recorded19.  The post-operative morbidity survey (POMS)20 was developed to 
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provide a true reflection of post-operative morbidity. It can be used to record 
general post-operative morbidity such as chest infection, urinary tract infection 
and pulmonary embolism as well as morbidity related to the surgical site such 
as wound infection. 
 
The POMS has been validated as a measure of post-operative morbidity21.  
During this validation process, the authors examined whether post-operative 
morbidity was a set of unrelated, disparate phenomena, or whether they were 
linked by a common underlying pathology.  It was thought that this pathology 
could be a mild variant of Multiple Organ Dysfunction Syndrome (MODS) 
resulting from a mild form of Systemic Inflammatory Response Syndrome 
(SIRS).  A low level of internal consistency was found between the POMS 
domains, suggesting that a single underlying pathology is not being measured.  
Therefore the POMS should not be used as a one-dimensional scale and a 
score derived from the summation of POMS domains is not valid.  
 
The POMS has been used to show that intra-operative gastric-to-end tidal 
carbon dioxide measurement may be a useful prognostic index of post-
operative morbidity22.  In another study, the POMS was used to find predictors 
of total morbidity burden on days 3, 5 and 8 after cardiac surgery23.  Pre-
operative albumin and haemoglobin levels, as well as weight, were found to be 
independently predictive of post-operative morbidity.  This suggests that 
interventions aimed to improve these pre-operatively may lead to reduced post-
operative morbidity and reduced health-care costs following cardiac surgery.  
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The POMS is also being used in a multicentre, prospective, blinded 
observational cohort study to investigate the effect of neoadjuvant 
chemotherapy and chemoradiotherapy on exercise capacity and outcome 
following upper gastrointestinal cancer surgery24.  The primary endpoints are 
physical fitness and one-year mortality following surgery.  Secondary endpoints 
are post-operative morbidity (assessed using the POMS on day 5) and patient 
related quality of life. 
 
The POMS was designed to identify morbidity of a type and severity that could 
delay discharge from hospital.  The data collection process is simple, allowing 
for routine screening of large numbers of patients.  The POMS assesses 
indicators of organ system dysfunction (e.g. inability to tolerate an enteral diet) 
rather than traditional diagnostic categories (e.g. deep vein thrombosis).  The 
survey assesses nine domains of morbidity (Table 3) using readily available 
data from observation charts, medication charts, patient notes, routine blood 
test results and direct questioning and observation of the patient.  The POMS 
requires no additional investigations.  The POMS has been shown to be 
reliable, valid and acceptable to patients21.   
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Table 3. Criteria for a positive POMS score 
 
Variable Criteria for positive result 
Pulmonary Requires supplementary oxygen or ventilatory support 
 
Infection Currently on antibiotics or temperature over 38°C in the 
last 24 hours 
 
Renal Oliguria (<500ml/day), elevated creatinine (>30% pre-op 
level), catheter in-situ (for non-surgical reason) 
 
Gastrointestinal Unable to tolerate enteral diet for any reason 
 
Cardiovascular Diagnostic tests or treatment within the last 24 hours for: 
myocardial infarction, hypotension (requiring 
pharmacological therapy or fluids >200ml/hour), 
atrial/ventricular arrhythmia or cardiogenic pulmonary 
oedema  
 
Central nervous 
system 
 
Presence of new focal deficit, coma, confusion, delirium 
Wound 
complications 
Wound dehiscence requiring surgical exploration or 
drainage of pus from operative wound with or without 
isolation of organisms 
 
Haematological Requirement of blood transfusion, platelets, fresh frozen 
plasma or cryoprecipitate within the last 24 hours  
 
Pain Wound pain requiring parenteral opioids or regional 
anaesthesia 
 
 
POMS has been used in outcomes25 and effectiveness research26.  In elective 
orthopaedic patients the POMS has shown that an increase in the revised 
cardiac index leads to an increase in non-cardiac post-operative morbidity27.  
The POMS has also shown that chronic kidney disease in orthopaedic patients 
leads to prolonged morbidity and increased hospital stay in a substantial 
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minority of patients28.  A further study uses the POMS to show that lower 
socioeconomic status in orthopaedic patients does not lead to increased post-
operative morbidity but does lead to a prolonged hospital stay with no morbidity 
present29.    
 
One study used the POMS to identify post-operative morbidity in a variety of 
surgical specialities30.  This study included 289 orthopaedic patients.  On post-
operative day 3 the most common forms of post-operative morbidity were pain 
(30.8%), pulmonary morbidity (30.1%), infection (26.6%), renal morbidity 
(24.9%) and gastrointestinal morbidity (20.1%). The incidence of morbidity 
decreased with time.  By post-operative day 15 the incidence of pain was 0.7%, 
pulmonary morbidity 1.7%, infection 7.6%, renal morbidity 1.0% and 
gastrointestinal morbidity 1.0%.  This heterogeneous group included both 
elective orthopaedic and trauma patients.  No further sub analysis of the data 
was performed. 
 
The relationship between short-term generic clinical outcome and long-term 
quality of life outcome is not yet understood.  One significant problem with 
quality of life measures is the time taken to collect data.  The POMS provides 
early post-operative information but it is unknown if there is any correlation with 
longer-term measures.  If short-term measures could predict longer-term quality 
of life, they could be used as early surrogate markers for longer-term function 
and well-being.  At present both short-term and long-term outcome measures 
are needed to assess the success of any intervention. 
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1.6.5 Surgical Site Infection 
 
 
Surgical site infection (SSI) is one form of post-operative morbidity.  It is a major 
risk in orthopaedic surgery.  SSI causes pain and can lead to wound 
dehiscence and generalized sepsis.  Further surgery and admission to intensive 
care may be necessary.  A patient with a SSI spends twice the average length 
of time in hospital31.  SSI is therefore not only distressing for the patient; it is 
also an economic burden for the health care provider. 
 
Superficial wound infection can spread to deeper tissues including bone.  A 
deep infection diagnosed within the first six weeks of primary joint replacement 
(hip or knee) is treated with repeated joint washouts, replacement of 
polyethylene components and intravenous antibiotics.  These interventions may 
be sufficient to eradicate the infection.  If a deep infection is diagnosed after the 
sixth post-operative week, revision joint replacement surgery is normally 
required (one-stage or two-stage) together with a prolonged course of 
intravenous antibiotics32.  If the infection cannot be eradicated, life-long 
antibiotics to suppress the infection, joint arthrodesis (fusion) or even limb 
amputation may be required.  
 
Wound surveillance in Orthopaedic Surgery became mandatory in the NHS in 
England in 2004.  Reported SSI rates depend on the method used for 
diagnosis, case mix, the thoroughness of surveillance and documentation and 
the length of patient follow-up.  Patient follow-up is essential in any wound 
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surveillance program since half of SSIs present after hospital discharge33.   
Therefore SSI rates cannot be defined as a ‘short-term’ outcome measure.  
Long-term follow-up of patients must be established to ensure true rates are 
reported.    
 
There is a misconception that SSIs are simple to define and diagnose.   Several 
definitions of SSI have been proposed and diagnosis varies between surgeons.  
Diagnosis cannot rely solely on microbiology results since this would delay the 
initiation of appropriate treatment.  There would also be false positive results 
from contaminants and false negative results when organisms fail to grow in the 
culture medium.   
 
SSIs were traditionally diagnosed using the hallmarks of pain (dolor), redness 
(rubor), heat (calor), swelling (tumor) and impairment of function.  As surgeons 
became increasingly accountable for their practice, more reliable and 
reproducible methods of diagnosing SSI became necessary.  Three SSI 
definitions in use today are the American Centres for Disease Control (CDC) 
definition, the English Nosocomial Infection National Surveillance Scheme 
(NINSS) definition and the English ASEPSIS definition. ASEPSIS is an acronym 
for Additional treatment, Serous discharge, Erythema, Purulent exudate, 
Separation of deep tissues, Isolation of bacteria and Stay as inpatient prolonged 
over fourteen days. 
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The CDC definition34 is used worldwide to classify wound infections.  It includes 
any wound infection within 30 days of surgery or one year if an implant is 
present.  The CDC definition divides SSIs into incisional and organ/space 
infections.  Incisional SSIs are further divided into superficial and deep 
infections (see table 4).  Although widely used, the CDC definition is weak since 
three out of the four diagnostic criteria are subjective.  On psychometric 
evaluation CDC has been shown to be unreliable35. 
Table 4. CDC definition of surgical site infection 
 
 Superficial infection 
(involving skin and superficial 
tissues) 
Deep infection 
(involving the fascial and 
muscle layers) 
 
Time period Occurs within 30 days of 
surgery 
Occurs within 30 days of 
surgery or within 1 year if 
implant present 
 
Site Involves only the skin and 
superficial tissue 
Related to the surgical site and 
involves deep tissues 
 
Further 
criteria 
Must fulfil one of the 
following: 
 Purulent discharge 
from superficial 
incision 
 Organisms isolated 
from incision 
 Pain, tenderness, 
swelling, redness or 
heat around the 
incision AND the 
incision deliberately 
opened by a surgeon 
(unless cultures are 
negative) 
 Diagnosis by a 
surgeon or physician 
 
Must fulfil one of the following: 
 Purulent discharge from 
deep incision 
 Spontaneous 
dehiscence or deliberate 
opening of a deep 
incision, following fever 
or pain or tenderness 
around the wound 
(unless cultures are 
negative) 
 Abscess involving a 
deep incision 
 Diagnosis by a surgeon 
or physician 
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The UK NINSS definition of SSI is based on CDC with two significant 
modifications. Firstly, pus cells must be present for a wound culture to be 
classified as positive.  Secondly, a surgeon’s diagnosis of infection is excluded 
as a sufficient criterion to diagnose SSI.  These changes were implemented to 
improve the objectivity of CDC but reproducibility of NINSS remains low36. 
 
ASEPSIS is a quantitative wound scoring method developed in 198637.  It 
provides a numerical score that indicates the severity of wound infection.  The 
score is calculated using objective criteria based on the wound’s physical 
appearance (e.g. erythema and serous exudate) and the clinical consequences 
of infection (e.g. prolonged hospital stay and readmission) (tables 5 and 6).  A 
score of over 10 indicates an increasing probability and severity of infection 
(table 7).   The original ASEPSIS scoring method was psychometrically tested 
and found to be objective and repeatable38.  The most recent revised version 
has not undergone the same evaluation. 
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Table 5. Points scale used to calculate ASEPSIS score 
 
Criterion Points 
Additional treatment Antibiotics 
 
10 
Drainage of pus under local 
anaesthetic 
 
5 
Debridement of wound under 
general anaesthetic 
 
10 
Serous discharge 
 
0-5 
Erythema 
 
0-5 
Purulent exudates 
 
0-10 
Separation of deep tissues 
 
0-10 
Isolation of bacteria 
 
10 
Stay in hospital over 14 days 
 
5 
 
Table 6. Point scale for ASEPSIS wound inspection score 
 
 
 
 
 
 Proportion of wound affected 
 
0% 
 
>0 -19% 20-39% 40-59% 60-79% 80-100% 
Serous exudate 0 
 
1 2 3 4 5 
Erythema 0 
 
1 2 3 4 5 
Purulent exudates 0 
 
2 4 6 8 10 
Separation of deep tissues 0 
 
2 4 6 8 10 
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Table 7. Interpretation of total ASEPSIS score 
 
ASEPSIS score Meaning 
0-10 No infection.  Normal healing. 
11-20 Disturbance of healing. 
21-30 Minor infection 
31-40 Moderate infection 
41 and over Severe infection 
 
Scoring methods provide more detailed and objective information regarding SSI 
than CDC and NINSS but they are more costly, complicated and time-
consuming to perform.  The average time taken to collect the data and calculate 
an overall ASEPSIS score is 59 minutes39.   
 
One of the domains for the POMS score is ‘wound infection’.  A positive result is 
defined as ‘wound dehiscence requiring surgical exploration or drainage of pus 
from operative wound with or without isolation of organisms’.  This definition 
could under-estimate the true wound infection rate.  The POMS ‘wound 
infection’ domain has not previously been compared to other definitions of 
surgical site infection to assess accuracy. 
1.6.6 Quality of life outcome measures 
 
Historically, the success or failure of an orthopaedic intervention was assessed 
and reported by the operating surgeon.  This trend is now changing with greater 
emphasis on Patient Reported Outcome Measures (PROMs).  There are 
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several PROMs available.  They fall into one of three broad categories: generic, 
disease-specific and joint-specific.  Generic surveys aim to investigate all 
aspects of quality of life and can be used to assess any medical or surgical 
intervention.  Disease-specific tools concentrate on disability relating to a 
particular condition and aim to elucidate the impact of a single disease entity on 
a patient’s quality of life.  Joint-specific tools are used to assess the impact of 
one particular joint on the patient’s quality of life.  This thesis concentrates on 
patient outcome following hip and knee joint replacement surgery (arthroplasty).  
Therefore, hip-specific and knee-specific assessment tools will be described 
later in this section. 
 
Analysis of PROMs data has traditionally been performed at the group level.  
Many recent studies have focused on individual patient reported outcomes.  
Individuals can be assessed in two ways: by responder criteria or by state-
attainment criteria.  With responder criteria, each patient is classified as a 
responder or a non-responder to treatment based on whether the change in 
health status exceeds a pre-defined threshold.  With state-attainment criteria, a 
patient is classified not on the basis of change, but on whether a certain level of 
low symptom severity is attained.  Research in both areas is experimental but 
may provide more relevant results than group level studies. 
1.6.6.1 Generic quality of life outcome measures 
 
Generic PROMs aim to assess all dimensions of health-related quality of life.  
The World Health Organization Quality of Life Group has recommended that 
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5 dimensions are assessed in any generic quality of life survey: physical health, 
psychological health, social relationship perceptions, function and well-being.  
Commonly used generic PROMs in orthopaedic literature include the Medical 
Outcomes Study 36-Item Short Form Health Survey (SF-36), the Medical 
Outcomes Study 12-Item Short Form Health Survey (SF-12), the Nottingham 
Health Profile (NHP) and the European Quality of Life 5-Dimension (Euroqol) 
questionnaire.   
1.6.6.1.1 The Medical Outcomes Study 36-Item Short Form Health  
Survey (SF-36) 
 
SF-36 is a multi-purpose questionnaire used to measure general health 
status40.  It was originally developed in American English.  A United Kingdom 
English version is now available.  The questionnaire refers to health over the 
previous 4 weeks but a more acute version that refers to health over the 
previous week is available.  The questionnaire contains 36 questions each of 
which has between 2 and 6 answers.  Each answer is awarded a score of 
between 0 (indicating poor health) and 100 (indicating good health).  The 
questions are grouped into one of eight health concepts: bodily pain (BP), 
physical functioning (PF), role limitations due to physical health (RP), general 
health (GH), mental health (MH), vitality (VT), social functioning (SF) and role 
limitations due to emotional health (RE).  There is also a health transition 
question that does not contribute to any of the 8 domains. 
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The 8 health concepts can be further amalgamated into 2 higher order groups.  
These are known as the Physical Component Summary (PCS) and the Mental 
Component Summary (MCS).  The PCS is calculated from the BP, PF, RP and 
GH scores.  It is most responsive to treatments that alter physical symptoms 
such as hip arthroplasty.   The MCS is calculated from the MH, VT, SF and RE 
scores and is most responsive to drugs and therapies that target psychiatric 
disorders.  Three of the scales (VT, GH and SF) have significant correlation with 
both the physical and mental summary measures. 
 
SF-36 takes approximately 10 minutes to complete.  It is proven to be suitable 
for self-administration, computerized administration or administration by an 
interviewer either in person or by telephone.  Scores are calculated by 
summated ratings and standardised SF-36 algorithms.  Individual question 
scores are summated without standardisation or weighting.  Standardisation is 
avoided by using questions with roughly similar means and standard deviations, 
and weighting is avoided by selecting equally representative questions. 
 
SF-36 has been evaluated in several studies.  It is proven to be valid and 
reliable41,42, sensitive and reproducible40.  It has been used in over 4,000 
publications assessing over 200 different diseases.  SF-36 has been specifically 
investigated in patients undergoing hip arthroplasty where it was shown to be 
both valid43 and reliable44.  However, these studies also showed that SF-36 has 
minor ‘floor’ and ‘ceiling’ effects45,46.  ‘Floor’ effect refers to the situation where a 
questionnaire is unable to measure a negative value that is lower than the 
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range provided in the choice of answers.  In this situation, if a patient reports the 
lowest value for a question and then deteriorates further, the deterioration will 
not be detected by the questionnaire.  ‘Ceiling’ effect refers to the opposite 
situation, where a questionnaire is unable to measure a positive value that is 
higher than the range provided in the choice of answers.  In this situation, if a 
patient reports the highest value for a question and then improves, the 
improvement will not be detected by the questionnaire. 
1.6.6.1.2 The Medical Outcomes Study 12-Item Short Form Health  
Survey (SF-12) 
 
 
SF-1247 is an abridged version of SF-36 containing 12 out of the 36 questions.  
SF-12 questions can be amalgamated to produce profiles of the eight SF-36 
health concepts but only if the sample size is sufficiently large.  SF-12 scores 
are calculated using weighted algorithms (i.e. the questions in SF-12 contribute 
different values to the overall score, unlike SF-36) and a computer program is 
available for this calculation. 
 
The main advantage of SF-12 over SF-36 is that it is shorter.  It is therefore 
quicker for patients to complete and quicker for research personnel to record 
and analyse data.  A disadvantage is that a computer program is necessary for 
scoring each survey.  A further disadvantage of SF-12 is that it has less 
construct validity and sensitivity than SF-36, producing less precise scores for 
the 8-scale health profile47.  This is less important in large group studies since 
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the confidence intervals are largely determined by sample size but could result 
in insignificant findings in smaller studies.   
1.6.6.1.3 Nottingham Health Profile (NHP) 
 
The Nottingham Health Profile (NHP) is a self-administered questionnaire that 
takes 5 to 10 minutes to complete.  It was developed in United Kingdom English 
and consists of 2 parts.  Part I contains 38 'yes/no' items covering 6 dimensions: 
pain, physical mobility, emotional reactions, energy, social isolation and sleep.  
Part II contains 7 'yes/no' questions concerning activities of daily living.  Each 
part is scored using weighted values giving a score of 0 (no problems at all) to 
100 (presence of maximal problems).  The two parts can be used 
independently.  The NHP is proven to be internally consistent, valid, 
reproducible and sensitive48.  No psychometric analysis of the NHP has been 
performed on patients undergoing hip or knee arthroplasty. 
 
Overall, the NHP has one major disadvantage when compared to SF-36 
concerning the response format.  The NHP uses dichotomous 'yes/no' 
responses, where as SF-36 has several choices for each response.  This allows 
the SF-36 to detect positive as well as negative states of health.  The NHP often 
explores only ill health.  A patient with an initial acceptable NHP score who 
makes an obvious clinical improvement may fail to show a change in the NHP 
score.  Furthermore, a false negative response is more likely with the NHP 
when a patient with good function must respond on a scale that only assesses 
dysfunction.  The dichotomous NHP response format produces higher 'ceiling' 
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effects in all dimensions when compared to SF-3649.  They both have equal 
minor 'floor' effects. 
1.6.6.1.4 EuroQol 
 
The EuroQol (EQ-5D)50 questionnaire contains 2 pages.   There are 15 
questions on the first page regarding 5 aspects of general health: mobility, self-
care, usual activities, pain and depression.  Each question has 3 possible 
answers: ‘no problem’, ‘moderate problem’ or ‘extreme problem’.  The second 
page of EuroQol aims to elucidate the overall health of the patient.  It contains a 
visual analogue scale with 0 indicating the worst possible health and 100 
indicating the best possible health.  
 
EuroQol was designed to be self-administered and takes 5 minutes to complete.  
It has been shown in studies to be both valid51 and reliable52.  However, 
EuroQol suffers from ‘ceiling’ effects due to the restricted response format.  This 
effect is partially overcome by the use of the visual analogue scale on the 
second page.  There is limited psychometric analysis of the questionnaire in 
patients undergoing hip and knee arthroplasty.  Test-retest reliability has been 
shown53 and there is some evidence of construct validity and responsiveness54.   
1.6.6.2 Disease-specific quality of life outcome measures 
 
Disease-specific PROMs provide patient-centred information about a particular 
disease.  This allows comparison of different surgical and medical treatment 
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options for that particular disease entity.  They can be used in both research 
and clinical practice.   
 
PROMs commonly used to assess hip and knee arthritis are the Western 
Ontario and MacMaster Universities (WOMAC) Osteoarthritis Index and the 
Arthritis Impact Measurement Scales (AIMS).  These measures are specific for 
arthritis and can be used to assess any joint and any intervention.   
1.6.6.2.1 The Western Ontario and MacMaster Universities  
(WOMAC) Osteoarthritis Index 
 
The WOMAC Index was developed in Canadian English for patients with 
osteoarthritis55.  The original version contained 5 subscales (WOMAC 5.0) but 
only three of these were retained for further development (WOMAC 3.0).  
Globalisation of WOMAC resulted in several refinements and the production of 
WOMAC 3.1.  This has been the standard form of the Index for several years.  It 
is self-administered and contains 24 questions covering three dimensions: pain, 
stiffness and physical function.  Other versions of the Index are available with 
differing numbers of questions and dimensions to meet different measurement 
needs.  The standard version uses a 48-hour timeframe but the Index is 
sufficiently robust to tolerate a variation in timescale of 24 hours to 1 month.  
The WOMAC Index is available in a 5-point Likert, 100mm visual analogue and 
11-point numerical rating format.   
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The WOMAC Index is valid, reliable, responsive, easy to complete and simple 
to score56.  It has been used in several hundred publications and has been 
translated and linguistically validated in over 65 languages.  Most clinical 
research uses the Likert and visual analogue versions of WOMAC 3.1.  
WOMAC has been extensively evaluated in patients undergoing hip arthroplasty 
where it has been shown to be responsive57, have high internal consistency and 
acceptable test-retest reliability58.    However, it shows post-operative ceiling 
effects for the pain and stiffness subscales in patients undergoing hip 
arthroplasty59, the same as with SF-36 and Euroqol.  One study showed 
WOMAC to be superior in responsiveness to generic outcome measures60 but 
disease-specific and generic outcome measures are generally used for different 
purposes.  The use of both instruments together provides more information than 
using either individually.  
1.6.6.2.2 The Arthritis Impact Measurement Scale (AIMS) 
  
The Arthritis Impact Measurement Scale (AIMS)61 was developed in American 
English to measure outcome in patients undergoing treatment for rheumatic 
disease.  It has since been shown to be sensitive to clinical improvement in 
patients with osteoarthritis.   
 
AIMS 262 is a modified version of the original AIMS, developed in American 
English. It was designed to be self-administered and takes 20 minutes to 
complete.   The questionnaire contains 78 questions exploring 12 concepts: 
mobility, walking and bending, hand and finger function, arm function, self-
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care tasks, household tasks, social activity, support from family and friends, 
arthritis pain, work, level of tension and mood.  The scores of each question 
within a health concept are simply added.  The range of scores for each 
concept depends upon the number of questions it contains.  In order to express 
each scale in the same units, a normalization procedure is performed so that 
each concept is expressed as a value from 0 to 10 with 0 representing good 
health status and 10 representing poor health status.   
 
The 12 concepts can be combined into 3 or 5 component models of health 
status.  The 3-component model groups the concepts into general categories of 
physical function, psychological status and pain.  The 5-component model 
combines the concepts into measures of lower limb function, upper limb 
function, affect, symptoms and social interaction.  AIMS2 has been 
psychometrically evaluated and been shown to be both valid and reliable61.   
 
A further version of AIMS has been produced specifically for patients 
undergoing hip arthroplasty63.  This questionnaire consists of 57 items that are 
scored and weighted to produce 4 subscales: physiologic function, self-concept, 
role function and interdependence.  Responsiveness, content and construct 
validity have been proved for this version of AIMS63 but reliability and other 
forms of validity remain unproven. 
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1.6.6.3 Joint-specific outcome measures 
 
Historically, the operating surgeon assessed outcome following hip and knee 
arthroplasty.  For hip surgery, tools such as the Harris Hip Score64 and Charnley 
Score65 were used.   For knee surgery, the American Knee Society Score66 and 
the Bristol Knee Score67 were used.  These scores were derived from clinical 
and radiological data and ultimately depended on the judgment of the surgeon.  
Patients and surgeons often differ in opinion68 and it became apparent that 
methods were needed to elicit the patient's perception of their surgery.  This 
lead to the design of joint-specific PROMs.  For the hip, the Oxford Hip Score 
(OHS)69, the Hip disability and Osteoarthritis Outcome Score (HOOS)70 and 
University of California at Los Angeles (UCLA) hip score71 were developed.  For 
the knee, the Knee disability and Osteoarthritis Outcome Score (KOOS)72 and 
the Oxford Knee Score (OKS)73 were devised.  These measures are commonly 
used in orthopaedic literature.  This creates a problem when different PROMs 
are grouped together in meta-analyses.  The heterogeneity of the responses 
may create bias and result in incorrect conclusions being drawn74. 
1.6.6.3.1 Harris Hip Score 
 
The Harris Hip Score64 was developed in American English as a means of 
assessing patients following hip arthroplasty.  The assessment is made up of 8 
questions and a physical examination.  The questions cover 3 dimensions:  pain 
(with a maximum score of 44), function (with a maximum score of 33) and level 
of activity (with a maximum score of 14).  The physical examination assesses 
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hip range of motion and a maximum of 9 points can be awarded.  The point 
score in each section are summated to give a maximum possible score of 100.  
A score of 90-100 is ‘excellent’, 80-89 is ‘good’, 70-79 is ‘fair’, 60-69 is ‘poor’ 
and a score of less than 60 is a ‘fail’. 
 
The original version of the assessment was performed entirely by the surgeon.  
This has now been modified to create a PROM.  This contains 7 questions 
regarding hip pain, walking aids, limping, walking distance, climbing stairs, 
putting on socks and shoes, and sitting.  Each question has between 3 and 7 
answers that are expressed on a Likert-type scale.  The scores from each 
question are summated to give a total score of between 0 and 100, where 0 
represents the best result.  The Harris Hip Score was found to be both valid and 
reliable in the assessment of outcome of total hip replacement75. 
1.6.6.3.2 Charnley Score 
 
Devised in 1972 in the United Kingdom, the Charnley Score65 grades hip pain, 
mobility and walking on a 6-point scale.  Walking is only assessed in patients 
who have no other condition that may affect their walking ability.  The surgeon 
performs the assessment.  Lower scores indicate greater disability.  Scores for 
different treatment groups can either be averaged or state-attainment criteria 
can be used where the number of patients scoring 5 or 6 in each group can be 
compared. 
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This assessment is simple to perform but reflects the opinions of both the 
surgeon and the patient.  There is little psychometric testing of the Charnley 
Score to support its use. 
1.6.6.3.3 Oxford Hip Score 
 
The Oxford Hip Score (OHS)69 is a joint-specific PROM designed to assess 
disability in patients undergoing total hip replacement.  The survey was 
developed in the United Kingdom and takes approximately 5 minutes to 
complete.  It assesses the patient’s health over the previous 4 weeks.  
  
The OHS contains 12 questions each with 5 Likert-type response choices.  The 
questions assess pain and functional ability from the patient's perspective.   The 
overall score ranges from 12-60 with a higher score indicating increasing 
disability. 
 
The psychometric properties of the OHS have been rigorously examined.  It has 
been used extensively in orthopaedic literature and is highly sensitive to 
patients undergoing primary total hip replacement59 and revision total hip 
replacement76.  The OHS is internally consistent, reproducible and valid77. 
1.6.6.3.4 The Hip Disability and Osteoarthritis Outcome Score 
 
The Hip disability and Osteoarthritis Outcome Score (HOOS)70 is a 40-item 
PROM based on the Knee disability and Osteoarthritis Outcome Score (KOOS).  
The questionnaire is self-administered and takes 8-10 minutes to complete.   
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Each question has 5 possible answers and is scored 0 - 4.  The questions are 
grouped into 5 subscales: pain, other symptoms, activities of daily living, sport 
and hip related quality of life.  The score for each subscale is simply the sum of 
the individual question scores.  HOOS is then transformed onto a 0 - 100 scale 
with 100 indicating the best possible outcome.  
 
HOOS contains all the WOMAC Likert 3.0 questions in an identical form so can 
also be used to calculate WOMAC scores.  HOOS has been shown to be both 
valid and responsive and 2 of the subscales (pain and other symptoms) have 
been shown to be more responsive than WOMAC70. 
1.6.6.3.5 The University of California at Los Angeles Hip Scale 
 
The University of California at Los Angeles (UCLA) hip scale71 is a PROM that 
has been routinely used to assess post-operative outcome in arthroplasty 
patients.  More recently it has been used to assess hip arthroscopy outcome. 
 
The scale explores 4 dimensions: pain, walking, function and activity.  There are 
10 points on the scale with 10 indicating the best outcome and 1 indicating the 
worst.  There is little psychometric evidence in the literature validating the UCLA 
hip scale following arthroplasty, but many studies still use it as a measure of 
outcome. 
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1.6.6.3.6 The American Knee Society Score 
 
The American Knee Society Score (AKSS)66 consists of 2 parts.  The first part is 
a knee score that considers pain, stability and range of movement.  The 
maximum number of points available for this section is 100 for a well-aligned 
knee with no pain, 125º of flexion and negligible antero-posterior and medio-
lateral instability.  There are point deductions for flexion contractures, extension 
lag, pain, limited range of motion, instability and mal-alignment. 
 
The second part of the AKSS is a function score that utilises walking distance 
and stair climbing as its main parameters.  The maximum score is 100.  This is 
given to those who can walk an unlimited distance unaided and ascend stairs 
normally.  There are point deductions for walking and stair-climbing limitations 
and the use of walking aids. 
 
The AKSS puts patients into 1 of 3 categories: those with no contra-lateral knee 
disease; those with contra-lateral knee disease; and those with multiple joint 
disease.  The AKSS is designed so the knee score is independent of other joint 
disease, but the function score can be influenced by pathology in other joints.  
The AKSS has been shown to be sensitive78, and have high inter- and intra-
observer reliability79.     
1.6.6.3.7 The Bristol Knee Score 
 
The Bristol Knee Score consists of 4 subscales: pain, function, movement and 
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deformity.  There is a maximum score of 15 for pain, 20 for function, 10 for 
range of movement and 15 for deformity.  A total score of 41-50 is deemed 
‘excellent’, a score of 36-40 ‘good’, 30-35 ‘fair’ and a score of less than 30 
‘poor’.  The Bristol Knee Score is not widely used in the literature and there are 
no validation studies for its use following arthroplasty.  
1.6.6.3.8 The Knee disability and Osteoarthritis Outcome Score 
 
The Knee disability and Osteoarthritis Outcome Score (KOOS)72 was developed 
as an extension of the WOMAC index to evaluate short-term and long-term 
symptoms and function in patients with knee injury and osteoarthritis.  It was 
developed at Lund University, Sweden and the University of Vermont, USA.   
American English and Swedish versions were developed simultaneously.  The 
score is made up of 5 subscales:  pain (9 items), other symptoms (7 items), 
function in daily living (17 items), function in sport and recreation (15 items) and 
knee-related quality of life.  KOOS has been validated in patients undergoing 
total knee replacement80.  The questionnaire has been modified for the foot and 
ankle (FAOS) and the hip (HOOS). 
 
KOOS is self-administered and takes approximately 10 minutes to complete.  A 
Likert-type scale is used for all answers.  There are 5 answer options ranging 
from 0 (no problems) to 4 (extreme problems).  Scores are transformed to a 0-
100 scale with 0 representing extreme problems and 100 representing no 
problems.  An aggregate score is not calculated since the 5 dimensions do not 
measure the same entity and therefore the 5 dimensions must be considered 
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separately.  KOOS has been shown to be valid81, sensitive to change82 and 
responsive72. 
1.6.6.3.9 Oxford Knee Score 
 
The Oxford Knee Score (OKS) was devised in the United Kingdom 73.  It 
consists of 12 questions, each of which has a choice of 5 answers.  Each 
question was originally scored from 1 to 5, with 1 representing the best outcome 
and 5 the worst.  This gave an overall possible score of 12 to 60 with 12 
representing the best outcome.   
 
This scoring system was deemed too confusing, so now each question is 
scored from 0 to 4 with 4 representing the best possible outcome.  This gives an 
overall possible score of 0 to 48 with 48 representing the best possible score.   
 
The OKS has been shown to be short, practical, reliable, valid and sensitive to 
change83.  However, it is also influenced by proximal pathology such as hip or 
spine problems84. 
1.7 The use of Outcome Measures as Bed  
Utilisation Tools 
 
 
Appropriately timed discharge of patients following surgery is essential for 
optimal patient care and efficient hospital functioning.  A patient that is 
discharged too early is at risk of under-diagnosis of post-operative morbidity 
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with consequent adverse outcome.  A patient whose discharge is delayed is at 
risk of developing a hospital-associated complication (e.g. hospital-acquired 
infection) and incurs an unnecessary cost to the health-care provider.  Post-
operative patients should be discharged at the earliest safe opportunity to 
reduce such complications and minimise the cost of each inpatient episode.  
Appropriate discharge timing should increase the throughput of patients and 
reduce waiting times.    
 
Many patients remain in hospital with no medical indication18.  One study 
showed that 31% of post-operative patients remained in hospital 
inappropriately85.  Payment by Results aims to reduce this figure by rewarding 
efficiency and encouraging increased activity. 
 
In order to improve efficiency, hospitals must first recognise inappropriate bed 
occupancy.  The Post-Operative Morbidity Survey (POMS)21 is the only 
validated prospective method of measuring short-term post-operative morbidity 
in the literature.  The POMS was designed to identify morbidity of a type and 
severity that could delay discharge from hospital.   
 
The most commonly used tool to assess appropriate bed utilisation in the 
literature is the Appropriateness Evaluation Protocol (AEP)86.  The AEP is a 
retrospective tool that relies on data from the inpatient record.  It has been 
shown to be valid and reliable in some studies86 but not in others87.  The POMS 
is a prospective tool that could be used in real time to assist with appropriate 
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patient discharge.  This is in contrast to the AEP, which is a retrospective tool 
that can only be used to evaluate past events.  Data for the POMS is collected 
directly from contemporary data sources during the inpatient stay where as the 
AEP relies solely on past patient records and is therefore dependent on 
completeness and accuracy of record keeping for reliable functioning. 
 
The AEP has been used in several European countries to examine bed 
utilization88 89 90 91.  In the USA, over 98% of post-operative inpatients had 
morbidity defined by the POMS21.  This implies that patients with a POMS score 
of zero are fit for discharge.  Therefore, as well as providing useful clinical 
research and audit data, the POMS may have utility for assessing and 
improving hospital bed utilisation. 
1.8 Validation of outcome measures 
 
 
Outcome measures must fulfil certain psychometric criteria to be good 
descriptors of clinical or quality-of-life phenomena.  They must be reliable, valid 
and sensitive to change.  They should be acceptable to patients, simple, easy to 
use and score, and preferably short. 
 
Reliability is a term used inconsistently in the literature.  It is a measure of the 
degree to which subjects can be distinguished from each other.  It can be 
defined as the ratio of the variance between subjects to the total variance.  A 
reliability value of zero indicates a completely unreliable measure and a 
reliability value of one indicates a perfectly reliable measure.   
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Reliability is dependent on the relationship between the measurement error and 
the variability between subjects.  Therefore, internal consistency and 
reproducibility are both components of reliability.    Internal consistency 
determines whether a survey measures a single variable. The test used to 
measure internal consistency is Cronbach's alpha92.  This summarizes the 
internal correlation of all questions in a survey onto a single scale.  The higher 
the alpha coefficient, the greater the likelihood the questionnaire is tapping into 
a single variable and is free from random error.   
 
Reproducibility investigates if a questionnaire produces the same results if 
repeated under the same conditions.  Inter-observer reliability (agreement 
between two or more observers on the same occasion), intra-observer reliability 
(same observer on separate occasions), and test-retest reliability (stability of the 
measure over time in the same subject) are all aspects of reproducibility.  
Paired sets of data can be compared using the kappa coefficient or the 
coefficient of reliability according to the method of Bland & Aitman93.  A higher 
coefficient indicates a more reproducible questionnaire. 
 
Validity examines whether a questionnaire measures what it purports to 
measure.  Several types of validity exist: content and face validity, criterion 
(convergent/concurrent) validity and construct validity.  Face and content 
validity assess whether a survey fully investigates the intended topic of interest.  
Content validity can be increased by conducting exploratory interviews with 
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patients prior to writing the questionnaire.  This will elucidate the priorities and 
concerns of patients rather than imposing clinical assumptions.  Face and 
content validity are subjective measures with no statistical methods to assess 
them.   
 
Criterion validity examines how a new measure relates to an established “gold 
standard” in the field.  This approach can only be used when a “gold standard” 
exists which begs the question of why a new measure is being developed.  For 
measures where no “gold standard” exists, construct validity examines the 
extent to which the results from the questionnaire support a predefined 
hypothesis.  It can be measured using Pearson correlation coefficients between 
the total score for the questionnaire and other measures considered to be 
associated with the underlying notion being investigated.  
 
Construct validity investigates if a single concept is being measured by the 
questionnaire.  If construct validity is proven, scores can be combined to 
produce one overall score.  Construct validity is tested by calculating the 
correlation between scale scores.  
 
Sensitivity to change or responsiveness indicates whether the survey is able to 
detect clinically significant changes.   It can be assessed by comparing outcome 
scores before and after an intervention and can be defined as the difference 
between the mean preoperative and post-operative scores divided by the 
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standard deviation of the preoperative scores.  An effect size of one is equal to 
a change of one standard deviation in the sample. 
1.9 Plan of investigation 
 
This research project begins with an observational cohort study investigating 
morbidity following hip and knee arthroplasty.  It describes the prevalence and 
pattern of post-operative morbidity for different types of hip and knee 
arthroplasty.  It investigates whether there is any difference in post-operative 
morbidity between the different arthroplasty groups.   
 
This initial study revealed that many post-operative arthroplasty patients 
remained in hospital with no apparent morbidity.  This led me to consider the 
use of the POMS as a bed utilisation tool and its ability to identify inappropriate 
bed occupancy following hip and knee arthroplasty. The number of 
inappropriate bed occupancy days for each type of arthroplasty is presented 
together with the potential cost saving if patients with no morbidity were 
discharged at the earliest opportunity.  The reasons patients remained in 
hospital with no identifiable morbidity are reported.  Particular attention is given 
to 2 groups of patients: those who developed morbidity following a period with 
no morbidity and patients re-admitted to the same hospital within one year of 
surgery.  Inappropriate bed utilisation rates are compared to other bed 
utilisation studies.   
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After assessing the utility of the POMS as a bed utilisation tool, I went on to 
assess whether it could act as an early surrogate marker for patient–reported 
outcome measures (PROMs).  One disadvantage of PROMs is the time taken 
to collect and analyse data. If an earlier surrogate marker for long-term PROMs 
could be found, operative and peri-operative procedures could be assessed 
more quickly.   At present there is no evidence that morbidity is associated with 
longer-term patient reported outcome.  I decided to investigate whether there is 
any association between POMS results in the early post-operative period and 
PROMs scores at 18 months post-surgery.  Traditionally, length of hospital stay 
has been used as an early marker of the success of a procedure.  I decided to 
also examine whether there is any association between length of hospital stay 
and PROMs scores to justify its use for this purpose.   
 
At the same time as investigating the POMS, I was given access to surgical site 
infection data on all trauma and orthopaedic inpatients at the same institution.  
Surgical site infection data was available on the entire study population in the 
POMS study.  I decided to compare the ‘wound’ domain of the POMS to the 
ASEPSIS score.  ASEPSIS is a validated measure of surgical site infection.  I 
calculated the sensitivity, specificity, positive predictive value, negative 
predictive value and overall accuracy of the ‘wound’ domain of the POMS 
compared to the ASEPSIS score. 
 
Discrepancies between the ‘wound’ domain of the POMS and the ASEPSIS 
score led me to consider how reliable and comparable other methods of 
  
 
 
 
 
 
 
60 
diagnosing wound infection are.   I decided to assess if three commonly used 
methods of diagnosing surgical site infection (CDC, NINSS and ASEPSIS) 
report similar rates of infection in the same series of patients. Different 
institutions use different methods to assess SSI.  If published SSI rates are to 
be meaningful, different definitions of SSI must give similar values to ensure 
that comparisons between surgeons and hospitals are fair. 
 
1.10 Summary 
 
 
1. Outcome measures evaluate the benefits and risks of surgery. 
2.  Outcome measures are necessary for research and audit purposes and 
to guide patients in their choice of surgeon and institution. 
3. The routine collection and reporting of outcome measures started in the 
UK in 2000 and has gradually evolved over the last fourteen years. 
4. Quality of surgery can be classified in different ways.  Quality is 
commonly divided into three dimensions: structure, process and 
outcome.  The Department of Health divided quality into three different 
dimensions: safety, effectiveness and expectation. 
5. When interpreting outcome data, adjustment must be made for patient 
risk factors.  Two commonly used risk adjustor scores in orthopaedic 
literature are ASA-PS and POSSUM. 
6. Post-operative outcome measures include mortality rates, morbidity rates 
and patient-reported outcome measures. 
7. The Post-Operative Morbidity Survey is the only validated measure of 
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post-operative morbidity in the UK.  It recognises morbidity of a severity 
that prevents discharge from hospital.  As such, it may have utility as a 
bed utilisation tool. 
8. Quality of life outcomes can be subdivided into generic measures, 
disease-specific measures and joint-specific measures.  They can be 
reported by surgeons or patients.  Patient-reported measures are less 
prone to bias. 
9. Outcome measures must be psychometrically evaluated to ensure they 
are reliable, valid and sensitive to change.   
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Chapter 2 Post-operative morbidity in  
Orthopaedic Patients 
 
2.1 Introduction 
 
 
In this chapter I will report results from a prospective observational cohort study 
investigating morbidity following hip and knee arthroplasty.  In the introduction I 
will describe the common types of hip and knee arthroplasty including hip 
resurfacing, partial knee replacement, total joint replacement and revision joint 
replacement.  I will report how morbidity is described in comparative 
arthroplasty studies.  
 
I will then proceed to describe the methodology of this cohort study.  I will 
describe the study setting, the study population, the data collection process and 
data analysis.  The same methodology and data is used for the bed utilisation 
analysis presented in Chapter 3. 
 
Following this I will present the results.  I will describe the characteristics of the 
study population.  I will report the prevalence and pattern of post-operative 
morbidity for each type of arthroplasty.  Statistical analysis will assess if there is 
any difference in morbidity between the different arthroplasty groups.   
 
I will conclude with a summary and discussion of the findings.  I will compare 
my results to other reports of morbidity following arthroplasty in the literature.  
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I will comment on the limitations of the study and suggest areas for further 
investigation.  
2.1.1 Reporting of morbidity following arthroplasty in 
peer-reviewed journals 
 
Morbidity following major surgery is inconsistently and poorly reported in the 
literature94.  In some randomised controlled trials comparing joint prostheses, 
reported in peer-reviewed journals, there is no mention of post-operative 
morbidity95.  However, this is unusual and most trials make an attempt to report 
‘post-operative complications’96.  These complications usually refer to joint 
specific problems such as dislocation or deep prosthetic infection rather than 
morbidity in other organ systems e.g. the respiratory or cardiovascular systems. 
 
There is no consistency in the reporting of post-operative morbidity in 
orthopaedic literature.  Papers report different events as a ‘complication’ and 
different time-scales are used.  One complication may be reported in one paper, 
and a different complication in another paper.  This makes direct comparisons 
between papers both inaccurate and misleading.  
 
The CONSORT (Consolidated Standards of Reporting Trials) statement97 
provides a standardised framework for randomised controlled trials.  There is 
evidence that this framework improves the standard of randomised controlled 
trials but the majority of surgical research does not adhere to it98.  An extension 
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to the CONSORT statement99 suggests that data regarding ‘harm’ should be 
reported.  A standardised definition of ‘harm’ should be used and the method of 
collecting ‘harm’ data should be clearly reported.  The statement emphasised 
that the personnel performing the assessment should be identified and the 
frequency and time frame of data collection reported.  At present, the only 
validated method of recording post-operative ‘harm’ is the Post-Operative 
Morbidity Survey (POMS)21.  The POMS has not previously been used to 
describe and compare morbidity between different types of hip and knee 
arthroplasty. 
2.1.2 Types of arthroplasty  
 
‘Arthroplasty’ is an alternative word for joint replacement.  Joint replacements 
are usually performed for arthritis: osteoarthritis and inflammatory arthritis.  
There are more rare indications such as metabolic bone disease, post-traumatic 
arthritis, avascular necrosis and tumour.  Arthroplasty is usually performed 
when a patient has significant joint pain, not relieved with simple analgesia, that 
is affecting their activities of daily living. 
 
This study looks at three types of hip arthroplasty (hip resurfacing, total hip 
replacement and revision total hip replacement) and three types of knee 
arthroplasty (unicondylar knee replacement, total knee replacement and 
revision total knee replacement).  A brief description of each type of arthroplasty 
is given below. 
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2.1.2.1 Hip resurfacing 
 
 
Hip resurfacing involves placing a metal cap over the head of the femur and a 
metal lining in the acetabulum (Images 1 and 2). The articular bearing surface is 
metal-on-metal.  Resurfacing evolved as an alternative to total hip replacement 
with several perceived advantages.  Firstly, there is restoration of normal 
anatomy allowing for a good range of hip motion and a stable joint with a low 
chance of dislocation.  Secondly, there is preservation of more femoral bone 
than in total hip replacement.  This can make revision surgery easier in the 
future.  
Image 1. Photograph of hip resurfacing implant 
 
Image 2. X-ray showing hip resurfacing implant 
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There are several risks associated with hip resurfacing and patient selection 
and counselling are very important.  Hip resurfacing should only be performed 
on young patients with no evidence of osteoporosis and no bone cysts in the 
femoral neck.  This reduces the risk of femoral neck fracture.  The success of 
hip resurfacing is not only dependent on patient-factors but also on surgeon-
factors.  The outcome of surgery is highly dependent on the operating surgeon’s 
experience100 and also on correct alignment of the implants101. 
 
 There have been recent controversies regarding hip resurfacing.  High levels of 
metal ions have been found in some patients’ blood102.  It has been 
hypothesised this may lead to an increased risk of cancer but at present there is 
no evidence to support this103.   The formation of ‘pseudotumours’ due to an 
immune-mediated response has also been reported104.  These tumours destroy 
soft tissue including muscle around the hip joint making revision surgery very 
difficult.  These problems have lead many surgeons to abandon hip resurfacing 
over the last two years. The National Joint Registry shows that the failure rate of 
resurfacing implants at 7 years following surgery is 11.81%105. 
2.1.2.2 Total hip replacement 
 
 
Total hip replacement is the most commonly performed orthopaedic procedure 
and generally improves both hip pain and mobility106.  It involves replacement of 
the entire femoral head and replacement of the acetabulum.  The prosthetic 
head is attached to a stem that is inserted into the femoral shaft.  
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Total hip implants can be cemented into bone or an uncemented technique can 
be used.  Uncemented components are coated in an osteoconductive layer 
(hydroxyapetite) to encourage bony ingrowth.  There are 3 commonly used 
bearing surfaces (the articular surfaces on the femoral head and acetabulum): 
metal-on-polyethylene (Images 3 and 4), metal-on-metal and ceramic-on-
ceramic.  They vary in their wear properties and longevity.  Metal-on-metal total 
hip replacements have recently become less popular due to the same problems 
encountered with metal-on-metal hip resurfacing. 
 
The National Joint Registry reports an overall failure rate of 3.08% for cemented 
implants at 7 years following surgery and a failure rate of 5.46% for uncemented 
implants at 7 following surgery105. 
Image 3. Photograph of metal femoral component of a total hip 
replacement  
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Image 4. X-ray showing metal-on-polyethylene total hip replacement 
 
 
2.1.2.3 Revision total hip replacement 
 
 
Revision total hip replacement is performed for failure of a primary total hip 
replacement.  There are many reasons for revision surgery including pain, 
aseptic loosening, instability of the joint, component mal-alignment, infection of 
the primary implant and wear of the original components107. 
 
Revision surgery usually takes longer to perform than a primary procedure.  A 
larger incision is generally needed and there is greater blood loss.  Specialist 
surgical instruments and implants are often required, together with different 
forms of bone graft and metal augments.  Revision surgery usually more 
invasive and technically more demanding than primary surgery and 
complication rates are generally reported to be higher108-110. 
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2.1.2.4 Unicondylar knee replacement 
 
 
Unicondylar knee replacement is a ‘half’ knee replacement.  It is indicated for 
patients with isolated arthritis in the medial or lateral compartment of the knee.  
It can be performed in the presence of patello-femoral arthritis.  The underlying 
concept is to preserve as much of the normal knee as possible and to replace 
only the damaged parts.  Knee kinematics are retained due to the preservation 
of all knee ligaments.  One in four patients with knee osteoarthritis is a suitable 
candidate for unicondylar knee replacement111.   
 
Medial unicondylar knee replacements are much more common than lateral 
replacements.  The femoral condyle and tibial plateau are resurfaced with metal 
components.  A polyethylene spacer is inserted between the two (Images 5 and 
6).   
 
When compared to total knee arthroplasty, UKR has been shown to provide 
greater patient satisfaction112, result in a shorter hospital stay113, cause less 
blood loss and hence decreased blood transfusion requirement114, result in a 
more speedy recovery115 and cost less for the implant113.  UKR preserves more 
bone stock than total knee arthroplasty, making revision surgery easier.  The 
National Joint Registry reports failure rates of 16.64% of this type of arthroplasty 
at 7 years following surgery105. 
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Image 5. Photograph of medial unicondylar knee implant 
 
 
 
 
 
 
 
Image 6. X-ray of unicondylar knee arthroplasty 
 
 
 
 
2.1.2.5 Total knee replacement  
 
 
Primary total knee replacement involves resurfacing of the tibial plateau and 
femoral condyles (Images 7 and 8).  The resurfacing components are usually 
made of metal but can be made from other materials such as oxinium (metal 
with a ceramic surface layer).  The components may be attached to bone using 
a cemented or uncemented technique (similar to total hip arthroplasty).  The 
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tibial and femoral components are separated by a polyethylene insert.  This 
insert can be attached to the tibial component or mobile. 
Image 7. Photograph of total knee replacements implants 
 
 
Image 8. X-ray of total knee replacement 
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Total knee replacements are either unconstrained or constrained.  
Unconstrained implants rely on the native medial and lateral collateral ligaments 
of the knee for varus/valgus stability and can either be posterior-cruciate 
ligament (PCL) retaining or sacrificing.  The main perceived advantage of PCL-
retaining implants is improved range of motion due to preservation of the knee 
‘roll-back’ mechanism.  However, this sliding movement is also a disadvantage 
since it produces increased polyethylene wear.  The main advantage of PCL-
sacrificing implants is decreased polyethylene wear due to a higher degree of 
conformity between the implant components.  As a disadvantage, the higher 
conformity results in a more restricted range of motion. 
 
Constrained knee replacements are used when the medial and lateral collateral 
ligaments are non-functional.  Constrained implants are either unhinged or 
hinged.  The main disadvantage of these implants is greater constraint of 
movement that creates higher stress levels at the bone-implant interface.  The 
components are therefore more prone to aseptic loosening and early failure.  To 
overcome this problem long intramedullary stems are used on the femoral and 
tibial components.  This spreads the stress at the bone-implant interface over a 
larger surface area. 
 
Total knee arthroplasty is a very good procedure to improve pain116 but total 
knee replacements do not feel like a ‘normal’ knee.  This is due to irregular 
kinematics117,118, abnormal patellar tracking119 and a decreased range of 
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motion120.  This is different to total hip arthroplasty where patients often report 
that the replaced hip feels the same as their native hip. 
 
The National Joint Registry reports that the overall failure rate of cemented total 
knee replacements at 7 years following surgery is 3.81%.  The failure rate of 
uncemented total knee replacements at 7 years following surgery is 4.75%105.       
2.1.2.6 Revision total knee replacement 
 
Revision total knee replacement is necessary when a primary implant fails.  The 
indications for revision surgery are similar to those for revision hip surgery.  
Polyethylene wear is more of a problem in TKR than THR since total knee 
replacements operate at the endurance level of polyethylene where as most 
total hip replacements operate well below it. 
 
Similar to revision hip surgery, revision knee surgery is usually longer, requires 
a larger incision and incurs a greater blood loss than primary knee surgery.  The 
aim is to preserve as much bone as possible and specialist equipment and 
implants are often needed.  Bone graft and metal augments are often required.  
As with revision hip surgery, the risks of revision knee surgery are higher than 
primary knee arthroplasty121. 
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2.2 Methods 
 
2.2.1 General 
 
This is a prospective longitudinal cohort study to evaluate the type and 
frequency of post-operative morbidity following lower limb arthroplasty using the 
Post-Operative Morbidity Survey (POMS). Ethical approval was gained from the 
Joint UCLH/UCL Committee on the Ethics of Human Research (reference 
number 01/0116) prior to commencement of the study.  The requirement for 
patient consent was waived as collection of the POMS became a routine part of 
service evaluation within the institution.  
2.2.2 Setting 
 
 
The data in this study was collected from the Middlesex Hospital between 
March 1st 2004 and February 28th 2005.  The Middlesex Hospital was part of the 
University College Hospital NHS Trust, London, UK.  It was a central London 
teaching hospital.  The Middlesex Hospital was closed in December 2005 when 
it merged with University College London Hospital and both hospitals moved 
into a new building.   
2.2.3 Patients 
 
 
All patients aged 18 or over undergoing elective lower limb arthroplasty were 
eligible for inclusion into this study.  There were no exclusion criteria, ensuring a 
consecutive sample was taken.  Elective lower limb arthroplasty procedures 
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included unicondylar knee replacement (UKR), total knee replacement (TKR), 
revision total knee replacement (RTKR), hip resurfacing (HR), total hip 
replacement (THR) and revision total hip replacement (RTHR). 
2.2.4 Data collection 
 
   
Data was collected by two study nurses.  The age, sex, measures of pre-
operative risk (ASA-PS score and variables needed to calculate the POSSUM 
score), surgical procedure, length of inpatient stay, mortality, post-operative 
destination (ward, High-Dependency Unit or Intensive Care Unit) and post-
discharge destination (home, rehabilitation unit or another hospital / care 
institution) were recorded for each patient.  This data was collected at the 
bedside and entered onto a standardised paper results form.  A strong 
emphasis was placed on completing results forms in their entirety to ensure 
complete data sets were obtained.  This data was entered into a Microsoft 
Access database (Microsoft Corporation, Redmond, WA, USA) in the Surgical 
Outcomes Research Centre in the Middlesex Hospital at a later date.   
 
POMS data was collected on post-operative days (POD) 3, 5, 8 and 15 if the 
patient remained in hospital.  Data was obtained from observation charts, 
medication charts, patient notes, routine blood test results and direct patient 
questioning, observation and examination.  Further information was gained from 
the hospital clinical information system and consultation with staff looking after 
the patient.  No additional investigations were required specifically for this study.  
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The staff looking after the patients (medical and nursing) were not aware of any 
study results i.e. they were blinded.   
2.2.5 Data analysis 
 
2.2.5.1 Patient characteristics 
 
 
For characteristics with continuous variability, the mean and range are given.  
For other categories, the proportion of patients in each group is stated. 
 
2.2.5.2 Pattern of POMS morbidity 
 
 
For each type of arthroplasty, the proportion of the study population with post-
operative morbidity as defined by the POMS is reported POD 3, 5, 8 and 15. 
2.2.5.3 Statistical analysis 
 
 
The aim of the analysis was to compare morbidity between different operation 
types. Not all comparisons between operations were of interest, with the focus 
on specific comparisons.  UKR was compared to TKR and HR was compared to 
THR to assess if the newer ‘less invasive’ procedures (UKR and HR) were 
associated with less post-operative morbidity than total joint replacements (TKR 
and THR). 
 
Primary joint replacement surgery is generally considered ‘less invasive’ than 
revision joint replacement surgery.  To assess if revision surgery is associated 
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with increased post-operative morbidity, THR was compared to RTHR and TKR 
compared to RTKR. 
 
To investigate if there is a difference in morbidity following hip and knee 
arthroplasty, analyses were performed between the TKR and THR groups and 
RTKR and RTHR groups. 
 
The outcome variable in each comparative analysis was the occurrence of 
different types of morbidity. The occurrence of morbidity was a binary measure: 
either present or absent.  Fisher’s exact test was used for analyses. 
 
At each time point (POD 3, 5, 8 and 15), there were six planned comparisons 
between the operation types.  These multiple comparisons produce an 
increased risk of finding a difference due to chance alone.  To allow for this 
issue a Bonferroni correction was applied to the p-values resulting from each 
statistical test. This involved multiplying the p-values by the number of tests 
performed (six in this case). 
 
The difference in the POSSUM morbidity risk scores between the different 
operation types was also examined. These values were found to have a 
positively skewed distribution so the Kruskal-Wallis test was used for the 
analysis.  
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Further analyses examined the morbidity differences between operations after 
adjusting for the POSSUM risk score. These analyses were performed using 
logistic regression.  Regression analyses were restricted only to comparisons 
between pairs of operations where an initial significant difference was observed.  
A Bonferroni adjustment was applied to the results of the regression analyses to 
allow for multiple testing. 
2.2 Results 
 
2.3.1 Study population characteristics 
 
2.3.1.1 Knee arthroplasty patients 
 
Table 8 shows a summary of the characteristics of the knee arthroplasty study 
population. 
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Table 8. Characteristics of 300 patients undergoing knee arthroplasty. All 
data expressed as percentage of patients for each procedure unless 
otherwise stated. 
 
 
Characteristic Unicondylar 
knee 
replacement  
Total knee 
replacement  
Revision total 
knee 
replacement  
Number of patients in study 
 
66 226 8 
Mean age (range) / years 66.1 
(45 – 87) 
70.3 
(23 – 90) 
71.6 
(46 – 88) 
 
Sex 
(% Female) 
54.5 60.6 75.0 
ASA-PS score I 24.2 13.3 25.0 
 
II 65.2 66.4 62.5 
 
III 7.6 18.6 0.0 
 
IV 0.0 0.0 0.0 
 
Missing 3.0 1.7 12.5 
 
Mean POSSUM 
risk (range) 
Morbidity 13.3 (6.5 - 39.7) 18.7 (9.3 – 53.0) 28.0  
(10.7 – 71.5) 
Mortality 2.4 (1.3 – 5.5) 3.3 (1.7 – 9.8) 5.8 (1.4 – 19.2) 
 
Post-op 
environment 
ICU / HDU 3.0 1.3 12.5 
 
>1 day ICU 1.5 0.9 12.5 
 
Ward 97.0 98.7 87.5 
 
Mean post-op length of stay (range) 
/ days 
5.5 (2 – 52) 5.6 (3 – 37) 22 (3 – 102) 
 
Return to theatre 3.0 0.0 12.5 
 
Return to ICU 1.5 0.0 0.0 
 
Died in hospital 1.5 0.0 0.0 
 
Discharge 
destination 
Home  98.5 99.6 100.0 
 
Rehabilitation  0.0 0.4 0.0 
 
Other hospital 0.0 0.0 0.0 
 
Death 1.5 0.0 0.0 
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A total of 300 patients underwent knee arthroplasty procedures during the study 
period (66 UKRs, 226 TKRS and 8 RTKRs).  The mean age of the study 
population was lowest in the UKR group (66.1), higher in the TKR group (70.3) 
and highest in the RTKR group (71.6).  Sex distribution was roughly even in the 
UKR group.  There was a higher proportion of females in both the TKR and 
RTKR groups (60.6% and 75.0% respectively).  1 UKR patient died after 
surgery.  The cause of death was cardiac arrest on POD 2.  Post-mortem 
examination showed the cardiac arrest was secondary to a pulmonary embolus.  
There were no deaths during the inpatient post-operative period in the TKR and 
RTKR groups.    
 
The ASA-PS grading of patients varied throughout the three groups.  There was 
a smaller proportion of ASA-PS Grade I patients in the primary TKR group 
(13.3%) compared to the UKR (24.2%) and RTKR (25.0%) groups.  The 
proportion of ASA-PS Grade II patients was similar in the three groups (65.2% 
in the UKR group, 66.4% in the TKR group and 62.5% in the RTKR group).  
There was a higher proportion ASA-PS Grade III patients in the primary TKR 
group (18.6%) compared to the UKR (7.6%) and RTKR (0.0%) groups.  No 
patients were ASA-PS Grade IV.  The ASA-PS grading of 1 UKR patient, 2 TKR 
patients and 1 RTKR was not recorded. 
 
The mean POSSUM risk scores for both morbidity and mortality were lowest in 
the UKR group (13.3 and 2.4 respectively), higher in the primary TKR group 
(18.7 and 3.3 respectively) and highest in the RTKR group (28.0 and 5.8 
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respectively).  The proportion of patients admitted to the Intensive Care Unit 
(ICU) post-operatively was low in the UKR and TKR groups (3.0% and 0.0% 
respectively) but higher in the RTKR group (12.5%).  There was only 1 patient 
admitted to ITU from the ward in the post-operative period.  This was the UKR 
patient who had a cardiac arrest on POD 2 and subsequently died. 
 
2 UKR patients returned to theatre.  The first patient developed a wound 
infection and returned to theatre for an open knee washout and change of 
polyethylene insert.  The second patient developed peritonitis secondary to a 
perforated gastric ulcer and was taken to theatre by the general surgical team 
for a laparotomy and ulcer repair.  No TKR patients required a second surgical 
intervention.  1 RTKR patient required a second operation for infection.  An 
open knee washout was performed together with exchange of polyethylene 
tibial insert.  The indication for revision surgery was infection of the primary 
prosthesis.   
 
Mean length of hospital stay was similar in the UKR and TKR groups (5.5 days 
and 5.6 days respectively).  It was longer in the RTKR group (22 days).  All 
UKR, RTKR and all but one TKR patients were discharged to their own home.  
The remaining TKR patient was discharged to a rehabilitation unit.    
2.3.1.2 Hip arthroplasty patients 
 
Table 9 shows the characteristics of the hip arthroplasty population. 
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Table 9. Characteristics of 229 patients undergoing hip arthroplasty. All 
data expressed as percentage of patients for each procedure unless 
otherwise stated. 
 
 
 
Characteristic Hip resurfacing  Total hip 
replacement  
Revision total 
hip 
replacement  
Number of patients in study 
 
32 162 35 
Mean age (range) / years 51.6 (22 – 70) 70.7 (21 – 91) 72.2 (26 – 88) 
 
Sex 
(% Female) 
50.0 60.5 62.9 
ASA-PS score I 53.1 11.1 8.6 
 
II 43.8 70.4 51.4 
 
III 3.1 15.4 37.1 
 
IV 0.0 1.2 0.0 
 
Missing 0.0 1.9 2.9 
 
Mean POSSUM 
risk (range) 
Morbidity 15.1 (7.6 – 60.6) 22.4 (9.3 – 65.7) 34.4 (9.3 – 90.5) 
 
Mortality 2.9 (1.4 – 14.1) 4.1 (1.7 – 16.5) 7.8 (1.7 – 42.1) 
 
Post-op 
environment 
ICU / HDU 0.0 4.9 14.3 
 
>1 day ICU 0.0 3.1 5.7 
 
Ward 100.0 95.1 85.7 
 
Mean post-op length of stay (range) 
/ days 
6.4 (4 – 13) 10.2 (3 – 81) 20.6 (5 – 93) 
 
Return to theatre 0.0 1.9 14.3 
 
Return to ICU 0.0 3.1 2.9 
 
Died in hospital 0.0 0.0 2.9 
 
Discharge 
destination 
Home  100.0 93.8 80.0 
 
Rehabilitation  0.0 6.2 17.1 
 
Other hospital 0.0 0.0 0.0 
 
Death 0.0 0.0 2.9 
 
  
 
 
 
 
 
 
83 
A total of 229 patients underwent hip arthroplasty procedures during the study 
period (32 HRs, 162 THRS and 35 RTHRs).  The mean age of the study 
population was lowest in the HR group (51.6).  The mean age of patients 
undergoing THR and RTHR was similar (70.3 and 71.6 respectively).  Sex 
distribution was roughly even in the HR group but there was a higher proportion 
of females in both the THR and RTHR groups (60.5% and 62.9% respectively).  
There were no deaths in the immediate post-operative period in the HR and 
THR groups.  There was one death in the RTHR group.  This patient died on 
POD 3 following a cardiac arrest.    
 
The ASA-PS grading of patients varied throughout the three groups.  Over half 
the HR patients were ASA-PS Grade I (53.1%).  This proportion was lower in 
the THR and RTHR groups (11.1% and 8.6% respectively).  Most THR patients 
(70.4%) were ASA-PS Grade II.  The proportion was lower in the RTHR (51.4%) 
and HR (43.8%) groups.  37.1% of RTHR patients were ASA-PS Grade III 
compared to 15.4% of THR patients and 3.1% of HR patients.  1.2% of THR 
patients were ASA-PS Grade IV.  No HR or RTHR patients were ASA-PS 
Grade IV.  The ASA-PS grading of 3 THR patients and 1 RTHR patient were not 
recorded. 
 
The mean POSSUM risk scores for both morbidity and mortality were lowest in 
the HR group (15.1 and 2.9 respectively), higher in the primary THR group (22.4 
and 4.1 respectively) and highest in the RTHR group (34.4 and 7.8 
respectively).  No HR patients were admitted to the Intensive Care Unit (ICU) 
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post-operatively. 4.9% of THR patients and 14.3% of RTHR patients were 
admitted to ICU following surgery.  5 THR patients were transferred to ICU from 
the ward.  The reasons for transfer included cardiac monitoring for atrial 
fibrillation and supraventricular tachycardia, ventilatory support following a 
pulmonary embolus and ventilatory support following further surgery for a 
dislocated hip.  1 RTHR patient with generalised sepsis was transferred to ICU 
for cardiac monitoring. 
 
No HR patients required a second surgical intervention during their inpatient 
stay.  3 THR patients required further surgery during their hospital stay: 2 
patients underwent closed reduction of a dislocated hip and 1 patient had an 
open hip washout and exchange of polyethylene liner for infection.  5 RTHR 
patients required a second operation during their inpatient stay.  3 patients 
required open hip washouts with exchange of polyethylene liner for possible 
deep infection.  The indication for revision hip surgery in these patients was 
infection of the primary prosthesis.  The other 2 RTHR patients returned to 
theatre to address periprosthetic fractures sustained from falls: 1 patient 
underwent open reduction and internal fixation of the fracture and 1 patient had 
the femoral component re-revised. 
 
Mean length of hospital stay was lowest in the HR group (6.4 days).  This 
increased in the THR group (10.2 days) and was considerably longer in the 
RTHR group (20.6 days).  All HR patients were discharged to their own home.  
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10 THR patients and 6 RTHR patients was discharged to a rehabilitation centre.  
The remaining patients were discharged to their own home.     
2.3.2 Pattern of post-operative morbidity  
 
2.3.2.1 Knee arthroplasty patients 
 
 
Table 10 shows a summary of morbidity following knee arthroplasty according 
to the POMS.  
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Table 10. Post-operative morbidity (defined by the POMS) in 300 elective 
knee arthroplasty patients on days 3, 5, 8 and 15. Figures are a percentage 
of the total number of patients in each arthroplasty group.  
 
2.3.2.1.1 Pulmonary morbidity 
 
 
Pulmonary morbidity is defined as ‘a new need for oxygen or respiratory 
support’.  No knee arthroplasty patient required respiratory support following 
surgery. 7.6% of UKR patients required supplementary oxygen on POD 3.  This 
reduced to 1.5% (1/66) on POD 5, 8 and 15.  This patient developed a 
 Unicondylar knee 
replacement 
(UKR) 
 
Total knee 
replacement  
(TKR) 
Revision total knee 
replacement  
(RTKR) 
 Day Day 
 
Day 
3 5 
 
8 15 3 5 8 15 3 5 8 15 
Pulmonary 7.6 1.5 
 
1.5 1.5 12.0 4.9 2.2 0.0 37.5 0.0 0.0 12.5 
Infection 10.6 6.1 
 
0.0 1.5 18.1 11.1 7.5 1.3 50.0 50.0 37.5 12.5 
Renal 10.6 4.6 
 
3.0 1.5 22.6 8.4 3.1 0.9 50.0 0.0 0.0 12.5 
Gastrointestinal 9.1 3.0 
 
1.5 0.0 16.8 8.4 2.7 0.4 0.0 0.0 0.0 12.5 
Cardiovascular 0.0 1.5 
 
1.5 0.0 3.5 4.4 4.0 0.9 12.5 12.5 12.5 0.0 
Neurological 0.0 0.0 
 
0.0 0.0 2.2 1.8 0.4 0.0 0.0 0.0 0.0 0.0 
Wound 3.0 1.5 
 
0.0 0.0 2.7 6.2 3.1 0.4 0.0 0.0 12.5 12.5 
Haematological 0.0 1.5 
 
0.0 0.0 2.7 0.4 0.4 0.0 0.0 0.0 0.0 0.0 
Pain 4.6 1.5 
 
1.5 0.0 7.1 0.0 0.0 0.0 25.0 0.0 0.0 0.0 
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perforated gastric ulcer 2 days following knee surgery, which was repaired by 
the general surgical team. The patient needed supplementary oxygen for a total 
of 15 days following his abdominal surgery and remained an inpatient for a total 
of 22 days. 
 
12.0% of TKR patients required supplementary oxygen on POD 3.  This figure 
reduced to 4.9% by POD 5 and to 2.2% by POD 8.  No TKR patients required 
oxygen on POD 15.  
 
37.5% of RTKR patients required supplementary oxygen on POD 3.  No RTKR 
patients required oxygen on POD 5 and 8.  Supplementary oxygen was 
restarted for one patient on POD 13 following a second surgical procedure 
(knee washout and replacement of polyethylene liner) for an infected 
prosthesis. 
2.3.2.1.2 Infectious morbidity 
 
 
The POMS definition of infectious morbidity is a patient ‘currently taking 
antibiotics’ and/or has had ‘a temperature of 38ºC or above in the last 24 hours’.  
On POD 3, 10.6% (7/66) of UKR patients had infectious morbidity. 3 of these 
patients had a temperature over 38ºC in the preceding 24 hours, 3 patients 
were started on antibiotics for a clinically suspected superficial surgical site 
infection and 1 patient was taking intravenous antibiotics following surgical 
repair of a perforated gastric ulcer. 
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On POD 5, the same 4 patients (6.1%) remained on antibiotics (3 for possible 
wound infection and 1 following rupture of gastric ulcer).  By POD 8, no UKR 
patient had infectious morbidity.  The patient who underwent repair of a 
perforated gastric ulcer was restarted on intravenous antibiotics on POD 11 and 
accounts for the 1 patient (1.5%) with infectious morbidity on POD 15. 
 
On POD 3, 18.1% (41/226) of TKR patients had infectious morbidity.  14 
patients had a temperature over 38ºC in the preceding 24 hours, 13 patients 
were started on antibiotics for possible superficial surgical site infection, 5 
patients were prescribed antibiotics for a clinically diagnosed chest infection, 5 
patients were taking antibiotics for urinary sepsis (based on clinical diagnosis 
and results from urine dipstick analysis) and 1 patient was started on antibiotics 
for a clinically diagnosed ear infection.  3 patients were taking antibiotics with no 
recorded reason.   
 
By POD 5, the percentage of TKR patients with infectious morbidity had fallen 
to 11.1% (25/226).  These patients all had infectious morbidity on POD 3.  
There were no ‘new’ patients with infection.  On POD 8 the percentage of TKR 
patients with infectious morbidity fell to 7.5% (17/226).  By POD 15, 1.3% 
(3/226) of TKR patients had infectious morbidity.  There were no ‘new’ patients: 
1 patient continued antibiotics for cellulitis surrounding the wound, 1 continued 
antibiotics for urinary sepsis and 1 for diarrhoea. 
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50.0% of RTKR patients had infectious morbidity on POD 3.  This remained the 
same on POD 5 and reduced to 37.5% by POD 8 and to 12.5% by POD 15.  
These figures represent patients who had infected primary prostheses and were 
taking planned intravenous antibiotics following their revision surgery.  Tissue 
samples were taken prior to surgery to ascertain organism sensitivity and plan 
an appropriate antibiotic regimen.   
2.3.2.1.3 Renal morbidity 
 
 
Renal morbidity is defined by the POMS as ‘oliguria of less than 500ml/day, a 
raised creatinine level of over 30% compared to pre-operatively, or a urinary 
catheter in-situ’.  On POD 3, 10.6% (7/66) of UKR patients had renal morbidity.  
5 patients had a catheter in-situ and 2 had oliguria (although it was noted that 
both patients had incontinence so urine output may not have been recorded 
accurately).  By POD 5, 4.6% (3/66) UKR patients had renal morbidity (all had a 
urinary catheters in-situ).  By POD 8, 3.0% of patients had renal morbidity and 
this fell to 1.5% (1/66) by POD 15.  This patient perforated a gastric ulcer 
following his knee surgery.  His fluid balance was still being monitored on POD 
15, necessitating a urinary catheter. 
 
22.6% (51/226) of TKR patients had renal morbidity on POD 3.  1 patient had 
acute renal failure with a high creatinine level, 9 patients had low urine output 
and 41 patients had a catheter in-situ.  The proportion of patients with renal 
morbidity fell to 8.4% on POD 5.  1 patient had on-going renal failure, 2 patients 
had oliguria and 16 had urinary catheters in-situ.  The proportion of patients 
  
 
 
 
 
 
 
90 
with renal morbidity fell further to 3.1% (7/226) on POD 8.  These patients had 
urinary catheters in-situ.  The figure reduced further to 0.9% (2/226) by POD 15.  
One patient had slowly improving renal failure and another had a catheter in-
situ. 
 
50.0% of RTKR patients had renal morbidity on POD 3.  These patients had a 
urinary catheter in-situ.  No RTKR patients had renal morbidity on POD 5 and 8.  
By POD 15, 1 RTKR patient had developed ‘new’ renal morbidity.  This patient 
developed generalised sepsis secondary to a deep knee infection with 
subsequent acute renal failure.  This required urethral catheterisation to monitor 
fluid balance.    
2.3.2.1.4 Gastro-intestinal morbidity 
 
 
The POMS defines post-operative gastro-intestinal morbidity as ‘unable to 
tolerate an enteral diet’ or a patient experiencing ‘nausea, vomiting or 
abdominal distension’.  9.1% of UKR patients had gastro-intestinal morbidity on 
POD 3.  This reduced to 3.0% by POD 5 and to 1.5% by POD 8.  No UKR 
patients had gastro-intestinal morbidity on POD 15. 
 
16.8% of TKR patients had gastro-intestinal morbidity on POD 3.  This reduced 
to 8.4% by POD 5, to 2.7% by POD 8 and to 0.4% (1/226) by POD 15.  This 
patient had felt nauseous since surgery but was eating normally. 
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No RTKR patients had gastro-intestinal morbidity on POD 3, 5 or 8.  1 patient 
(12.5%) developed gastro-intestinal morbidity by POD 15.  This patient had 
generalised sepsis secondary to an infected knee joint.  He was vomiting 
regularly and was not able to tolerate an enteral diet. 
2.3.2.1.5 Cardiovascular morbidity 
 
 
The POMS defines cardiovascular morbidity as ‘ischaemia or hypotension 
requiring drug therapy or fluid therapy of over 200ml per hour, atrial or 
ventricular arrhythmia, cardiogenic pulmonary oedema or new anticoagulation’.  
No UKR patient had cardiovascular morbidity on POD 3.  By POD 5, 1 patient 
(1.5%) had developed cardiovascular morbidity: atrial fibrillation following 
perforation of a gastric ulcer.  The same patient was still being treated for the 
arrhythmia on POD 8.  By POD 15 no UKR patient had cardiovascular 
morbidity. 
 
3.5% (8/226) of TKR patients had cardiovascular morbidity on POD 3. 6 
patients were restarted on warfarin they had been taking pre-operatively.  2 
patients were prescribed anticoagulation to treat DVTs.  By POD 5, 4.4% 
(10/226) of TKR patients had cardiovascular morbidity.  4 of these patients were 
‘new’.  3 patients were prescribed anticoagulation for deep vein thrombosis and 
1 patient had a myocardial infarction.  The proportion of TKR patients with 
cardiovascular morbidity fell to 4.0% by POD 8 and fell further to 0.9% by POD 
15. 
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No RTKR patients had cardiovascular morbidity on POD 3 and 5.  By POD 8, 1 
patient had developed cardiovascular morbidity.  This patient restarted warfarin 
he had been taking preoperatively.  He continued to take warfarin on POD 15. 
2.3.2.1.6 Neurological morbidity 
 
 
The POMS defines neurological morbidity as a ‘new confusion/delirium, focal 
deficit or coma’.  No UKR or RTKR patients developed neurological morbidity in 
the post-operative period.  2.2% (5/226) of TKR patients had neurological 
morbidity on POD 3. 3 patients were confused, 1 patient had a cerebro-vascular 
accident (CVA) and 1 patient developed acute psychosis.  The proportion of 
TKR patients with neurological morbidity reduced to 1.8% by POD 5 and to 
0.4% by POD 8.  By POD 15 no TKR patient had neurological morbidity. 
2.3.2.1.7 Wound morbidity 
 
 
The POMS defines wound morbidity as a ‘wound dehiscence requiring surgical 
exploration or drainage of pus from the operative wound with or without isolation 
of organisms’.  3.0% of UKR patients had wound morbidity on POD 3.  This 
reduced to 1.5% by POD 5.  No UKR patient had wound morbidity on POD 8 
and 15. 
 
2.7% of TKR patients had wound morbidity on POD 3.  This rose to 6.2% by 
POD 5.  This included 8 ‘new’ patients who had not been diagnosed with wound 
morbidity on POD 3.  By POD 8, 3.1% of TKR patients had wound morbidity 
and this figure fell to 0.4% by POD 15. 
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No RTKR patients had wound morbidity on POD 3 and 5.  By POD 8, 1 patient 
had developed wound morbidity.  The indication for revision surgery in this 
patient was infection of the primary prosthesis.  The patient developed recurrent 
infection in the revision replacement necessitating further surgery.  His wound 
morbidity remained on POD 15.    
2.3.2.1.8 Haematological morbidity 
 
 
The POMS defines haematological morbidity as a patient requiring ‘red blood 
cells, platelets, fresh frozen plasma or cryoprecipitate within the last 24 hours’.  
On POD 3 no UKR patients had haematological morbidity.  1 patient (1.5%) had 
haematological morbidity on POD 5.  This patient perforated a gastric ulcer and 
required a red cell transfusion following his abdominal surgery.  No UKR patient 
had haematological morbidity on POD 8 and 15. 
 
2.7% of TKR patients had haematological morbidity on POD 3.  This reduced to 
0.4% on POD 5 and 8.  By POD 15, no TKR patient had haematological 
morbidity.  All haematological morbidity referred to red cell transfusion.  No 
knee arthroplasty patient required post-operative platelets, fresh frozen plasma 
or cryoprecipitate. 
 
No RTKR patient had haematological morbidity on POD 3, 5, 8 or 15. 
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2.3.2.1.9 Pain morbidity 
 
 
The POMS defines pain morbidity as ‘surgical wound pain significant enough to 
require parenteral opioids or regional anaesthesia’.  4.6% of UKR patients had 
pain morbidity on POD 3.  This reduced to 1.5% by POD 5 and 8.  By POD 15, 
no UKR patient had pain morbidity. 
 
7.1% of TKR patients had pain morbidity on POD 3.  No TKR patients had pain 
morbidity on POD 5, 8 or 15.  25.0% of RTKR patients had pain morbidity on 
POD 3.  No RTKR patients had pain morbidity on POD 5, 8 or 15. 
2.3.2.2 Hip arthroplasty patients 
 
 
Table 11 shows a summary of morbidity following hip arthroplasty according to 
the POMS. 
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Table 11. Post-operative morbidity (defined by the POMS) in 229 elective 
hip arthroplasty patients on days 3, 5, 8 and 15. Figures are a percentage 
of the total number of patients in each arthroplasty group.  
 
2.3.2.2.1 Pulmonary morbidity 
 
No hip arthroplasty patient required respiratory support following surgery.  All 
figures represent patients requiring supplementary oxygen.  3.1% of HR 
patients required oxygen on POD 3.  No HR patient had pulmonary morbidity on 
POD 5, 8 or 15. 
 
 Hip resurfacing 
(HR) 
Total hip 
replacement  
(THR) 
 
Revision total hip 
replacement  
(RTHR) 
 Day Day 
 
Day 
3 5 
 
8 15 3 5 8 15 3 5 8 15 
Pulmonary 3.1 0.0 0.0 0.0 15.4 3.7 3.7 0.0 25.7 14.3 5.7 11.4 
 
Infection 6.3 6.3 0.0 0.0 20.4 13.6 5.6 4.3 71.4 57.1 37.1 25.7 
 
Renal 15.6 0.0 0.0 0.0 35.8 14.2 4.3 1.2 77.1 25.7 25.7 17.1 
 
Gastrointestinal 6.3 3.1 0.0 0.0 11.7 6.8 2.5 1.2 17.1 17.1 8.6 11.4 
 
Cardiovascular 0.0 0.0 0.0 0.0 4.3 4.9 4.3 2.5 3.0 5.7 11.4 5.7 
 
Neurological 0.0 0.0 0.0 0.0 1.2 0.6 1.2 0.0 5.7 5.7 2.9 2.9 
 
Wound 0.0 6.3 0.0 0.0 4.3 9.3 3.7 1.9 0.0 17.1 8.6 5.7 
 
Haematological 6.3 0.0 0.0 0.0 4.3 2.5 1.2 0.0 11.4 8.6 8.6 2.9 
 
Pain 3.1 3.1 0.0 0.0 8.6 1.2 0.0 0.0 28.6 5.7 2.9 5.7 
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15.4% of THR patients required supplementary oxygen on POD 3.  This 
reduced to 3.7% on POD 5 and 8.  By POD 15 no THR patient had pulmonary 
morbidity. 
 
25.7% of RTHR patients had pulmonary morbidity on POD 3.  This reduced to 
14.3% by POD 5 and to 5.7% by POD 8.  By POD 15 the figure increased to 
11.4% (4/35).  1 patient had been on supplementary oxygen since surgery and 
3 patients were ‘new’.  The ‘new’ patients had returned to theatre for further 
surgery due to infection.  Supplementary oxygen was started following their 
second operative intervention. 
2.3.2.2.2 Infectious morbidity 
 
 
On POD 3, 6.3% (2/32) of HR patients had infectious morbidity.  1 patient had a 
temperature of over 38ºC in the preceding 24 hours and 1 patient was 
prescribed antibiotics for a clinically suspected superficial surgical site infection.  
On POD 5 the same 2 patients had infectious morbidity.  No HR patient had 
infectious morbidity on POD 8 and 15. 
 
On POD 3, 20.4% (33/162) of THR patients had infectious morbidity.  8 patients 
had a temperature exceeding 38ºC in the preceding 24 hours.  The remaining 
25 patients were prescribed antibiotics: 11 for a clinically suspected surgical site 
infection, 6 for clinically diagnosed chest infection, 4 for urinary tract infection, 1 
for endocarditis and 1 for an infected intravenous catheter site.  The reason for 
prescribing antibiotics was not recorded for 2 patients.  By POD 5 the 
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percentage of THR patients with infectious morbidity had fallen to 13.6% 
(22/162).  These patients all had infectious morbidity on POD 3.  There were no 
‘new’ patients.  On POD 8 the number of THR patients with an infection had 
fallen to 5.6% (9 patients).  There were no ‘new’ patients.  By POD 15, 4.3% 
(7/162) of THR patients had infectious morbidity.  1 patient had a ‘new’ 
diagnosis of an infected intra-venous cannula site.  
 
71.4% of RTHR patients had infectious morbidity on POD 3.  This reduced to 
57.1% by POD 5 and reduced further to 37.1% by POD 8.  By POD 15, 25.7% 
of RTHR patients had infectious morbidity.  These figures represent patients 
with known infected primary prostheses.  The reason for revision hip surgery 
was to eradicate infection.  The administration of appropriate antibiotics was 
planned pre-operatively. 
2.3.2.2.3 Renal morbidity 
 
 
On POD 3, 15.6% (5/32) of HR patients had renal morbidity.  These patients 
had a urinary catheter in-situ.  No HR patient had renal morbidity on POD 5, 8 
and 15. 
 
35.8% (58/162) of THR patients had renal morbidity on POD 3.  2 of these 
patients had a low urine output.  The remaining patients had a urinary catheter 
in-situ.  The percentage of THR patients with renal morbidity on POD 5 reduced 
to 14.2% (all had a urinary catheter in-situ) and reduced further to 4.3% by POD 
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8.  By POD 15, 1.2% (2/162) of THR patients had renal morbidity.  Both these 
patients had failed a trial without catheter.   
 
77.1% of RTHR patients had renal morbidity on POD 3 (all patients had a 
urinary catheter in-situ).  This figure reduced to 25.7% by POD 5 and 8 and 
reduced again to 17.1% by POD 15. 
2.3.2.2.4 Gastro-intestinal morbidity 
 
 
6.3% of HR patients had gastro-intestinal morbidity on POD 3.  This reduced to 
3.1% by POD 5.  No HR patients had gastro-intestinal morbidity on POD 8 and 
15. 
 
11.7% of THR patients had gastro-intestinal morbidity on POD 3.  This reduced 
to 6.8% by POD 5 and to 2.5% by POD 8.  1.2% (2/162) of THR patients had 
gastro-intestinal morbidity on POD 15.  Both these patients felt nauseous but 
were tolerating an enteral diet. 
 
17.1% (6/35) of RTHR patients had gastro-intestinal morbidity on POD 3.  4 
patients were nauseous and unable to tolerate an enteral diet, 1 patient had 
haematemesis (endoscopy showed oesophagitis secondary to reflux) and 1 
patient had melaena requiring a 4-unit red cell transfusion (colonoscopy, 
oesophago-gastro-duodenoscopy and abdominal imaging did not reveal the 
source of bleeding).  The proportion of RTHR patients with gastro-intestinal 
morbidity remained at 17.1% on POD 5.  By POD 8 the proportion of RTHR 
  
 
 
 
 
 
 
99 
patients with gastro-intestinal morbidity had reduced to 8.6%.  The figure 
increased to 11.4% on POD 15.  This increase represented one ‘new’ patient 
who had further surgery on POD 15 for an infected prosthesis.  The patient was 
last on the operating list and did not eat all day to maintain an empty stomach 
for surgery. 
 2.3.2.2.5 Cardiovascular morbidity 
 
 
No HR patient had cardiovascular morbidity on POD 3, 5, 8 or 15.  4.3% (7/162) 
of THR patients had cardiovascular morbidity on POD 3.  2 patients were re-
started on warfarin they had been taking pre-operatively, 1 patient was 
prescribed warfarin for a deep vein thrombosis, 2 patients had myocardial 
infarctions (1 of these patients also had bilateral pulmonary emboli) and 2 
patients developed supraventricular tachycardia.  On POD 5 the proportion of 
THR patients with cardiovascular morbidity rose to 4.9%.  There was one ‘new’ 
patient who was restarted on warfarin for atrial fibrillation.  The patient had been 
taking warfarin pre-operatively.  The proportion of THR patients with 
cardiovascular morbidity fell to 4.3% by POD 8 and fell further to 2.5% by POD 
15. 
 
3.0% (1/35) of RTHR patients had cardiovascular morbidity on POD 3.  This 
patient had a supraventricular tachycardia.  5.7% (2/35) of RTHR patients had 
cardiovascular morbidity by POD 5.  This included one ‘new’ patient who was 
prescribed anticoagulation for a pulmonary embolus.  By POD 8 the proportion 
of RTHR with cardiovascular morbidity increased further to 11.4% (4/35).  
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The increase represented 2 ‘new’ patients: one was re-started on warfarin 
(which he had been taking pre-operatively for atrial fibrillation) and the other 
patient was prescribed warfarin for a deep vein thrombosis.  By POD 15 the 
proportion of RTHR patients with cardiovascular morbidity had fallen to 5.7% 
(2/35).  One of these patients had developed a pulmonary embolus by POD 5 
and proceeded to develop endocarditis by day POD 15.  This patient was 
transferred to the Heart Hospital for aortic valve replacement. 
2.3.2.2.6 Neurological morbidity 
 
 
No HR patient had neurological morbidity on POD 3, 5, 8 or 15.  1.2% (2/162) of 
THR patients had neurological morbidity on POD 3.  Both patients were 
confused.  The proportion of patients with neurological morbidity reduced to 
0.6% by POD 5 and increased to 1.2% by POD 8.  This increase represented 
one ‘new’ patient who developed right-sided weakness.  Brain imaging revealed 
a small region of ischaemia.  Symptoms resolved within a few days confirming a 
transient ischaemic attack (TIA).  By POD 15 no THR patients had neurological 
morbidity. 
 
On POD 3, 5.7% (2/35) of RTHR patients had neurological morbidity.  1 patient 
had acute confusion and 1 patient had right arm weakness.  Brain imaging 
confirmed an ischaemic stroke.  The figure remained the same on POD 5 and 
reduced to 2.9% by POD 8 and 15.  
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2.3.2.2.7 Wound morbidity 
 
 
No HR patient had wound morbidity on POD 3.  This increased to 6.3% (2/32) 
by POD 5.  Both patients had purulent discharge from the surgical site.   No HR 
patient had wound morbidity on POD 8 and 15. 
 
4.3% of THR patients had wound morbidity on POD 3.  This rose to 9.3% by 
POD 5.  This represented 8 ‘new’ patients who did not have wound morbidity on 
POD 3.  By POD 8 the proportion of THR patients with wound morbidity had 
fallen to 3.7%.  The proportion fell further to 1.9% by POD 15. 
 
No RTHR patients had wound morbidity on POD 3.  By POD 5, 17.1% (6/35) of 
RTHR patients had developed wound morbidity.  The indication for revision 
surgery in these patients was infection of the primary prosthesis.  They all 
developed a surgical site infection following revision surgery.  The proportion of 
RTHR patients with wound morbidity reduced to 8.6% by POD 8 and to 5.7% by 
POD 15.  
2.3.2.2.8 Haematological morbidity 
 
 
On POD 3, 6.3% of HR patients had haematological morbidity.  No HR patients 
had haematological morbidity on POD 5, 8 and 15.  All haematological morbidity 
following hip arthroplasty represented red cell transfusion.  No hip arthroplasty 
patient required platelets, fresh frozen plasma or cryoprecipitate. 
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4.3% of THR patients had haematological morbidity on POD 3.  This reduced to 
2.5% on POD 5 and to 1.2% on POD 8.  By POD 15 no THR patient had 
haematological morbidity.   
 
11.4% of RTHR patients had haematological morbidity on POD 3.  This reduced 
to 8.6% on POD 5 and 8, and reduced further to 2.9% by POD 15. 
2.3.2.2.9 Pain morbidity 
 
3.1% of HR patients had pain morbidity on POD 3.  This figure remained the 
same on POD 5.  No HR patients had pain morbidity on POD 8 and 15.  8.6% of 
THR patients had pain morbidity on POD 3.  This reduced to 1.2% by POD 5.  
No THR patients had pain morbidity on POD 8 and 15.  28.6% of RTHR 
patients had pain morbidity on POD 3.  This reduced to 5.7% by POD 5, and 
further to 2.9% by POD 8.  This figure increased to 5.7% by POD 15.  This 
represented 1 ‘new’ patient who had undergone further surgery on POD 13 for a 
periprosthetic fracture.  It was 2 days after his second surgical procedure. 
 
2.3.3 Comparison of post-operative morbidity between 
different types of arthroplasty 
 
2.3.3.1 Pulmonary morbidity 
 
 
Pulmonary morbidity following different types of hip and knee arthroplasty was 
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compared using Fisher’s exact tests.  Table 12 gives the Bonferroni adjusted p-
values resulting from these tests. 
Table 12. Bonferroni adjusted p-values from Fisher’s exact tests 
comparing pulmonary morbidity between different types of arthroplasty 
 
Time UKR vs 
TKR 
TKR vs 
RTKR 
HR vs 
THR 
THR vs 
RTHR 
TKR vs 
THR 
RTKR vs 
RTHR 
 
       
POD 3 1.00 0.41 0.51 0.88 1.00 1.00 
POD 5 1.00 1.00 1.00 0.17 1.00 1.00 
POD 8 1.00 1.00 1.00 1.00 1.00 1.00 
POD 15 1.00 0.21 1.00   0.005 1.00 1.00 
       
 
 
The results suggest no statistically significant difference in pulmonary morbidity 
between operation types for POD 3, 5 and 8. 
 
On POD 15 there is a significant difference in morbidity between the THR and 
RTHR groups.  RTHR has a higher morbidity, with 11% of patients having 
pulmonary morbidity compared to no THR patients. 
2.3.3.2 Infection morbidity 
 
 
Infection following different types of hip and knee arthroplasty was compared 
using Fisher’s exact tests.  Table 13 gives the Bonferroni adjusted p-values 
resulting from these tests. 
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Table 13. Bonferroni adjusted p-values from Fisher’s exact tests 
comparing post-operative infection between different types of 
arthroplasty 
Time UKR vs 
TKR 
TKR vs 
RTKR 
HR vs 
THR 
THR vs 
RTHR 
TKR vs 
THR 
RTKR vs 
RTHR 
 
       
POD 3 1.00 0.28 0.46 <0.001 1.00 1.00 
POD 5 1.00 0.06 1.00 <0.001 1.00 1.00 
POD 8 0.10 0.14 1.00 <0.001 1.00 1.00 
POD 15 1.00 0.78 1.00   0.002 0.61 1.00 
       
 
The results suggest no significant difference between the majority of operations 
compared.  The exception is between THR and RTHR, where a significant 
difference is observed on POD 3, 5, 8 and 15. The results suggest that on each 
of these days, infection is higher for RTHR than for THR.  For example, on POD 
3, 71% of RTHR patients had an infection, compared to 20% of THR patients. 
 
Additionally, there was slight evidence that RTKR had a higher infection rate 
than TKR on POD 5, but this result was not quite statistically significant. 
2.3.3.3 Renal morbidity 
 
 
Renal morbidity following different types of hip and knee arthroplasty was 
compared using Fisher’s exact tests.  Table 14 gives the Bonferroni adjusted p-
values from these tests. 
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Table 14. Bonferroni adjusted p-values from Fisher’s exact tests 
comparing post-operative renal morbidity between different types of 
arthroplasty 
Time UKR vs 
TKR 
TKR vs 
RTKR 
HR vs 
THR 
THR vs 
RTHR 
TKR vs 
THR 
RTKR vs 
RTHR 
 
       
POD 3 0.21 0.54 0.22 <0.001 0.04 1.00 
POD 5 1.00 1.00 0.10 0.76 0.58 1.00 
POD 8 1.00 1.00 1.00   0.002 1.00 1.00 
POD 15 1.00 0.60 1.00   0.003 1.00 1.00 
       
 
 
Statistically significant differences for renal morbidity between THR and RTHR 
were observed on POD 3, 8 and 15, although no difference was observed on 
POD 5. Where there was a difference, renal morbidity was higher for RTHR 
than for THR. For example, on POD 8, 26% of RTHR patients had renal 
morbidity but only 4% of THR patients. 
 
A significant difference in renal morbidity between TKR and THR was observed 
on POD 3, with a higher occurrence of morbidity for THR than for TKR. No 
significant difference for renal morbidity between these two operation types was 
observed on subsequent days. 
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2.3.3.4 Gastrointestinal morbidity 
 
 
Gastrointestinal morbidity following different types of hip and knee arthroplasty 
was compared using Fisher’s exact tests.  Table 15 gives the Bonferroni 
adjusted p-values from these tests. 
Table 15. Bonferroni adjusted p-values from Fisher’s exact tests 
comparing post-operative gastrointestinal morbidity between different 
types of arthroplasty 
Time UKR vs 
TKR 
TKR vs 
RTKR 
HR vs 
THR 
THR vs 
RTHR 
TKR vs 
THR 
RTKR vs 
RTHR 
 
       
POD 3 1.00 1.00 1.00 1.00 1.00 1.00 
POD 5 1.00 1.00 1.00 0.53 1.00 1.00 
POD 8 1.00 1.00 1.00 0.65 1.00 1.00 
POD 15 1.00 0.40 1.00 0.06 1.00 1.00 
       
 
There was difference in gastrointestinal morbidity between any of the operations 
compared.  There was slight evidence that RTHR patients have a higher 
occurrence of gastrointestinal morbidity than THR patients on POD 15 but this 
result was not quite statistically significant. 
2.3.3.5 Cardiovascular morbidity 
 
 
Cardiovascular morbidity following different types of hip and knee arthroplasty 
was compared using Fisher’s exact tests.  Table 16 gives the Bonferroni 
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adjusted p-values from these tests. 
Table 16. Bonferroni adjusted p-values from Fisher’s exact tests 
comparing post-operative cardiovascular morbidity between different 
types of arthroplasty 
Time UKR vs 
TKR 
TKR vs 
RTKR 
HR vs 
THR 
THR vs 
RTHR 
TKR vs 
THR 
RTKR vs 
RTHR 
 
       
POD 3 1.00 1.00 1.00 1.00 1.00 1.00 
POD 5 1.00 1.00 1.00 1.00 1.00 1.00 
POD 8 1.00 1.00 1.00 0.66 1.00 1.00 
POD 15 1.00 0.60 1.00 1.00 1.00 1.00 
       
 
 
No statistically significant difference in post-operative cardiovascular morbidity 
was observed between operation types at any of the four time points. 
2.3.3.6 Neurological morbidity 
 
 
Neurological morbidity following different types of hip and knee arthroplasty was 
compared using Fisher’s exact tests.  Table 17 gives the Bonferroni adjusted p-
values from these tests. 
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Table 17. Bonferroni adjusted p-values from Fisher’s exact tests 
comparing post-operative neurological morbidity between different types 
of arthroplasty 
Time UKR vs 
TKR 
TKR vs 
RTKR 
HR vs 
THR 
THR vs 
RTHR 
TKR vs 
THR 
RTKR vs 
RTHR 
 
       
POD 3 1.00 1.00 1.00 0.87 1.00 1.00 
POD 5 1.00 1.00 1.00 0.49 1.00 1.00 
POD 8 1.00 1.00 1.00 1.00 1.00 1.00 
POD 15 1.00 1.00 1.00 1.00 1.00 1.00 
       
 
The results suggest no significant difference in post-operative neurological 
morbidity between operation types. 
2.3.3.7 Wound morbidity 
 
 
Wound morbidity following different types of hip and knee arthroplasty was 
compared using Fisher’s exact tests.  Table 18 gives the Bonferroni adjusted p-
values from these tests. 
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Table 18. Bonferroni adjusted p-values from Fisher’s exact tests 
comparing post-operative wound morbidity between different types of 
arthroplasty 
Time UKR vs 
TKR 
TKR vs 
RTKR 
HR vs 
THR 
THR vs 
RTHR 
TKR vs 
THR 
RTKR vs 
RTHR 
 
       
POD 3 1.00 1.00 1.00 1.00 1.00 1.00 
POD 5 1.00 1.00 1.00 1.00 1.00 1.00 
POD 8 1.00 1.00 1.00 1.00 1.00 1.00 
POD 15 1.00 0.40 1.00 1.00 1.00 1.00 
       
 
There was no statistically significant difference in post-operative wound 
morbidity between any of the observed groups. 
2.3.3.8 Haematological morbidity 
 
 
Haematological morbidity following different types of hip and knee arthroplasty 
was compared using Fisher’s exact tests.  Table 19 gives the Bonferroni 
adjusted p-values from these tests. 
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Table 19. Bonferroni adjusted p-values from Fisher’s exact tests 
comparing post-operative haematological morbidity between different 
types of arthroplasty 
Time UKR vs 
TKR 
TKR vs 
RTKR 
HR vs 
THR 
THR vs 
RTHR 
TKR vs 
THR 
RTKR vs 
RTHR 
 
       
POD 3 1.00 1.00 1.00 0.66 1.00 1.00 
POD 5 1.00 1.00 1.00 0.65 0.99 1.00 
POD 8 1.00 1.00 1.00 0.24 1.00 1.00 
POD 15 1.00 1.00 1.00 1.00 1.00 1.00 
       
 
There was no statistically significant difference in post-operative haematological 
morbidity between any of the observed groups. 
2.3.3.9 Pain morbidity 
 
Pain morbidity following different types of hip and knee arthroplasty was 
compared using Fisher’s exact tests.  Table 20 gives the Bonferroni adjusted p-
values from these tests. 
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Table 20. Bonferroni adjusted p-values from Fisher’s exact tests 
comparing post-operative pain morbidity between different types of 
arthroplasty 
 
Time UKR vs 
TKR 
TKR vs 
RTKR 
HR vs 
THR 
THR vs 
RTHR 
TKR vs 
THR 
RTKR vs 
RTHR 
 
       
POD 3 1.00 0.71 1.00 0.02 1.00 1.00 
POD 5 1.00 1.00 1.00 0.87 1.00 1.00 
POD 8 1.00 1.00 1.00 1.00 1.00 1.00 
POD 15 1.00 1.00 1.00 0.18 1.00 1.00 
       
 
The results suggest a significant difference in pain morbidity between the THR 
and RTHR groups on POD 3.  Pain was present in 29% of RTHR patients at 
this time point but in only 9% of THR patients.  No other differences in post-
operative pain morbidity between operations were observed. 
2.3.3.10 The presence of any morbidity 
 
 
The proportion of patients with the presence of any type of morbidity as defined 
by the POMS following different types of hip and knee arthroplasty is shown in 
Table 21. 
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Table 21. The proportion of patients with any type of morbidity on post-
operative days 3, 5, 8 and 15.  Figures are a percentage of the total 
number of patients in each arthroplasty group.  
Time UKR 
(n=66) 
TKR 
(n=226) 
RTKR 
(n=8) 
HR 
(n=32) 
THR 
(n=162) 
RTHR 
(n=35) 
 
       
POD 3 26.7% 49.1% 75.0% 28.1% 54.9% 91.4% 
POD 5 10.5% 27.0% 50.0% 15.6% 37.0% 71.4% 
POD 8 4.5% 16.4% 62.5% 0.0% 17.3% 57.1% 
POD 15 1.5% 3.1% 12.5% 0.0% 8.0% 40.0% 
       
 
The presence of morbidity in each arthroplasty group was compared using 
Fisher’s exact tests.  Table 22 gives the Bonferroni adjusted p-values from 
these tests. 
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Table 22. Bonferroni adjusted p-values from Fisher’s exact tests 
comparing the presence of any post-operative morbidity between different 
types of arthroplasty 
 
Time UKR vs 
TKR 
TKR vs 
RTKR 
HR vs 
THR 
THR vs 
RTHR 
TKR vs 
THR 
RTKR vs 
RTHR 
 
       
POD 3   0.008 1.00 0.04 <0.001 1.00 1.00 
POD 5 0.03 1.00 0.14   0.002 0.27 1.00 
POD 8 0.08 0.03 0.03 <0.001 1.00 1.00 
POD 15 1.00 1.00 0.79 <0.005 0.22 1.00 
       
 
 
The results suggest significant increased morbidity following RTHR compared 
to THR at all four time points following surgery. For example, at POD 3, over 
90% of RTHR patients had morbidity, compared to just over half of THR 
patients. 
 
There was a difference between UKR and TKR on POD 3 and 5, and also a 
slight evidence of a difference on POD 8. Morbidity was higher for TKR than for 
UKR at all these time points. 
 
There were further differences in morbidity on POD 8 between TKR and RTKR, 
and also between HR and THR. On this day RTKR had a higher morbidity than 
TKR, whilst THR had a higher rate of morbidity than HR.  Differences between 
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these operation types were not statistically significant on POD 3, 5 and 15. 
2.3.4 Comparison of post-operative morbidity between 
different types of arthroplasty with POSSUM risk 
adjustment 
2.3.4.1 POSSUM morbidity scores in the arthroplasty groups 
 
A possible confounding variable in a comparison of operation types is the 
difference in risk of morbidity between the operation groups.  An analysis was 
performed to compare the POSSUM morbidity scores between the 6 types of 
arthroplasty.  The POSSUM values were found to have a positively skewed 
distribution so the Kruskal-Wallis test was used for the analysis.  The results are 
summarised in Table 23. The median and inter-quartile ranges are reported for 
each operation type, together with a p-value indicating the overall difference 
between the six operations. 
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Table 23.  POSSUM morbidity scores in the six arthroplasty groups 
 
Operation POSSUM morbidity score 
Median (IQR) 
P-value 
   
UKR 11.7 (8.8, 14.2) <0.001 
TKR 18.5 (16.2, 21.1)  
RTKR 22.5 (16.4, 31.9)  
HR 11.4 (9.6, 14.8)  
THR 18.5 (14.2, 26.9)  
RTHR 31.2 (18.5, 42.3)  
   
 
The results suggest a highly significant difference in POSSUM morbidity scores 
between the arthroplasty groups. Scores were lowest for the UKR and HR 
groups, with a median value of around 11 in both. The highest scores were for 
RTHR, which had a median score of 31. 
2.3.4.2 Comparison of post-operative morbidity between 
different types of arthroplasty with adjustment for POSSUM 
scores 
2.3.4.1.1 THR vs RTHR 
 
 
The initial analyses comparing morbidity between the arthroplasty groups with 
no adjustment suggested some differences in morbidity between THR and 
RTHR, with morbidity higher for RTHR when a difference was found. The 
POSSUM scores shown in Table 23 show that the risk for morbidity was 
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higher in the RTHR groups than the THR group.  Therefore, any differences in 
morbidity could be attributable to a difference in risk score rather than a 
difference between operation types. 
 
For this reason further regression analyses were performed specifically to re-
visit the significant differences between operations, adjusting for differences in 
POSSUM score between operation types.  The majority of differences observed 
were between THR and RTHR. The results of the unadjusted and POSSUM-
adjusted differences between these two hip procedures are summarised in 
Table 24. The difference in morbidity between operations is reported as an odds 
ratio, together with corresponding confidence intervals. The odds ratio is the 
odds of morbidity for RTHR relative to the odds for THR.  Bonferroni adjusted p-
values indicating the significance of the results are also reported. 
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Table 24.  Unadjusted and POSSUM-adjusted differences between post-
operative morbidity following THR and RTHR 
 
Morbidity Time Unadjusted Adjusted 
  OR (95% CI) (*) P-value OR (95% CI) (*) P-value 
      
Pulmonary POD 15 (†)  (†)  
      
Infection POD 3 9.77 (4.27, 22.3) <0.001 8.18 (3.45, 19.4) <0.001 
 POD 5 8.48 (3.79, 19.0) <0.001 8.92 (3.71, 21.5) <0.001 
 POD 8 10.0 (3.85, 26.2) <0.001 9.82 (3.50, 27.6) <0.001 
 POD 15 7.66 (2.63, 22.4) <0.001 4.92 (1.52, 16.0) 0.05 
      
Renal POD 3 6.05 (2.58, 14.2) <0.001 4.59 (1.90, 11.1)   0.006 
 POD 8 7.66 (2.63, 22.4) <0.001 3.77  (1.12, 
12.7) 
0.19 
 POD 15 16.6 (3.18, 86.1)   0.006 9.71 (1.63, 57.7) 0.07 
 
Pain POD 3 4.23 (1.69, 10.6) 0.01 2.31 (0.82, 6.53) 0.69 
 
Any POD 3 
POD 5 
POD 8 
POD 15 
8.75 (2.57, 29.7) 
4.25 (1.91, 9.46) 
6.38 (2.91, 14.0) 
7.64 (3.16, 18.5) 
  0.006 
<0.001 
<0.001 
<0.001 
6.10 (1.74, 21.4) 
3.38 (1.47, 7.81) 
4.14 (1.77, 9.68) 
4.45 (1.68, 11.8) 
0.03 
0.02 
  0.006 
0.02 
 
(*) Odds Ratios given as odds of morbidity for RTHR relative to THR 
(†) No occurrences of morbidity for THR, thus logistic regression unable to be performed 
 
 
The initial analyses found a difference in the presence of pulmonary morbidity 
between THR and RTHR on POD 15. There were no occurrences of morbidity 
for THR so logistic regression could not be performed in this instance. 
 
The results suggest that differences in post-operative infection between THR 
and RTHR remain after adjusting for the POSSUM morbidity score.  The result 
at POD 15 is of borderline statistical significance. 
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The difference in renal morbidity following RTHR compared to THR remained 
on POD 3 after adjusting for the POSSUM risk score. Renal morbidity was still 
higher for RTHR than THR at POD 8 and 15 but the difference was no longer 
statistically significant.   
 
There was no longer a statistically significant difference in pain at POD 3 
between the two operations after adjusting for the POSSUM score.  
 
A difference in the presence of any type of morbidity following RTHR as 
compared to THR remained on POD 3, 5, 8 and 15 after adjusting for the 
POSSUM score.  The size of difference in morbidity between operations was 
slightly reduced after adjustment for POSSUM. 
2.3.4.1.2 THR vs TKR 
 
 
Logistic regression was also used to compare TKR and THR where a previous 
difference was observed. The results are summarised in Table 25. 
Table 25. Unadjusted and POSSUM-adjusted differences between post-
operative morbidity for THR and TKR 
 
Morbidity Time Unadjusted Adjusted 
  OR (95% CI) (*) P-value OR (95% CI) (*) P-value 
      
Renal POD 3 1.91 (1.22, 2.99) 0.02 1.70 (1.08, 2.70) 0.14 
      
(*) Odds Ratios given as odds of morbidity for THR relative to TKR 
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The results suggest that the difference in renal morbidity is still raised for THR 
relative to TKR after adjusting for the POSUM score but this difference is no 
longer of statistical significance. 
2.3.4.1.3 TKR vs UKR 
 
 
The next comparison was made between the TKR and UKR groups where a 
previous difference was observed on POD 3 and 5. The results are summarised 
in Table 26. 
Table 26.  Unadjusted and POSSUM-adjusted differences between post-
operative morbidity for TKR and UKR 
 
Morbidity Time Unadjusted Adjusted 
  OR (95% CI) (*) P-value OR (95% CI) (*) P-value 
      
Any POD 3 2.63 (1.44, 4.79) 0.01 1.91 (1.00, 3.62) 0.29 
 POD 5 3.17 (1.37, 7.31) 0.04 2.18 (0.91, 5.22) 0.48 
      
(*) Odds Ratios given as odds of morbidity for TKR relative to UKR 
 
 
The results suggest that after adjusting for the POSSUM score, there was no 
longer a statistically significant difference between the two types of knee 
arthroplasty on either POD 3 or 5. 
2.3.4.1.4 RTKR vs TKR 
 
 
The next comparison was made between the RTKR and TKR groups where a 
previous difference was observed on POD 8. The results are summarised in 
Table 27. 
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Table 27.  Unadjusted and POSSUM-adjusted differences between post-
operative morbidity for RTKR and TKR 
 
Morbidity Time Unadjusted Adjusted 
  OR (95% CI) (*) P-value OR (95% CI) (*) P-value 
      
Any POD 8 8.51 (1.94, 37.2) 0.02 6.40 (1.31, 31.2) 0.13 
      
(*) Odds Ratios given as odds of morbidity for RTKR relative to TKR 
 
 
The results suggest that, after adjustment, the difference between the two types 
of knee arthroplasty for the presence of any morbidity at POD 8 is no longer 
statistically significant. 
 
The initial analyses also found a difference in the presence of any morbidity 
between HR and THR on post-operative day eight. There were no occurrences 
of morbidity for HR, and thus logistic regression could not be performed in this 
instance. 
2.4 Discussion 
 
2.4.1 Summary of post-operative morbidity following 
lower limb arthroplasty and suggestions for 
improvement 
 
This is the first time the POMS has been used to record and compare morbidity 
following different types of lower limb arthroplasty.  Overall, the most prevalent 
types of morbidity are ‘infection’ and ‘renal’.  There are lower levels of 
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‘pulmonary’, ‘pain’ and ‘gastro-intestinal’ morbidity.  There is little 
‘cardiovascular’, ‘neurological’, ‘wound’ or ‘haematological’ morbidity.  The study 
shows that many patients remain in hospital with no morbidity as defined by the 
POMS.   
 
Medical staff treating arthroplasty patients should be aware of the prevalence of 
post-operative morbidity in all organ systems.  This will allow prompt diagnosis 
and treatment of morbidity, minimising its impact.  Knowing the prevalence of 
morbidity following arthroplasty allows appropriate pre-operative patient 
education and counselling.  This enables patients to have realistic expectations 
regarding the post-operative period. 
 
To reduce post-operative morbidity, the prevalence and type of morbidity must 
first be known.  This will allow targets to be set for the future.  Morbidity with the 
highest prevalence or greatest long-term impact can be targeted first.  The 
following paragraphs summarise the causes of each category of morbidity and 
suggest ways to reduce morbidity rates.   
 
All pulmonary morbidity in this study referred to the use of supplementary 
oxygen.  The administration of supplementary oxygen could be audited to 
assess if it was required in all cases.  If inappropriate use was found, guidelines 
for correct prescribing could be produced and the audit cycle repeated.  In this 
way, pulmonary morbidity due to the inappropriate use of oxygen could be 
reduced. 
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Morbidity due to infection included wound infections, chest infections and 
urinary tract infections.  Surgical wounds can become infected either in theatre 
or on the ward.  Many measures are already in place to keep surgical site 
infection rates to a minimum but further methods could be trialled such as the 
use of antibiotic-coated sutures in theatre and the use of ‘ring-fenced’ beds on 
the ward to ensure that arthroplasty patients do not come into contact with 
infected patients.  To reduce the rate of chest infections, greater input from 
chest physiotherapists could be trialled.  To reduce the rate of urinary tract 
infections, earlier removal of catheters could be trialled. 
 
Renal morbidity was mainly due to the presence of a urinary catheter.  Some 
catheters may remain in-situ longer than necessary.  A trial of earlier removal of 
urinary catheters could be conducted in an effort to reduce renal morbidity and 
speed up patient discharge.  The incidence of urinary retention would need to 
be closely monitored.  If the incidence increased, the trial would need to be 
modified or abandoned. 
 
Most gastro-intestinal morbidity was due to nausea or the patient unable to 
tolerate an enteral diet.  Wider use of anti-emetics could reduce these 
problems.  Routine prescription of anti-emetics in the first 3 days following 
surgery could be trialled in an attempt to reduce gastro-intestinal morbidity.  
Adverse effects of the anti-emetic medication would need to be monitored.  If 
adverse effects outweighed the benefits of a reduction in nausea, the trial 
should be abandoned. 
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Cardiovascular morbidity was mainly due to the re-introduction of warfarin in 
patients who were taking anticoagulation pre-operatively.  Restarting 
anticoagulation can be done as an outpatient.  It may be prudent to remove this 
criterion from the definition of cardiovascular morbidity since it is not an 
adequate reason for a patient to remain in hospital.  Even patients who require 
subcutaneous injections of anticoagulant until the correct serum warfarin level is 
achieved can be treated on an outpatient basis.   
 
Another cause of cardiovascular morbidity was the diagnosis of deep vein 
thrombosis (DVT) and pulmonary embolism (PE).  The rate of DVT was 0% 
following UKR, RTKR and HR.  Rate of DVT following TKR was 2.2% (5/226), 
following THR was 1.2% (2/162) and following RTHR was 5.7% (2/35).  Rate of 
PE was 0% following UKR, TKR, RTKR and HR.  Rate of PE following THR was 
0.6% (1/162) and following RTHR was 2.9% (1/35).  These rates are 
comparable or better than those published in the literature122. To improve rates 
further, earlier post-operative physiotherapy could be introduced.  Further audit 
would be needed to assess the impact. 
 
Another cause of cardiovascular morbidity was myocardial infarction (MI).  The 
rate of MI following UKR, RTKR, HR and RTHR was 0%.  The rate of MI 
following TKR was 0.4% (1/226) and following THR was 1.2% (2/162).  A further 
cause of cardiovascular morbidity was development of a new cardiac 
arrhythmia.  No TKR, RTKR or HR patient developed a new arrhythmia. 
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1.5% (1/66) of UKR patients developed a cardiac arrhythmia, 0.8% (2/226) of 
THR patients and 2.9% (1/35) of RTHR patients.  The rate of MI and new onset 
cardiac arrhythmia is low in all groups.  The rate should be audited regularly to 
ensure it does not increase.   
 
Neurological morbidity was very infrequent.  1 TKR patient (0.4%) and 1 THR 
patient (0.6%) suffered a CVA post-operatively.  1.3% (3/226) of TKR patients 
and 1.2% (2/162) of THR patients had acute post-operative confusion.  1 patient 
(0.4%) developed acute psychosis following TKR.  These rates should be 
audited regularly to ensure they remain low.   
 
Wound morbidity is mainly due to superficial surgical site infection.  As already 
discussed, methods to reduce surgical site infection rate such as the use of 
‘ring-fenced’ beds, minimal dressing changes and alternate wound closure 
methods could be trialled to see if any improvement could be made. 
 
Haematological morbidity was entirely due to the requirement for red cell 
transfusion.  Attempts could be made to reduce this by the more judicious use 
of a ‘cell saver’ during surgery, by ensuring good haemostasis prior to wound 
closure and by trying different pressure dressings to reduce post-operative 
bleeding.   
 
Pain morbidity could be reduced by using larger volumes of local anaesthetic at 
the time of surgery and ensuring that all patients receive regular analgesia in 
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the early post-operative period.  Patients could be discharged with a short 
course of low-dose opioids.  The on-going use of opioids could be removed 
from the definition of pain morbidity since it is not an adequate reason for a 
patient to remain in hospital.  
2.4.2 Pattern of POMS morbidity over time 
 
In general, with increasing time after surgery, there was a decrease in the 
proportion of patients with each type of morbidity.  However, there were 
exceptions to this trend as described below.   
 
 Pulmonary morbidity increased between POD 8 and 15 in both the RTKR 
and RTHR groups.  This increase represented 4 patients who required 
supplementary oxygen following second surgical procedures to treat 
infected prostheses. 
 Infectious morbidity increased in the UKR group between POD 8 and 15 
due to 1 patient restarting antibiotics following gastric ulcer repair. 
Infectious morbidity increased in the THR group between POD 8 and 15 
due to one patient developing an infection at the site of a peripheral intra-
venous cannula. 
 Renal morbidity increased in the RTKR group between POD 8 and 15.  
This was due to 1 patient with generalised sepsis secondary to an 
infected prosthesis who had a urinary catheter inserted to monitor fluid 
balance. 
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 Gastro-intestinal morbidity increased between POD 8 and 15 in the 
RTKR group due to 1 patient vomiting secondary to generalised sepsis.  
 Cardiovascular morbidity increased in the UKR group between POD 3 
and 5 due to a patient developing atrial fibrillation (AF) following a 
perforated gastric ulcer.  Cardiovascular morbidity increased in the TKR 
group between POD 3 and 5 due to 3 patients diagnosed with DVT and 1 
patient diagnosed with MI.  Cardiovascular morbidity increased in the 
RTHR group between POD 3 and 5, and again between POD 5 and 8.  
These increases were due to 1 patient in each time interval being 
diagnosed with a PE.  Patients restarted on anticoagulation they were 
taking pre-operatively have not been included here. 
 Neurological morbidity increased in the THR group between POD 5 and 
8 due 1 patient having a CVA. 
 Wound morbidity increased in all groups except UKR.  8 TKR patients 
were diagnosed with wound morbidity between POD 3 and 5.  1 RTKR 
patient was diagnosed with wound morbidity between POD 5 and 8.  2 
HR patients were diagnosed with wound morbidity between POD 3 and 
5.  8 THR patients were diagnosed with wound morbidity between POD 3 
and 5.  6 RTHR patients were diagnosed with wound morbidity between 
POD 3 and 5. 
 Haematological morbidity increased in the UKR group between POD 3 
and 5 due to 1 patient requiring a red cell transfusion following abdominal 
surgery to repair a perforated gastric ulcer. 
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 Pain morbidity increased in the RTHR group between POD 8 and 15 due 
to 1 patient having pain following a second surgical procedure to reduce 
and fix a periprosthetic fracture. 
2.4.3 Differences in post-operative morbidity between 
types of lower limb arthroplasty 
 
The only risk-adjusted statistical difference in post-operative morbidity was 
found between primary and revision hip arthroplasty.  The presence of any type 
of morbidity was increased following RTHR compared to THR on POD 3, 5, 8 
and 15.  There was more infectious morbidity following RTHR compared to THR 
on POD 3, 5, 8 and 15.  There was more renal morbidity following RTHR 
compared to THR on POD 3. 
 
This result is expected since revision hip arthroplasty usually takes longer to 
perform than primary arthroplasty, it usually involves a larger incision with 
greater dissection of tissues and there is often greater blood loss.  Therefore it 
seems intuitive that patients will have more morbidity following revision hip 
arthroplasty than primary arthroplasty.   
 
The indication for many revision arthroplasty procedures is infection of the 
primary prosthesis.  For this reason a higher rate of post-operative infection is 
expected in the revision arthroplasty group since infection is present pre-
operatively.  The higher rate of renal morbidity in the revision arthroplasty group 
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was mainly due to an increased number of patients with a urinary catheter in-
situ.  Revision arthroplasty usually involves greater blood loss than primary 
arthroplasty and anaesthetic times are usually longer.  For these reasons more 
revision arthroplasty patients require monitoring of their fluid balance in the 
early post-operative period (necessitating the placement of a urinary catheter), 
which could account for the difference in renal morbidity levels. 
 
No difference in post-operative morbidity was seen between primary and 
revision knee arthroplasty. The most likely reason for this is the low number of 
patients in the RTKR group.  If greater numbers had been included in the study, 
a difference may have been found.  This area requires further study. 
 
After adjusting for POSSUM morbidity scores, no difference in post-operative 
morbidity was found between UKR and TKR, and HR and THR.  UKR and HR 
preserve more bone stock than total total joint replacements making revision 
surgery potentially easier.  For this reason UKR and HR are often described as 
‘less invasive’ than total joint replacements.  This study shows that UKR and HR 
produce the same levels of post-operative morbidity as total joint arthroplasty.  
However, the study populations in the UKR and HR groups are small and this 
result may represent a type 2 error.  Further investigation with larger study 
numbers is needed for further clarification. 
 
After adjusting for POSSUM morbidity scores, no difference in post-operative 
morbidity was found between primary hip and knee arthroplasty.  Similarly, 
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no difference was found between revision hip and knee arthroplasty.  
Arthroplasty procedures on the hip inflict the same levels of post-operative 
morbidity as arthroplasty procedures on the knee. 
2.4.4 Comparison with other morbidity estimates 
 
 
Post-operative morbidity following primary and revision lower limb arthroplasty 
has not previously been compared using the POMS method.  There are few 
studies in the orthopaedic literature that directly compare morbidity following 
primary and revision arthroplasty.  There are many case series reporting the 
outcome of various types of arthroplasty.  Direct comparisons between series 
are difficult due to the reporting of different measures of morbidity over varying 
timescales.  Furthermore, most studies do not adjust for patient and surgical 
factors when reporting morbidity. 
 
Most case series and studies comparing alternate prostheses report the 
incidence of limb-related morbidity only.  Commonly reported morbidity includes 
deep vein thrombosis123-125, periprosthetic fracture126-128 and deep surgical site 
infection129-131.  Our study collected morbidity relating to complete organ 
systems rather than individual diagnoses.  There are very few studies in the 
literature that explore all aspects of morbidity following arthroplasty but there 
are some case series that report different aspects of non-limb related post-
operative morbidity.  These papers will be discussed below in relation to the 
findings from this study. 
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2.4.4.1 Pulmonary morbidity 
 
 
Wallace et al132 reported on a series of 31,510 primary hip arthroplasty patients 
and 32,303 primary knee arthroplasty patients.  Data was collected from GP 
databases and was analysed retrospectively.  Morbidity was reported for six 
months following surgery.  Respiratory tract infection rate was 0.55% in the hip 
group and 0.59% in the knee group.   
 
Mantilla et al133 retrospectively examined the medical records of 10,244 primary 
hip and knee arthroplasty patients and reported morbidity for 30 days following 
surgery.  The rate of pulmonary embolus was 0.7%. 
 
Parvizi et al 134 conducted a prospective analysis of post-operative morbidity in 
1,636 patients for 6 weeks following primary hip and knee replacement.  They 
reported 25 pulmonary emboli (1.53%) and 4 cases of pneumonia (0.24%). 
 
The POMS definition of pulmonary morbidity is ‘a new need for oxygen or 
respiratory support’.  Cardiac pathologies, as well as primary pulmonary 
pathologies, often require the administration of oxygen.  This could partially 
explain the higher rate of pulmonary morbidity reported in this study (12.0% on 
POD 3 in the TKR group and 15.4% on POD 3 in the THR group) compared to 
the studies described above.  A further explanation could be that this study was 
conducted prospectively where as the first two studies described above were 
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performed retrospectively.  Prospective studies will always capture more events 
than retrospective studies.  A further explanation could be that oxygen was 
given unnecessarily to patients in this study. 
2.4.4.2 Infection 
 
Wallace et al132 reported a respiratory infection rate of 0.55% following hip 
arthroplasty and 0.59% following knee arthroplasty.  The wound infection rate 
was 2.23% in the hip group and 3.41% in the knee group. The urinary tract 
infection rate was 2.45% in the hip group and 2.23% in the knee group.  This 
gives an overall infection rate of 5.23% in the hip arthroplasty group and 6.23% 
in the knee arthroplasty group (although this summation may not be accurate 
since more than one type of infection may have occurred in the same patients).   
 
Parvizi et al 134 reported an overall urinary tract infection rate of 3.06% following 
hip and knee arthroplasty.  The rate of pneumonia was 0.24% and the rate of 
wound infection was 0.67%.  This gives an overall combined rate of infection of 
3.97% (although again, this summation may be inaccurate for the same reasons 
as described above). 
 
Pulido et al135 reported on prospectively collected data from 9,245 patients 
following primary hip and knee arthroplasty.  The rate of deep infection was 
0.7%.  Mean time of follow-up was 43 months.  Other types of infection were not 
reported. 
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The rate of infectious morbidity in this study (18.1% for TKR on POD 3 and 
20.4% for THR on POD 3) is higher than in the studies described above. There 
are several possible explanations for this.  The most obvious explanation is a 
difference in the definition of infectious morbidity.  The POMS definition is a 
patient ‘currently taking antibiotics’ and/or has had ‘a temperature of 38ºC or 
above in the last 24 hours’.  There are many indications for antibiotics including 
prophylaxis and the treatment of infection at any site (e.g. upper respiratory 
tract infection, ear infection, phlebitis).  Patients taking antibiotics for these 
reasons would not have been captured in the studies described above.  Also, a 
temperature over 38ºC does not always indicate an infection.  Many hip and 
knee replacements are performed in patients with rheumatoid arthritis.  These 
patients can have a rise in body temperature due the inflammatory nature of 
their underlying condition rather than an active infection.  Therefore, our 
infectious morbidity rate may be an over-estimate.  The fact this study was 
conducted prospectively rather than retrospectively could also partially account 
for the higher rates of infection.   
2.4.4.3 Renal morbidity 
 
 
Parvizi et al 134 reported an acute renal failure rate of 0.86%.  The rate of renal 
morbidity was much higher in our study (22.6% for TKR on POD 3 and 35.8% 
for THR on POD 3).  The most likely reason for this higher rate of morbidity is 
the POMS definition: ‘oliguria of less than 500ml/day, a raised creatinine level of 
over 30% compared to pre-operatively, or a urinary catheter in-situ’.  Most renal 
morbidity in our study was due to the presence of a urinary catheter.  Out of 
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the 529 patients in our study, only 1 patient developed acute renal failure 
(0.19%).  This rate of renal failure is comparable with that reported by Parvizi. 
2.4.4.4 Gastro-intestinal morbidity 
 
Parvizi et al 134 reported gastric immobility in 0.73% of patients and nausea and 
vomiting in 0.61% of patients  following arthroplasty. Rates of gastrointestinal 
morbidity were higher in our study with the highest rates seen on POD 3 (16.8% 
in TKR group and 11.7% in THR group).  POMS defines gastrointestinal 
morbidity as ‘unable to tolerate an enteral diet’ or the patient experiencing 
‘nausea, vomiting or abdominal distension’.  Parvizi would not have identified 
patients unable to tolerate an enteral diet as having morbidity, which could 
largely explain the difference in the figures between the 2 studies.  
2.4.4.5 Cardiovascular morbidity 
 
 
Wallace et al132 reported a combined rate of pulmonary embolus and deep vein 
thrombosis of 2.86% following hip arthroplasty and 2.76% following knee 
arthroplasty.  The rate of myocardial infarction in the hip group was 0.40% and 
in the knee group 0.41%.  
 
Mantilla et al133 reported a 0.4% rate of myocardial infarction, 0.7% rate of 
pulmonary embolus and 1.5% rate of deep vein thrombosis following hip and 
knee arthroplasty.  
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Lalmohammed et al136 investigated 95,227 patients for 6 weeks following 
primary THR and TKR.  The data was collected retrospectively using Danish 
health registries.  The rate of myocardial infarction in the THR group was 0.51% 
and in the TKR group was 0.21%.   
 
Pedersen et al137 used retrospective information from Danish health registries to 
report on the rate of cardiovascular events in 83,756 patients following primary 
hip and knee arthroplasty.  The combined rate of myocardial infarction and 
stroke was reported as 0.5%, the rate of symptomatic venous thromboembolism 
was 1.3% and the rate of a major bleed was 0.6%. 
 
Parvizi et al 134 reported a 0.06% rate of cardiac arrest, 5.07% rate of 
arrhythmias, 0.61% rate of congestive cardiac failure, 0.37% rate of myocardial 
infarction, 0.24% rate of hypotensive crisis, 0.37% rate of pulmonary embolus 
and 1.53% rate of deep vein thrombosis.  This gives a combined value of 8.25% 
(but this summation may be invalid since individual patients may have 
experienced more than one type of cardiovascular morbidity).  
 
The rate of cardiovascular morbidity in our study (4.4% of TKR patients and 
4.9% of THR patients on POD 5) was similar to the rate reported by Parvizi.   
The definition of POMS cardiovascular morbidity is ‘ischaemia or hypotension 
requiring drug therapy or fluid therapy of over 200ml per hour, atrial or 
ventricular arrhythmia, cardiogenic pulmonary oedema or new anticoagulation’.  
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Therefore our study and Parvizi’s study collected similar data allowing a 
meaningful comparison to be made.   
 
If the cardiovascular morbidity domain of POMS is broken down into its 
components, the rate of MI in our study (0.4% following TKR and 1.2% following 
THR) was similar to that reported by Wallace, Mantilla, Lalmohammed and 
Parvizi.  The rate of DVT (2.2% following TKR and 1.2% following THR) and PE 
(0% following TKR and 0.6% following THR) in our study was also comparable 
or lower than that reported by Wallace, Mantilla and Parvizi. 
2.4.4.6 Neurological morbidity 
 
 
Wallace et al132 reported a 0.50% rate of stroke following primary hip 
arthroplasty and a 0.44% rate of stroke following knee arthroplasty.  
Lalmohamed et al138 retrospectively looked at 66,583 patients using Danish 
health registries for 6 weeks following primary THR.  An overall stroke rate of 
1.14% was reported (0.22% ischaemic, 0.56% haemorrhagic, 0.36% 
unspecified). 
 
Parvizi et al 134 reported a stroke rate of 0.37% following hip and knee 
arthroplasty.  Mortazavi139 et al reported a 0.2% rate of stroke at a mean of 62 
months following primary hip and knee arthroplasty. 
 
The rate of neurological morbidity in our study (2.2% in TKR group at post-
operative day three and 1.2 % in THR group on post-operative day three) is 
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higher than in the studies described above.  The most likely reason for this is 
the wording of POMS definition of neurological morbidity: ‘new confusion/ 
delirium, focal deficit or coma’.  The studies described above only report the 
rate of stroke.  This study reports the combined rate of stroke, transient 
ischaemic attack, confusion and reduced consciousness.  The rate of stroke in 
our study was 1/226 (0.4%) in the TKR group and 0/162 (0%) in the THR group, 
which is comparable or better than the rates in the studies described above. 
2.4.4.7 Wound morbidity 
 
 
Wallace et al132 reported a wound infection rate of 2.23% following hip 
arthroplasty and 3.41% following knee arthroplasty.  Parvizi et al 134 reported a 
4.52% rate of persistent wound discharge and a 0.67% rate of wound infection. 
 
Pulido et al135 reported a deep infection rate of 0.7% in 9,245 patients following 
primary hip and knee arthroplasty.  Data was collected prospectively.  Mean 
time of follow-up was 43 months. 
 
The definition of POMS morbidity is ‘wound dehiscence requiring surgical 
exploration or drainage of pus from the operative wound with or without isolation 
of organisms’.  The rate of wound morbidity was higher in our study (6.2% in 
TKR patients and 9.3% in THR patients on POD 5) than in the studies 
described above.  Possible reasons for this discrepancy include the use of 
different definitions of wound morbidity and the use of different methods of data 
collection (prospective data collected at the patient’s bedside vs 
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retrospective data collected from medical notes).  However, these explanations 
cannot be assumed and a real difference between this study and previous 
studies may exist.  Surgical site infection is a major risk of arthroplasty surgery, 
with potentially catastrophic consequences.   For these reasons, I will 
investigate the wound domain of POMS further in Chapter 5 of this thesis. 
2.4.4.8 Haematological morbidity 
 
 
Verlicchi et al140 reported a 69% (185/268) red cell transfusion rate for HR, 53% 
(263/497) transfusion rate for THR, 72% (71/98) for RTHR, 43% (233/541) for 
TKR and 41% (9/22) for RTKR.  Evans et al141 reported a red cell transfusion 
rate of 0.9 % (1/102) following TKR, 13.5% (7/52) following THR, 27.3% (3/11) 
following RTKR and 56.3% (9/16) following RTHR.  Gombotz et al142 reported a 
30% (367/1223) red cell transfusion rate following THR and 25% (307/1227) 
transfusion rate following TKR.  
 
The POMS definition of haematological morbidity is ‘transfusion of red blood 
cells, platelets, fresh frozen plasma or cryoprecipitate within the last 24 hours’.  
The only blood product given to any arthroplasty patient following surgery was 
red cells.  The rates of transfusion in this study are much lower than those 
reported in the studies above.  The most likely reason for this is the fact that 
data was only collected on POD 3, 5, 8 and 15.  Red cells transfused in the 
preceding 24 hours were recorded.  Therefore, transfusions that were given on 
other days (e.g. POD 1 and 2) would not have been captured in this study.  The 
rate of transfusion also depends on other factors such as the patient’s pre-
  
 
 
 
 
 
 
138 
operative haemoglobin level, the volume of operative blood loss, use of an intra-
operative ‘cell saver’, the quality of surgical haemostasis and wound closure, 
and the threshold haemoglobin level for transfusion.  Any of these factors could 
have contributed to the lower transfusion level in our study. 
2.4.4.9 Pain 
 
There are many studies examining pain following hip and knee arthroplasty143-
145.  It is difficult to make meaningful comparisons between studies since 
different tools are used to assess pain severity, pain is reported at different time 
points and different analgesia regimens are used.  Petre et al146 reported on a 
series of 352 patients following hip and knee arthroplasty.  Patients had a mean 
pain score of between 4 and 5 (on a VAS scale with a maximum score of 10) in 
the first five post-operative days. 
 
The POMS definition of pain morbidity is ‘surgical wound pain significant 
enough to require parenteral opioids or regional anaesthesia’.  A low proportion 
of patients were reported as having pain morbidity (7.1% of TKR patients on 
POD 3 with none thereafter, 6.3% of THR patients POD 5 with none thereafter).  
These figures appear favourable to the study mentioned above.  However, 
since different measures of pain have been used, direct comparisons may not 
be valid.  
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2.4.5 Strengths of the study 
 
 
This study has several strengths.  Firstly, there is a large population sample 
size.  Secondly, specially trained staff collected complete prospective data sets. 
The same clearly defined data was collected on all patients allowing meaningful 
comparisons between arthroplasty groups. 
2.4.6 Limitations of the study 
 
 
There are several limitations to this study.  Firstly, this study was conducted at a 
single site and therefore the results may not be transferable to other centres.  
Secondly, the number of revision arthroplasty patients was lower than the 
primary arthroplasty groups.  Therefore, results regarding morbidity following 
revision arthroplasty may be less accurate than those regarding morbidity 
following primary arthroplasty.  This is particularly pertinent for the revision knee 
arthroplasty group, which only contained 8 patients.    
2.5 Summary 
 
1. Morbidity following arthroplasty has previously been poorly recorded. 
2. This is the first time the POMS has been used to record morbidity 
following hip and knee arthroplasty. 
3. The most common types of morbidity following hip and knee arthroplasty 
are infection and renal morbidity.  Pulmonary, pain and gastro-intestinal 
morbidity are less common.  Cardiovascular, wound, neurological and 
haematological morbidity are the least common. 
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4. Most post-operative morbidity decreases with time after surgery. 
5. Medical staff treating arthroplasty patients should be aware of the 
prevalence of post-operative morbidity in all organ systems.  This allows 
prompt diagnosis and treatment of morbidity, minimising its impact. 
6. Knowing the prevalence of morbidity following arthroplasty allows 
appropriate pre-operative patient education and counselling.  This 
enables patients to have realistic expectations regarding the post-
operative period. 
7. There is a statistically significant risk-adjusted difference in the presence 
of any type of post-operative morbidity following primary and revision hip 
arthroplasty on POD 3, 5, 8 and 15. Morbidity is higher in the RTHR 
group. 
8. There are statistically significant risk-adjusted higher levels of infection 
following RTHR than THR on POD 3, 5, 8 and 15.  On POD 3, there are 
higher levels of renal morbidity following RTHR than THR. 
9. There is no difference in post-operative morbidity following primary and 
revision knee arthroplasty. The most likely reason for this is the low 
number of patients in the RTKR group.  
10. After adjusting for POSSUM morbidity scores, no difference in post-
operative morbidity was found between UKR and TKR, and HR and 
THR.  This could be a result of a type 2 error due to a small study 
population in the UKR and HR groups.  Further investigation with larger 
study numbers is required. 
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11. After adjusting for POSSUM morbidity scores, no difference in post-
operative morbidity was found between hip and knee procedures. 
12. Most levels of post-operative morbidity in this study are higher than in 
previously published studies.  The use of different definitions of morbidity 
could partially account for the discrepancy. The definitions of POMS 
morbidity in different organ systems are broad and will therefore capture 
more events than narrowly defined measures of morbidity.  Different 
methods of data collection could also account for the discrepancy; this 
study collected data prospectively, which will always capture more 
events than retrospectively collected data. 
13.  This study provides baseline data against which future audits can be 
compared.  Strategies can be implemented to reduce morbidity levels 
and the audit cycle repeated to evaluate their impact. 
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Chapter 3: POMS as a bed utilisation tool 
 
3.1 Introduction 
 
This chapter assesses the use of the POMS as a bed utilisation tool and its 
ability to identify inappropriate bed occupancy following hip and knee 
arthroplasty.  I will describe the methods used to collect and analyse the POMS 
data and I will present the results for both hip and knee arthroplasty procedures.   
 
The number of inappropriate bed occupancy days for each type of arthroplasty 
will be calculated together with the potential cost saving if patients with no 
morbidity were discharged at the earliest opportunity.  I will describe the 
reasons why patients remained in hospital with no identifiable morbidity.  I will 
identify patients who developed morbidity following a period with no morbidity 
and report the number of patients re-admitted to the same hospital within one 
year of surgery.  I will conclude with a discussion of the results including the 
strengths and weaknesses of this study.  I will compare the results to other bed 
utilisation studies.  Finally I will present a summary of key findings. 
 
Appropriately timed discharge of patients following surgery is essential for 
optimal patient care and efficient hospital functioning.  A patient discharged 
early is at risk of under-diagnosis of medical complications with consequent 
adverse outcome.  A patient whose discharge is delayed is at risk of 
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developing a hospital-associated complication (e.g. hospital-acquired infection) 
and incurs an unnecessary cost to the health-care provider.  Post-operative 
patients should be discharged at the earliest safe opportunity to reduce the rate 
of hospital-associated complications and the cost of each inpatient episode.  
Appropriate discharge timing should increase patient throughput and reduce 
waiting times.    
 
Historically, hospitals in the UK were paid according to contracts with no 
financial incentive to treat increased numbers of patients.  This changed in 2000 
when the NHS Plan147 announced that hospital income would be directly linked 
to activity.  Payment by Results6 began in 2003 and now every healthcare 
provider is paid a sum (tariff) for each procedure undertaken.  In the UK many 
patients remain in hospital with no medical indication18.  One study showed that 
31% of post-operative patients remained in hospital inappropriately 85.  Payment 
by Results aims to reduce this figure by rewarding efficiency and encouraging 
increased activity. 
 
In order to improve efficiency, hospitals must first recognise inappropriate bed 
occupancy.  The Post-Operative Morbidity Survey (POMS)20 is the only 
validated prospective method of measuring short-term post-operative morbidity 
in the literature.  
 
In the US over 98% of post-operative inpatients had morbidity defined by the 
POMS20.  This implies that patients with a POMS score of zero are fit for 
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discharge.  Therefore, as well as providing useful clinical research and audit 
data, the POMS may have utility for assessing and improving hospital bed 
utilisation. 
 
The aim is this chapter is to assess the utility of the POMS as a bed utilisation 
tool and its ability to identify inappropriate bed occupancy following hip and 
knee arthroplasty. The reasons patients remain in hospital with no identifiable 
morbidity will be reported and particular attention will be given to 2 groups of 
patients: those who developed morbidity following a period with no morbidity 
and patients re-admitted to the same hospital within one year of surgery.  
Inappropriate bed utilisation rates will compared to other bed utilisation studies.   
3.2 Methods 
 
The methods used to collect the POMS data are described fully in Chapter 2.  
The patient demographics are also described in detail.    POMS data was 
collected on post-operative days (POD) 3, 5, 8 and 15 if the patient remained in 
hospital.  Presence of post-operative morbidity was defined as occurring in any 
patient meeting POMS criteria for morbidity in one or more domain of the survey 
on the day of data collection.   The reason for patients remaining in hospital 
without morbidity was recorded on POD 8 and 15.  The use of mobility aids on 
these days was also recorded.   
 
The number and percentage of patients with no identifiable morbidity according 
to the POMS was calculated for POD 3, 5, 8 and 15.  The number of days a 
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patient remained in hospital with no morbidity was calculated by subtracting the 
number of the POD on which the patient first had a POMS score of zero from 
their total length of stay.  An overall estimated cost saving was calculated by 
multiplying this figure by the average cost for one inpatient night on an 
orthopaedic ward. 
 
The number of patients with post-operative morbidity, subsequent to having a 
period free of morbidity, was recorded.  The number of readmissions to the 
same hospital in the first year following discharge was also recorded. 
3.3 Results 
 
Data collection was completed on 529 patients.  Characteristics of the study 
population are shown in tables 8 and 9 in Chapter 2.  The mean age of the 
study population was 68.9 years, the median ASA grade was 2 and 62% of 
patients were female.  The median length of stay was 7 days and the overall 
inpatient mortality rate was 0.4%. 
3.3.1 Hip arthroplasty patients 
 
The location of hip arthroplasty patients on POD 3, 5, 8 and 15 is shown in table 
28. 
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Table 28. Location of 229 hip arthroplasty patients on POD 3, 5, 8 and 15  
  POD 3 POD 5 POD 8 POD 15 
 
 
 
Procedure 
HR Patients 
discharged 
0/32 
(0%) 
2/32 
(6%) 
27/32  
(84%) 
32/32 
(100%) 
Inpatients 
POMS >0 
8/32 
(25%) 
5/32 
(16%) 
0/32 
(0%) 
0/32 
(0%) 
Inpatients 
POMS = 0 
24/32 
(75%) 
25/32 
(78%) 
5/32 
(16%) 
0/32 
(0%) 
THR Patients 
discharged 
0/162 
(0%) 
13/162  
(8%) 
78/162  
(48%) 
138/162 
(85%) 
Inpatients 
POMS >0 
87/162 
(54%) 
62/162 
(38%) 
29/162 
(18%) 
13/162 
(8%) 
Inpatients 
POMS = 0 
75/162  
 
(46%) 
 
87/162 
 
(54%) 
55/162 
 
(34%) 
11/162 
 
(7%) 
RTHR Patients 
discharged 
0/35 
(0%) 
0/35 
(0%) 
3/35 
(9%) 
20/35 
(57%) 
Inpatients 
POMS >0 
31/35 
(89%) 
25/35 
(71%) 
21/35 
(60%) 
14/35 
(40%) 
Inpatients 
POMS = 0 
4/35 
(11%) 
10/35 
(29%) 
11/35 
(31%) 
1/35 
(3%) 
TOTAL Patients 
discharged 
0/229 
(0%) 
16/229 
(7%) 
109/229 
(47%) 
191/229 
(83%) 
Inpatients 
POMS >0 
127/229 
(55%) 
92/229 
(40%) 
50/229 
(22%) 
27/229 
(12%) 
Inpatients 
POMS = 0 
103/229 
(45%) 
122/229 
(53%) 
71/229 
(31%) 
12/229 
(5%) 
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A significant proportion of hip resurfacing patients remained in hospital with no 
morbidity on POD 3 (75%) and POD 5 (78%).  This reduced to 16% by POD 8.  
All hip resurfacing patients were discharged by POD 15.  Similarly, a significant 
proportion of total hip replacement patients remained in hospital with no 
identifiable morbidity on POD 3 (46%) and POD 5 (54%).  This reduced to 34% 
by POD 8 and to 7% by POD 15.  The proportion of revision total hip 
replacement patients remaining in hospital with no identifiable morbidity was 
lower than the other hip arthroplasty groups (11% on post-POD 3, 29% on POD 
5, 31% on POD 8 and 3% on POD 15). 
 
Discharge status and prevalence of morbidity for all hip arthroplasty patients 
combined are presented in figure 1.   
Figure 1 Discharge status and prevalence of morbidity following hip 
arthroplasty 
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3.3.2 Knee arthroplasty patients 
 
The location of patients on POD 3, 5, 8 and 15 is shown in table 29.   
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Table 29. Location of 300 knee arthroplasty patients on POD 3, 5, 8 and 15  
  POD 3 POD 5 POD 8 POD 15 
 
 
 
Procedure 
UKR Patients 
discharged 
7/66 
(11%) 
33/66 
(50%) 
59/66 
(89%) 
65/66 
(98%) 
Inpatients 
POMS >0 
17/66 
(26%) 
7/66 
(11%) 
3/66 
(5%) 
1/66 
(2%) 
Inpatients 
POMS = 0 
42/66 
(63%) 
26/66 
(39%) 
4/66 
(6%) 
0/66 
(0%) 
TKR Patients 
discharged 
0/226 
(0%) 
22/226 
(10%) 
145/226 
(64%) 
211/226 
(93%) 
Inpatients 
POMS >0 
114/226 
(50%) 
90/226 
(40%) 
38/226 
(17%) 
7/22 
(3%) 
Inpatients 
POMS = 0 
112/226 
 
(50%) 
 
114/226 
 
(50%) 
43/226 
 
(19%) 
8/226 
 
(4%) 
RTKR Patients 
discharged 
0/8 
(0%) 
1/8 
(13%) 
1/8 
(13%) 
6/8 
(75%) 
Inpatients 
POMS >0 
6/8 
(75%) 
4/8 
(50%) 
5/8 
(62%) 
1/8 
(12.5%) 
Inpatients 
POMS = 0 
2/8 
(25%) 
3/8 
(37%) 
2/8 
(25%) 
1/8 
(12.5%) 
TOTAL Patients 
discharged 
7/300 
(2%) 
56/300 
(19%) 
205/300 
(68%) 
282/300 
(94%) 
Inpatients 
POMS >0 
137/300 
(46%) 
101/300 
(34%) 
46/300 
(15%) 
9/300 
(3%) 
Inpatients 
POMS = 0 
156/300 
(52%) 
143/300 
(47%) 
49/300 
(17%) 
9/300 
(3%) 
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A significant proportion of UKR patients remained in hospital with no morbidity 
on POD 3 (63%) and POD 5 (39%).  This reduced to 6% by POD 8.  All UKR 
patients were discharged by POD 15.  Similarly, a significant proportion of TKR 
patients remained in hospital with no identifiable morbidity on POD 3 (50%) and 
POD 5 (50%).  This reduced to 19% by POD 8 and to 4% by POD 15.  The 
proportion of RTKR patients remaining in hospital with no identifiable morbidity 
was similar to the primary knee arthroplasty group (52% on POD 3, 47% on 
POD 5, 17% on POD 8 and 3% on POD 15). 
 
Discharge status and prevalence of morbidity for all knee arthroplasty patients 
combined are presented in figure 2.   
Figure 2 Discharge status and prevalence of morbidity following all types 
of knee arthroplasty 
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3.3.3 Overall inappropriate bed occupancy days 
 
Table 30 and figure 3 show the average number of days that patients remained 
in hospital with no identifiable morbidity.   HR patients stayed an average of 
2.36 days, THR patients 4.19 days and revision THR patients 10.37 days.  UKR 
patients stayed an average of 1.76 days with no identifiable morbidity, TKR 
patients 2.73 days, and revision TKR patients 14.38 days.   
Table 30. Number of inappropriate inpatient days classified by type of 
arthroplasty 
 
 Total number of 
patients 
Total number of 
inappropriate 
inpatient days 
Average number 
of inappropriate 
inpatient days per 
patient 
HR 32 78 2.43 
THR 162 678 4.19 
RTHR 35 363 10.37 
UKR 66 111 1.68 
TKR 226 620 2.74 
RTKR 8 115 14.38 
Total 529 1965 3.71 
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Figure 3. Average number of inappropriate inpatient days classified by 
type of arthroplasty 
 
 
 
3.3.4 Cost of inappropriate bed occupancy days 
 
 
529 patients were included in this study.  These patients remained in hospital 
for a total of 1965 days with no morbidity as defined by the POMS.  A surgical 
inpatient bed costs up to £400 per night148.  If these patients had been 
discharged when their POMS score was zero a saving of up to £786,000 could 
have been made. 
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3.3.5 Reasons for patients with no morbidity remaining 
in hospital 
Of the 529 patients participating in this study, 120 remained in hospital with no 
morbidity defined by the POMS on POD 8.  By POD 15, there were 20 patients 
in hospital with no identifiable morbidity.  The reasons given for non-discharge 
are shown in figure 4.   
Figure 4. Reasons hip and knee arthroplasty patients remained in hospital 
with no morbidity on post-operative days 8 and 15 
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The most common reason for patients remaining in hospital with no morbidity 
was on-going physiotherapy and occupational therapy input.  Other reasons 
included waiting for home equipment, waiting for a rehabilitation bed, waiting for 
a social services package of care and patients feeling unwell with negative 
investigations.   
 
Of the patients remaining in hospital with no morbidity identified by the POMS, 
24% were mobilising with a Zimmer frame, 55% were mobilising with two 
crutches, 14% with a single crutch and 7% were mobilising unaided.  This study 
did not record how far each patient could mobilise or if they were able to climb 
stairs. 
3.3.6 New morbidity and readmission 
 
Several patients in the study developed morbidity as an inpatient following a 
period with no morbidity.  Re-starting anticoagulation medication that the patient 
was taking pre-operatively was not counted as morbidity in this evaluation.   
 
Some patients had a second surgical procedure during their inpatient stay.  
They developed morbidity after the second surgical procedure following a 
period without morbidity between the two procedures.  This occurred in the 
following situations: 
 1 UKR patient developed a perforated duodenal ulcer 2 days after his 
knee surgery. This patient developed infectious, cardiovascular and 
haematological morbidity following his laparotomy. 
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 1 RTKR patient had no morbidity on POD 8.  He subsequently developed 
a deep knee infection and returned to theatre on POD 12 for knee 
washout and change of liner.  On post-operative day 15 he had 
pulmonary, renal and gastro-intestinal morbidity. 
 3 RTHR patients had no morbidity on POD 8.  2 of these patients 
developed deep infection and returned to theatre on POD 9 and POD 12 
respectively for hip washout and change of liner.  They both had 
pulmonary morbidity and 1 had gastro-intestinal morbidity on POD 15.  
The other patient fell and sustained a periprosthetic fracture.  He 
returned to theatre for surgical fixation.  On POD 15 he had pulmonary 
and pain morbidity. 
 
Some patients developed morbidity after a period with no morbidity without a 
further surgical procedure.  This occurred in the following cases: 
 4 TKR patients had no morbidity on POD 3 and developed 
cardiovascular morbidity by POD 5.  3 patients had deep vein 
thromboses and 1 patient had a myocardial infarction. 
 8 TKR patients had no morbidity on POD 3 and developed wound 
morbidity on POD 5. 
 1 RTKR had no morbidity on POD 5 and developed wound morbidity by 
POD 8.  The indication for revision surgery was infection of the primary 
prosthesis. 
 2 HR patients had no morbidity on POD 3 and developed wound 
morbidity by POD 5. 
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 8 THR patients had no morbidity on POD3 and developed wound 
morbidity by POD 5. 
 1 THR patient had no morbidity on POD 5 and developed neurological 
morbidity by POD 8 due to a CVA. 
 1 THR patient had no morbidity on POD 8 and developed infectious 
morbidity by POD 15 due to an infected peripheral intra-venous cannula 
site.  This could have been avoided if the cannula had been removed 
and the patient discharged on POD 8. 
 2 RTHR patients had no morbidity and then developed cardiovascular 
morbidity (on POD 5 and 8 respectively) due to the commencement of 
anticoagulation for pulmonary emboli. 
 6 RTHR patients had no morbidity on POD 3 and developed wound 
morbidity by POD 5.  The indication for revision surgery in these patients 
was infection of the primary prosthesis. 
 
In summary, 33 out of 501 patients who underwent a single surgical procedure 
developed morbidity as defined by the POMS after a period of time with no 
morbidity.  25 of these patients developed wound morbidity, 6 developed 
cardiovascular morbidity, 1 patient developed neurological morbidity and 1 
patient developed infectious morbidity.   
 
Of the 25 patients who developed wound morbidity, 24 of them had no morbidity 
on POD 3 and developed wound morbidity by POD 5. 1 RTKR patient had no 
morbidity on POD 5 and developed wound morbidity by POD 8.  
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Of the 6 patients that developed cardiovascular morbidity following a period with 
no morbidity, 5 of them had no morbidity on POD 3 and developed morbidity by 
POD 5.  3 patients had a DVT, 1 had a PE and 1 had an MI. 1 RTHR patient 
had no morbidity on POD 5 and developed cardiovascular morbidity on POD 8.  
This patient had a PE. 
 
1 THR patient had no morbidity on POD 5 and had a CVA by POD 8.  This is a 
rare event (1/529).  1 patient had no morbidity on POD 8 and developed 
infectious morbidity (an infected peripheral cannula site) by POD 15.  
 
No patient in this study was readmitted to the same hospital within one year of 
discharge for any reason relating to his or her surgery. 
 
3.4 Discussion 
 
3.4.1 Summary 
    
This study identifies that many patients remain in hospital with no identifiable 
morbidity following hip and knee arthroplasty in a UK teaching hospital.  The 
rate of inappropriate bed occupancy varies with the type of arthroplasty and 
time after surgery.  Two general trends are seen.  Firstly, the more ‘invasive’ the 
surgery, the longer a patient remains in hospital with no identifiable morbidity.  
Thus revision arthroplasty patients remain in hospital with no morbidity longer 
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than primary total knee/hip replacement patients who remain longer than 
unicondylar knee/hip resurfacing patients.   Secondly, the proportion of patients 
remaining in hospital with no morbidity decreases with time following surgery.  
This trend is seen in the UKR, TKR, HR and THR groups.  In the revision 
arthroplasty groups there is a rise in patients with no morbidity between POD 3 
and 5.  The proportion then decreases.  
 
The most common reason for patients remaining in hospital with no identifiable 
morbidity was on-going physiotherapy and occupational therapy.  This suggests 
that improving both pre- and post-operative therapy planning could reduce 
inappropriate bed occupancy.  Prior to surgery, patients could be taught their 
post-operative physiotherapy exercises in group classes.  Occupational 
therapists could assess each patient’s home environment and ensure 
necessary modifications are made prior to surgery.  In the post-operative period 
‘fast-track’ pathways could be used to ensure maximum therapy input at the 
earliest possible opportunity.   Some physiotherapy and occupational therapy 
could be provided post-operatively at the patient’s home rather than as an 
inpatient.  This would require safety and cost evaluation prior to implementation.   
 
3 of the top 5 reasons for patients remaining in hospital with no identifiable 
morbidity relate to ‘social’ issues (awaiting home equipment, awaiting a 
rehabilitation bed, awaiting a package of care from social services).  Pre-
operative clinics could identify and address these problems prior to admission.  
Such clinics could also be used to manage patient expectation so that each 
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patient is made aware of the difficulties they may encounter in the post-
operative period and the expected timing of discharge.   
 
This is the first time the POMS has been used as a bed utilisation tool.  It has 
not been validated for this purpose but has previously been used to identify 
patients in hospital without morbidity20,21.  In the US over 98% of inpatients had 
morbidity defined by the POMS20 suggesting that those with a POMS score of 
zero were rapidly discharged. In a previous UK study, 63% of orthopaedic 
patients remained in hospital with no morbidity on POD 3 and 42% on POD 5 
suggesting that discharge efficiency was lower in the UK institution.   
 
Use of the POMS as a bed utilisation tool relies on the assumption that it 
captures all reasons for remaining in hospital.  In this study, the main reason for 
remaining in hospital with no identifiable morbidity was ‘on-going physiotherapy 
and occupational therapy input’.  A specific concern in this patient group is that 
these patients may not be sufficiently mobile to be discharged safely.  Including 
a specific domain for mobility may improve the sensitivity of the POMS for 
morbidity requiring hospitalisation following orthopaedic surgery.  Criteria for a 
positive result could include an inability to mobilise 10 metres or climb a single 
flight of stairs.   Whilst this domain could be especially relevant for orthopaedic 
patients, this requires further investigation.   
 
Use of the POMS as a “fitness for discharge” tool in hospital rests on the 
assumption that patients do not develop new morbidity after they have 
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become free from morbidity, either in hospital or following discharge.  33 of 442 
(7%) patients remaining in hospital with no morbidity subsequently developed 
‘new’ morbidity without undergoing any further surgery.  Following discharge, no 
patients were readmitted to the study hospital in the first post-operative year for 
complications linked to surgery. 
 
Of the 33 patients who developed ‘new’ morbidity, 25 developed wound 
morbidity.  A proportion of wound infections may have been due to hospital 
acquired infection.  If these patients had been discharged when first free of 
morbidity, they may not have developed infection.  However, this cannot be 
assumed.  Of the 25 patients who developed wound morbidity, 24 of them had 
no morbidity on POD 3 and developed wound morbidity by POD 5.  Thus, if an 
arthroplasty patient is discharged before POD 5, regular wound review should 
be performed by a medical practitioner up until this day.  1 RTKR patient had no 
morbidity on POD 5 and developed wound morbidity by POD 8.  Thus, if a 
revision arthroplasty patient is discharged before POD 8, regular wound review 
should be performed by a medical practitioner up until this day.  A doctor or 
nurse, in either a primary or secondary care setting, could perform the review.  
If this protocol is followed, there should be prompt diagnosis and treatment of 
surgical site infection, thus minimising its impact. 
 
1 patient developed infectious morbidity (an infected peripheral cannula site) 
after a period with no morbidity.  If the patient had been discharged when first 
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free of morbidity, the cannula would have been removed and this infection 
would have been prevented. 
 
Of the 6 patients who developed cardiovascular morbidity following a period 
with no morbidity, 3 had a DVT, 2 had a PE and 1 had an MI.  1 THR patient 
had a CVA after a period with no morbidity. These results stress the importance 
of patient education regarding the symptoms of DVT, PE, MI and CVA prior to 
discharge.  Patients should be made aware that these morbidities could occur 
following a period of feeling ‘well’ with no apparent morbidity.  Patients should 
be given clear written instructions about what to do if they suspect one of these 
complications is occurring.  As long as these precautionary measures are put in 
place, POMS has potential as a bed utilisation tool. 
3.4.2 Strengths of study 
 
This study has several strengths.  A large consecutive dataset was collected 
prospectively using a validated methodology for measuring post-operative 
morbidity.  This is the first published study to prospectively evaluate the 
appropriateness of discharge following hip and knee arthroplasty surgery 
specifically. 
3.4.3 Limitations of study 
 
The weaknesses of this study are that it was conducted in a single centre, the 
POMS is not validated as a bed utilisation tool, there was not daily recording of 
data so the calculation of excess days are an approximation, and patient 
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mobility was not fully assessed.  Data was collected regarding mobility aids but 
the distance each patient could mobilise was not recorded.  
3.4.4 Comparison with other countries 
    
The most commonly used tool to assess appropriate bed utilisation in the 
literature is the Appropriateness Evaluation Protocol (AEP)86.  The AEP is a 
retrospective tool that relies on data from the inpatient record.  It has been 
shown to be valid and reliable in some studies86 but not in others87.  The POMS 
is a prospective tool that could be used in real time to assist with appropriate 
patient discharge.  The AEP is a retrospective tool that can only be used to 
evaluate past events.  Data for the POMS is collected directly from 
contemporary data sources whilst the patient is in hospital; the AEP relies solely 
on past patient records and is therefore dependent on completeness and 
accuracy of record keeping for reliable functioning. 
 
The AEP has been used in several European countries to examine bed 
utilization.  In Portugal 50% of inpatient days were deemed inappropriate88, in 
Italy 37.3%18, in Germany 28%89, in Switzerland 8-15%90 and in France 7%91.  
This study indicates bed utilisation in the UK is comparable to that seen in 
Portugal and Italy but such a direct comparison may have limited validity since 
different bed utilisation tools have been used.   
 
The finding that many fewer patients remain in hospital with no morbidity (as 
defined by the POMS) in the US20 when compared with the UK suggests 
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that bed utilisation in the US is superior to that seen in the UK.  The 
implementation of ‘payment by results’ in the UK aims to improve appropriate 
bed occupancy to optimise patient care and improve efficiency.  If the patients 
in this study had been discharged when they first had no morbidity defined by 
the POMS, a saving of over £750,000 could have been made in one year 
(based on a cost of £400 per bed-day). 
3.5 Summary 
 
1. Many patients in the UK remain in hospital following lower limb 
arthroplasty with no identifiable morbidity. 
2. The number of patients remaining in hospital with no morbidity varies 
with type of arthroplasty and time following surgery. 
3. Two general trends are seen. Firstly, patients undergoing more 
‘invasive’ surgery remain in hospital with no morbidity longer than 
patients undergoing less ‘invasive’ surgery.  Secondly, with increasing 
time after surgery, fewer patients with no identifiable morbidity remain 
in hospital.   
4. The most common reason for non-discharge of patients with no 
morbidity is on-going physiotherapy and occupational therapy input. 
5. For the POMS to be used as a bed utilisation tool, it must capture all 
morbidity.  Mobility is an important factor when assessing if an 
arthroplasty patient is fit for discharge.  The POMS does not assess 
this.  Addition of a mobility domain may make the POMS more 
reliable as a bed utilisation tool for orthopaedic patients. 
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6. Use of the POMS as a bed utilisation tool assumes that patients do 
not develop morbidity after a period without morbidity (when they 
would be discharged).  A small proportion of inpatients developed 
wound, cardiovascular and neurological morbidity following a period 
without morbidity.  To address this, certain precautionary measures 
need to be taken before and after patient discharge. 
7. Primary arthroplasty patients should have wound reviews till POD 5 
and revision arthroplasty patients should have wound reviews till POD 
8. 
8. Patients should be aware they could develop wound infection, deep 
vein thrombosis, pulmonary embolus, myocardial infarction, and 
stroke after hospital discharge.  They should receive clear written 
instructions about the symptoms of these conditions and what to do if 
they occur.   
9. Bed utilisation in the US is superior to that in the UK using the POMS 
as a measure.  Savings could be made if bed utilisation was improved 
in the UK.  POMS could be used to identify patients remaining in 
hospital without clinically significant morbidity and could be used 
prospectively as a bed utilisation tool.   
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Chapter 4: Can short-term post-operative 
morbidity predict longer-term outcome? 
 
4.1 Introduction 
 
Patient-reported outcome measures (PROMs) are commonly used to report the 
success or otherwise of an orthopaedic intervention149,150.  One disadvantage of 
PROMs is the time taken to collect and analyse data.  PROMs can be assessed 
at any point in time, from a few weeks post-surgery up to several years post-
surgery.  If an earlier surrogate marker for long-term PROMs could be found, 
operative and peri-operative procedures could be assessed more quickly and 
outliers identified.  Thus both positive and negative results could be circulated 
earlier and appropriate action taken.  This should ultimately lead to better 
patient care.  
 
There is evidence that short-term post-operative morbidity is associated with a 
risk of premature death151,152, but there is no evidence that morbidity is 
associated with longer-term patient reported outcome.  The POMS is a short-
term measure of morbidity.  Data is collected whilst the patient is in hospital 
following surgery.  This chapter will investigate whether there is any association 
between POMS results in the early post-operative period and PROM scores at 
18 months post-surgery.  
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Traditionally, length of hospital stay has been used as an early marker of the 
success of a procedure.  I will examine whether there is any association 
between length of hospital stay and PROM scores to justify its use for this 
purpose.  I will also investigate if there are any patient or operation 
characteristics that are associated with better PROM scores at 18 months post-
surgery.  I will concentrate on patient age, sex, ASA score and length of 
operation. 
 
In this chapter I will first provide background information about PROMs, the 
scoring properties of PROMs and POMS, length of inpatient stay as an outcome 
measure, patient factors that may have an association with long-term outcome 
and the association between length of operating time and outcome.  I will then 
describe the methods used to collect the data for this chapter including patient 
demographics, operation information, POMS scores and PROM scores.  I will 
describe the statistical methods used to analyse the data. 
 
I will then present the results, first for hip arthroplasty patients and then for knee 
arthroplasty patients.  I will report the association between short-term measures 
of outcome (POMS and length of hospital stay) and longer-term measures of 
outcome (PROMs at 18 months post-surgery).  I will report the association 
between patient factors and PROMs, and operation time and PROMs.   
 
Following this I will discuss conclusions that can be drawn from the results.  I 
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will comment on the strengths and limitations of the study and I will end the 
chapter with a summary of the key points. 
 
The aim of this chapter is to assess whether the POMS can act as an early 
surrogate marker for patient–reported outcome measures (PROMs). If an earlier 
surrogate marker for long-term PROMs could be found, procedures could be 
assessed more quickly ultimately leading to better patient care.   
4.1.1 Patient-reported outcome measures 
 
The outcome of orthopaedic procedures was traditionally evaluated by the 
operating surgeon.  Outcomes included examination findings (e.g. joint range of 
motion), x-ray appearance and walking distance.  It became apparent that such 
evaluations were often influenced by the opinion of the surgeon and did not truly 
reflect the function of the patient68.  This lead to the development of patient-
reported outcome measures (PROMs).  PROMs have multiple uses including 
monitoring the effectiveness of interventions, for internal audit purposes and in 
clinical trials to compare different surgical procedures as well as peri-operative 
interventions.  PROMs can be used by patients to guide them in their choice of 
surgeon and hospital.  Health-care providers can use PROMs to guide the 
allocation of resources. 
 
As described in Chapter 1, PROMs used to assess orthopaedic procedures can 
be divided into 3 broad categories: generic, disease-specific and joint-specific.   
Outcome measures in each category evaluate different aspects of a 
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patient’s health and for this study I chose to evaluate one measure from each 
group: SF-36 (generic), WOMAC (disease-specific) and the Oxford Hip/Knee 
Score (joint-specific). 
4.1.2 Scoring properties of POMS and PROMs 
 
Both PROMs and the POMS are composed of multiple items. PROMs for 
orthopaedic procedures are reported as an overall score.  This score is 
calculated from the sum, or in some cases the weighted sum, of the item 
scores.  When the POMS was developed it was hypothesised it could measure 
a single underlying construct (i.e. systemic morbidity associated with surgery).  
When the internal consistency of the POMS was tested, it was discovered this 
is not the case153.  This lack of homogeneity means that the POMS does not 
have the scaling properties necessary to generate an overall score.  The POMS 
can only be used to define the presence or absence of morbidity following 
surgery i.e. the POMS provides a dichotomous ‘yes/no’ result.  
4.1.3 Length of stay as a measure of outcome 
 
In the past, length of hospital stay has been used as a surrogate for clinical 
outcome.  Length of stay is accurately recorded by most hospitals so is a readily 
available piece of data.  If length of hospital stay is to be used as a measure of 
outcome, two discharge criteria must be fulfilled.  Firstly, all patients must be 
discharged at the same level of ‘wellness’ e.g. when patients are able to walk a 
certain distance.  If one hospital discharges patients who can walk 10 metres 
and another hospital discharges patients who can walk 25 metres, the 
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second hospital will have longer inpatient times and ‘worse’ outcome results.  
This would be unfair and not a true reflection of patient health status.  Secondly, 
all patients must be discharged as soon as they are ‘well’.  It is known that 
length of hospital stay is influenced by many factors other than the health status 
of the patient17,18.  In the UK it is common for ‘well’ patients to remain in hospital 
for reasons such as awaiting placement in a rehabilitation centre or care home.   
4.1.4 Patient factors and long-term outcome 
 
 
Evidence exists that patients with higher ASA scores (ASA 3 or 4) have worse 
functional outcome following hip and knee arthroplasty than those with lower 
ASA scores (1 or 2)154.  There is conflicting evidence whether there is a 
difference in outcome between ASA grade 1 and 2 patients.  A recent analysis 
of the New Zealand Joint Registry showed a difference in outcome between 
ASA grade 1 and ASA grade 2 hip arthroplasty patients but no difference in 
outcome between ASA grade 1 and ASA grade 2 knee arthroplasty patients154.  
 
There is good evidence that increasing age is associated with decreasing 
functional outcome scores following hip and knee arthroplasty155,156.  However, 
relative scores rather than absolute scores show that older patients generally 
show a significant improvement in functional outcome following surgery.  Thus, 
the fact that they attain on average a lower level of function than younger 
patients should not be cited as a reason for refusing surgery.   
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It has recently been shown that overall patient satisfaction is determined by 
many factors other than PROMs including meeting pre-operative expectations 
and adequate pain relief.  When looking at overall patient satisfaction, age is not 
a determining factor157.  
There is conflicting evidence as to whether there is a difference in outcome 
between males and females following hip arthroplasty158,159.  It is thought that 
the modular design of total hip replacements allows for sufficient variation in the 
implant to accommodate differences in anatomy between the two sexes160.  
There is some evidence that males have a superior functional outcome than 
females following knee arthroplasty161.  This led to the development of knee 
replacements specifically for females.  However, most studies show that there is 
no difference in outcome become gender-neutral and gender-specific 
replacement in females162. 
4.1.5 Operation time and long-term outcome 
 
It is unknown whether the time taken to perform a arthroplasty procedure has 
any effect on long-term outcome. There are comparative studies investigating 
different methods of performing arthroplasty e.g. standard surgery versus 
minimally invasive surgery163,164 and standard surgery versus computer-
assisted surgery165,166.  Minimally invasive surgery and computer-assisted 
surgery generally take longer to perform than standard surgery.  However, there 
are several variables between study groups so outcome cannot simply be 
attributed to operation time alone.  It is unknown if the time taken to perform the 
  
 
 
 
 
 
 
171 
same standardised arthroplasty procedure has any effect on long-term 
outcome. 
 
In general, less experienced surgeons take longer to perform an operation than 
more experienced surgeons167.  It is known that ‘high volume’ experienced 
surgeons have better outcomes than ‘low volume’ less experienced 
surgeons167.   Therefore it seems logical that shorter operation times could be 
associated with better long-term outcome.   
 
Furthermore, arthroplasty for complex joint problems (e.g. significant joint 
deformity, bone erosion or soft tissue disease) takes longer to perform than 
standard arthroplasty.  Patients with complex joint problems will have lower pre-
operative function than patients with simple osteoarthritis undergoing standard 
arthroplasty.  Pre-operative function is known to be associated with post-
operative function.  This is further reason to suggest that patients with longer 
operation times may have poorer long-term outcome.   
4.2 Methods 
 
 
The methods used to collect the POMS data are fully described in Chapter 2.  
POMS data was collected from March 1st 2004 till February 28th 2005 at the 
Middlesex Hospital.  Results were recorded on post-operative days (POD) 3, 5, 
8 and 15 if the patient remained in hospital. 
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Operation time was taken from the anaesthetic record.  It was calculated as the 
time the patient entered the operating room to the time the patient left the 
operating room.    
 
Patients who underwent TKR and THR in the first 6 months of the POMS study 
(March 1st 2004 – August 31st 2004) were contacted by post 18 months after 
discharge requesting them to complete SF-36, WOMAC and Oxford hip/knee 
questionnaires and return them in pre-paid envelopes.  If questionnaires were 
not returned within 1 month, each patient was contacted by telephone.  If they 
agreed to participate in the study, a second set of questionnaires was posted to 
them.  All surveys and questionnaires were scored according to standard 
protocols.  
 
Examination of the SF-36, WOMAC and Oxford scores revealed that they were 
approximately normally distributed.  Therefore all analyses were performed 
using linear regression.  Analysis was performed separately for the knee 
arthroplasty and hip arthroplasty groups.   
 
Analysis was performed in two stages.  Firstly the effect of each variable 
(presence or absence of POMS on POD 3, 5, 8 and 15, length of stay and 
patient demographics) upon the long-term outcome (SF-36, WOMAC and 
Oxford scores) was assessed individually in a series of univariable analyses.  
Secondly, the joint effect of each of the variables upon each outcome was 
assessed in a multivariable analysis.  Due to the fairly small sample sizes, 
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these analyses were restricted to variables showing some evidence of an 
association with the outcome in the univariable analyses (p<0.2).  A backwards 
selection procedure was used to retain only the statistically significant variables 
in the final model. 
4.3 Results 
 
 
111 patients underwent primary TKR and 88 patients underwent primary THR 
during the study period.  All patients participated in the initial POMS phase of 
the study.  Of these 199 patients, 123 participated in the second part of the 
study by completing quality of life questionnaires at 18 months post-surgery.  
The 76 patients who did not participate in the second part of the study were 
contacted by post and telephone but both were unsuccessful. 
 
Of the 123 patients who fully participated in the study, 76 underwent total hip 
replacement and 47 underwent total knee replacement.  The average age of the 
patients undergoing total hip replacement was 64.2.  26 (34%) were male.  17 
(22%) were graded as ASA 1, 43 (57%) ASA 2 and 16 (21%) ASA 3.  The 
average length of surgery was 199 minutes.  The average age of the patients 
undergoing total knee replacement was 69.7 and 15 (32%) were male.  10 
(21%) were graded as ASA 1, 27 (58%) ASA 2 and 10 (21%) ASA 3.  The 
average length of surgery was 162 minutes. 
4.3.1 Hip arthroplasty patients 
 
4.3.1.1 Association between POMS and PROMS 
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4.3.1.1.1 SF-36 
 
 
Initially the separate effect of each variable (presence of morbidity on POD 3, 5, 
8 and 15) upon this outcome was examined.  A summary of results is given in 
table 31.  The first column of figures provides the mean and standard deviation 
SF-36 score in each category.  The next column gives the regression 
coefficients with corresponding confidence intervals.  This coefficient represents 
the difference in outcome between each category and a reference category.  P-
values indicating the significance of the results are also reported. 
Table 31. Association between the presence of morbidity on post-
operative days 3, 5, 8 and 15 and SF-36 scores at 18 months post hip 
arthroplasty 
 
Variable Category Mean (SD) Coefficient 
(95% CI) 
P-value 
POD 3 POMS –ve 
 
47.6 (14.1) 0 0.82 
POMS +ve 
 
44.1 (19.7) 3.5 
(-10.2, 12.5) 
POD 5 POMS –ve 
 
48.8 (15.6) 0 0.38 
POMS +ve 
 
44.5 (20.7) 4.3 
(-3.0, 13.1) 
POD 8 POMS –ve 
 
50.4 (18.2) 0 0.43 
POMS +ve 
 
44.4 (16.9) 6.0 
(-5.8, 14.7) 
POD 15 POMS –ve 
 
48.9 (17.0) 0 0.79 
POMS +ve 
 
46.4 (11.1) 2.5 
(-11.4, 12.6) 
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These results show that there is no association between the presence of 
morbidity in the first 15 days following hip arthroplasty and SF-36 scores at 18 
months post-surgery. 
4.3.1.1.2 WOMAC 
 
The separate effect of each variable (presence of morbidity on POD 3, 5, 8 and 
15) upon WOMAC scores was examined.  A summary of results is given in 
table 32. 
Table 32. Association between the presence of morbidity on post-
operative days 3, 5, 8 and 15 and WOMAC scores at 18 months post hip 
arthroplasty 
Variable Category Mean (SD) Coefficient 
(95% CI) 
P-value 
POD 3 POMS –ve 
 
27.1 (21.8) 0 0.53 
POMS +ve 
 
30.6 (21.8) 3.6 
(-7.6, 14.7) 
POD 5 POMS –ve 
 
27.3 (20.3) 0 0.42 
POMS +ve 
 
31.8 (23.4) 4.0 
(-5.9, 14.0) 
POD 8 POMS –ve 
 
28.1 (22.6) 0 0.33 
POMS +ve 
 
33.6 (19.4) 5.5 
(-5.6, 16.6) 
POD 15 POMS –ve 
 
27.5 (20.6) 0 0.007 
POMS +ve 
 
50.6 (22.5) 23.1 
(6.7, 39.6) 
 
These results show that there is no association between the presence of 
morbidity on POD 3, 5 and 8 and WOMAC scores at 18 months post-surgery.  
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There is a statistically significant association between the presence of morbidity 
on POD 15 and poorer WOMAC scores at 18 months post-surgery.  On POD 
15, hip arthroplasty patients with morbidity had WOMAC scores that were on 
average 23 units higher than patients without morbidity.   
4.3.1.1.3 Oxford Hip Score 
 
The separate effect of each variable (presence of morbidity POD 3, 5, 8 and 15) 
upon Oxford Hip Scores was examined.  A summary of results is given in table 
33. 
Table 33. Association between the presence of morbidity on post-
operative days 3, 5, 8 and 15 and Oxford Hip Scores at 18 months post hip 
arthroplasty 
Variable Category Mean (SD) Coefficient 
(95% CI) 
P-value 
POD 3 POMS –ve 
 
24.6 (10.4) 0 0.63 
POMS +ve 
 
26.0 (11.6) 1.4 
(-4.4, 7.2) 
POD 5 POMS –ve 
 
24.3 (9.5) 0 0.30 
POMS +ve 
 
27.0 (12.9) 2.7 
(-2.4, 7.9) 
POD 8 POMS –ve 
 
24.3 (11.1) 0 0.11 
POMS +ve 
 
28.9 (11.3) 4.6 
(-1.1, 10.3) 
POD 15 POMS –ve 
 
24.7 (10.8) 0 0.02 
POMS +ve 
 
34.7 (12.8) 10.0 
(1.4, 18.7) 
 
These results show no association between the presence of morbidity on POD 
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3, 5 and 8 and Oxford Hip Scores at 18 months post-surgery.  There is a 
statistically significant association between the presence of morbidity on POD 
15 and poorer Oxford Hip Scores at 18 months surgery.  On POD 15, patients 
with morbidity had Oxford Hip Scores that were on average 10 units higher than 
patients without morbidity.   
4.3.1.2 Association between length of stay and long-term 
outcome 
The effect of length of stay on SF-36, WOMAC and Oxford Hip scores is shown 
in Table 34.  The regression coefficients are reported for a 5-day increase in 
length of stay. 
Table 34. Association between length of hospital stay and PROMs at 18 
months post hip arthroplasty 
 Coefficient for a 5-day 
increase in length of stay 
(95% CI) 
P-value 
SF-36 
 
2.8 
(-1.8, 7.9) 
0.12 
WOMAC 
 
4.9 
(1.7, 8.1) 
0.003 
Oxford Hip Score 
 
3.2 
(1.6, 4.8) 
<0.001 
 
These results show there is no association between length of hospital stay and 
SF-36 scores at 18 months post-surgery.  Length of stay is significantly 
associated with WOMAC scores.  A 5-day increase in the length of hospital stay 
was associated with a 5-unit increase in WOMAC score.  There is a highly 
significant association between length of stay and Oxford Hip Scores.  A 5-day 
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increase in length of stay was associated with a 3-unit increase in Oxford Hip 
Score. 
4.3.1.3 The effect of patient factors on long-term outcome 
 
4.3.1.3.1 Patient Age 
 
 
The effect of patient age on SF-36, WOMAC and Oxford Hip scores is shown in 
Table 35.  The regression coefficients are reported for a 10-year increase in 
age. 
Table 35. Association between patient age and PROMs at 18 months post 
hip arthroplasty 
 
 
These results show no statistical association between patient age and patient-
reported outcome measures at 18 months post-surgery. 
4.3.1.3.2 Patient Sex 
 
The effect of sex on SF-36, WOMAC and Oxford Hip scores is shown in Table 
36.  The coefficient represents the difference in outcome between the two 
categories (male and female). 
 Coefficient  
(95% CI) 
P-value 
SF-36 
 
1.7 
(-1.4, 3.2) 
0.29 
WOMAC 
 
1.3 
(-1.7, 4.0) 
0.38 
Oxford Hip Score 
 
1.1 
(-0.5, 2.7) 
0.17 
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Table 36. Association between sex and PROMs at 18 months post hip 
arthroplasty 
Outcome 
measure 
Sex Mean (SD) Coefficient 
(95% CI) 
P-value 
SF-36 Female 49.1 (18.3) 0 0.64 
Male 46.4 (23.0) 2.7 
(-11.8, 16.9) 
WOMAC Female 24.4 (19.9) 0 0.14 
Male 32.2 (22.3) 7.8 
(-2.6, 18.3) 
Oxford Hip 
Score 
Female 23.6 (12.0) 0 0.28 
Male 26.6 (10.9) 3.0 
(-2.5, 8.4) 
 
These results show no statistical association between the sex of a patient and 
patient-reported outcome measures at 18 months post-surgery. 
4.3.1.3.3 ASA grade 
 
 
The effect of ASA grade on SF-36, WOMAC and Oxford Hip scores is shown in 
Table 37.  The coefficient represents the difference in outcome between each 
category and the reference category (ASA grade 1). 
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Table 37. Association between ASA grade and PROMs at 18 months post 
hip arthroplasty 
Outcome ASA grade Mean (SD) Coefficient 
(95% CI) 
P-value 
SF-36 1 57.5 (18.1) 
 
0 0.21 
2 49.8 (17.6) 
 
7.7 
(-2.2, 17.2) 
3 46.7 (13.8) 
 
10.6 
(0.2, 21.8) 
WOMAC 1 19.5 (16.3) 0 
 
0.05 
2 30.7 (22.5) 11.3 
(-0.8, 22.3) 
3 37.7 (21.8) 18.2 
(3.5, 32.9) 
Oxford Hip 
Score 
1 21.5 (8.3)  
 
0 0.14 
2 25.8 (11.5) 4.3 
(-2.1, 10.6) 
3 29.3 (12.5) 7.8 
(0.1, 15.5) 
 
These results show that although there is a tendency towards patients with 
higher ASA scores having worse long-term SF-36 and Oxford Hip Scores, this 
is not statistically significant.  There is some stronger evidence (p = 0.05) that 
ASA grade is associated with WOMAC scores. ASA grade 3 patients scored 18 
units higher than ASA grade 1 patients. 
4.3.1.4 Association between length of operation and outcome 
 
The effect of length of operation on SF-36, WOMAC and Oxford Hip scores is 
shown in Table 38.  The regression coefficients are reported for a one-hour 
increase in length of time of operation. 
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Table 38. Association between length of operation and PROMs at 18 
months post hip arthroplasty 
 Coefficient  
(95% CI) 
P-value 
SF-36 
 
2.8 
(-3.4, 8.0) 
0.15 
WOMAC 
 
4.0 
(-1.0, 8.9) 
0.11 
Oxford Hip Score 
 
3.0 
(0.5, 5.5) 
0.02 
 
These results show that although there is a tendency towards patients with 
longer operations having worse long-term SF-36 and WOMAC Scores, this is 
not statistically significant.  There is stronger evidence (p = 0.02) that a longer 
operation time is associated with worse Oxford Hip scores.  A one-hour 
increase in operation time is associated with a 3-unit increase in Oxford Hip 
Score. 
4.3.1.5 Multivariable analysis of results 
 
4.3.1.5.1 SF-36 
 
 
None of the studied variables (POMS scores, length of patient stay, patient 
factors and length of operation) had any association with SF-36 scores so no 
multivariable analysis was performed. 
4.3.1.5.2 WOMAC 
 
The multivariable analysis considers variables showing some association with 
outcome.  The presence of POMS morbidity on POD 15, ASA grade and length 
of stay were associated with WOMAC scores using univariable analysis.   
  
 
 
 
 
 
 
182 
On multivariable analysis, only length of stay was significantly associated with 
WOMAC scores at 18 months post-surgery.  There was no additional effect of 
POMS score on POD 15 or ASA grade, having adjusted for this variable.  As 
this variable was the only variable in the final model, the size effects were 
equivalent to those found in the univariable analysis. 
4.3.1.5.3 Oxford Hip Score 
 
 
A multivariable analysis again suggested that only post-operative length of stay 
was statistically significant.  There were no additionally significant variables 
after accounting for this factor. 
4.3.2 Knee arthroplasty patients 
 
4.3.2.1 Association between POMS and PROMS 
 
4.3.2.1.1 SF-36 
 
Initially the separate effect of each variable (presence of morbidity POD 3, 5, 8 
and 15) upon this outcome was examined.  A summary of results is given in 
table 39.  The coefficient represents the difference in outcome between each 
category and a reference category. 
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Table 39. Association between the presence of morbidity on post-
operative days 3, 5, 8 and 15 and SF-36 scores at 18 months post knee 
arthroplasty 
Variable Category Mean (SD) Coefficient 
(95% CI) 
P-value 
POD 3 POMS –ve 
 
54.3 (17.2) 0 0.77 
POMS +ve 
 
50.1 (23.7) 3.2 
(-15.5, 22.0) 
POD 5 POMS –ve 
 
52.9 (20.5) 0 0.59 
POMS +ve 
 
48.1 (18.3) 4.8 
(-14.9, 23.9) 
POD 8 POMS –ve 
 
52.0 (18.7) 0 0.49 
POMS +ve 
 
49.1 (15.8) 2.9 
(-9.9, 15.4) 
POD 15 POMS –ve 
 
49.9 (24.0) 
 
0 0.83 
POMS +ve 
 
46.4 (8.7) 3.5 
(-19.6, 26.8) 
 
These results show no association between the presence of morbidity in the 
first 15 days following knee arthroplasty and SF-36 scores 18 months after 
surgery. 
4.3.2.1.2 WOMAC 
 
The separate effect of each variable (presence of morbidity on POD 3, 5, 8 and 
15) upon WOMAC scores was examined.  A summary of results is given in 
table 40. 
 
 
 
 
  
 
 
 
 
 
 
184 
 
Table 40. Association between the presence of morbidity on post-
operative days 3, 5, 8 and 15 and WOMAC scores at 18 months post knee 
arthroplasty 
Variable Category Mean (SD) Coefficient 
(95% CI) 
P-value 
POD 3 POMS –ve 
 
23.3 (15.8) 0 0.06 
POMS +ve 
 
33.8 (21.0) 10.6  
(-0.3, 21.5) 
POD 5 POMS –ve 
 
25.2 (16.5) 0 0.11 
POMS +ve 
 
34.7 (22.6) 9.5 
(-2.1, 21.1) 
POD 8 POMS –ve 
 
28.5 (18.9) 0 0.96 
POMS +ve 
 
28.1 (21.5) -0.3 
(-15.4, 14.7) 
POD 15 POMS –ve 
 
28.2 (19.5) 0 0.67 
POMS +ve 
 
34.0 (5.7) 5.8 
(-22.2, 33.9) 
 
These results show no association between the presence of morbidity on POD 
3, 5, 8 and 15 and WOMAC scores at 18 months post-surgery.  There is a 
tendency towards an association between the presence of morbidity on POD 3 
and POD 5 and poorer WOMAC scores at 18 months surgery but this is not 
statistically significant. 
4.3.2.1.3 Oxford Knee Score 
 
The separate effect of each variable (presence of morbidity on POD 3, 5, 8 and 
15) upon Oxford Knee Scores was examined.  A summary of results is given in 
table 41. 
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Table 41. Association between the presence of morbidity on post-
operative days 3, 5, 8 and 15 and Oxford Knee Scores at 18 months post 
knee arthroplasty 
Variable Category Mean (SD) Coefficient 
(95% CI) 
P-value 
POD 3 POMS –ve 
 
25.5 (10.2) 0 0.34 
POMS +ve 
 
28.3 (10.0) 2.8 
(-3.1, 8.8) 
POD 5 POMS –ve 
 
25.9 (10.1) 0 0.39 
POMS +ve 
 
28.6 (10.3) 2.7 
(-3.6, 9.0) 
POD 8 POMS –ve 
 
27.0 (10.3) 0 0.80 
POMS +ve 
 
26.0 (9.3) -1.1 
(-9.0, 7.0) 
POD 15 POMS –ve 
 
26.6 (10.2) 0 0.42 
POMS +ve 
 
32.5 (3.5) 5.9 
(-8.8, 20.6) 
 
These results show no association between the presence of morbidity on POD 
3, 5, 8 and 15 and Oxford Knee Scores at 18 months post-surgery.   
4.3.2.2 Association between length of stay and long-term 
outcome 
The effect of length of stay on SF-36, WOMAC and Oxford Knee scores is 
shown in Table 42.  The regression coefficients are reported for a 5-day 
increase in length of stay. 
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Table 42. Association between length of hospital stay and PROMs at 18 
months post knee arthroplasty 
 Coefficient  
(95% CI) 
P-value 
SF-36 
 
4.1 (-2.2, 10.3) 0.20 
WOMAC 
 
9.6 (0.7, 18.5) 0.04 
Oxford Knee Score 
 
3.6 (-1.2, 8.4) 0.14 
 
These results show no association between length of hospital stay and SF-36 
and Oxford Knee Scores at 18 months post knee arthroplasty.  Length of stay is 
significantly associated with WOMAC scores.  A 5-day increase in hospital stay 
was associated with a 10-unit increase in the WOMAC score.   
4.3.2.3 Effect of patient factors on long-term outcome 
 
4.3.2.3.1 Patient Age 
 
The effect of patient age on SF-36, WOMAC and Oxford Knee scores is shown 
in Table 43.  The regression coefficients are reported for a 10-year increase in 
age. 
Table 43. Association between patient age and PROMs at 18 months post 
knee arthroplasty 
 Coefficient  
(95% CI) 
P-value 
SF-36 
 
0.8 
(-4.8, 6.7) 
0.68 
WOMAC 
 
-1.9 
(-6.4, 2.6) 
0.40 
Oxford Knee Score 
 
-1.0 
(-3.4, 1.4) 
0.39 
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These results show no statistical association between patient age and patient-
reported outcome measures at 18 months post-surgery. 
4.3.2.3.2 Patient Sex 
 
The effect of sex on SF-36, WOMAC and Oxford Knee scores is shown in Table 
44.  The coefficient represents the difference in outcome between the two 
categories (male and female). 
Table 44. Association between sex and PROMs at 18 months post knee 
arthroplasty 
Outcome 
measure 
Sex Mean (SD) Coefficient 
(95% CI) 
P-value 
SF-36 Female 51.7 (19.8) 0 0.77 
Male 49.7 (21.5) 2.0 
(-14.1, 16.4) 
WOMAC Female 27.8 (20.0) 0 0.89 
Male 28.7 (19.0) 0.9  
(-11.3, 13.0) 
Oxford Knee 
Score 
Female 27.7 (12.1) 0 0.68 
Male 26.4 (9.2) -1.3 
(-7.7, 5.1) 
 
These results show no statistical association between sex and patient-reported 
outcome measures at 18 months post knee arthroplasty. 
4.3.2.3.3 ASA grade 
 
 
The effect of ASA grade on SF-36, WOMAC and Oxford Knee scores is shown 
in Table 45.  The coefficient represents the difference in outcome between each 
category and the reference category (ASA grade 1). 
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Table 45. Association between ASA grade and PROMs at 18 months post 
knee arthroplasty 
Outcome ASA grade Mean (SD) Coefficient 
(95% CI) 
P-value 
SF-36 1 54.3 (16.2) 
 
0 0.32 
2 51.0 (18.1) 
 
3.3 
(-7.9, 14.6) 
3 46.6 (13.8) 
 
7.7 
(-5.0, 20.9) 
WOMAC 1 24.3 (11.8) 0 
 
0.42 
2 27.4 (20.4) 3.1 
(-11.2, 17.4) 
3 35.2 (21.3) 10.9 
(-6.4, 28.2) 
Oxford Knee 
Score 
1 23.2 (6.1) 
 
0 0.05 
2 25.8 (10.2) 2.6 
(-4.6, 9.7) 
3 33.4 (10.8) 10.2 
(1.5, 18.9) 
 
These results show there is no statistical association between ASA grade and 
SF-36 and WOMAC scores following knee arthroplasty.  There is some 
evidence of an association between ASA grade and Oxford Knee Score 
although this is of borderline statistical significance (p = 0.05).  There was a 
relatively small difference between patients with an ASA grade of 1 and 2.  
However, ASA grade 3 patients had an average Oxford Knee Score ten units 
higher than ASA grade 1 patients. 
4.3.2.4 Association between length of operation and outcome 
 
 
The effect of length of operation on SF-36, WOMAC and Oxford Knee scores is 
shown in Table 46.  The regression coefficients are reported for a one-hour 
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increase in length of operation. 
Table 46. Association between length of operation and PROMs at 18 
months post knee arthroplasty 
 Coefficient  
(95% CI) 
P-value 
SF-36 
 
2.6 
(-7.9, 12.8) 
0.65 
WOMAC 
 
1.8 
(-10.9, 14.4) 
0.78 
Oxford Knee Score 
 
0.3 
(-6.4, 7.0) 
0.93 
 
These results show no statistical association between length of knee surgery 
and PROMs. 
4.3.2.5 Multivariable analysis of results 
 
4.3.2.5.1 SF-36 
 
 
None of the studied variables (POMS scores, length of patient stay, patient 
factors and length of operation) had any association with SF-36 scores so no 
multivariable analysis was performed. 
4.3.2.5.2 WOMAC 
 
 
A multivariable analysis was performed using factors showing some association 
with the WOMAC scores on univariable analysis.  These variables included 
POMS score on POD 3 and 5, and length of stay. Multivariable analysis 
suggested that only post-operative length of stay was significantly associated 
with WOMAC scores at 18 months post-surgery.  There was no additional effect 
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of the POMS scores on POD 3 and 5 once length of stay had been adjusted for.  
As length of hospital stay was the only variable in the final model, the size 
effects are equivalent to those found in the univariable analysis. 
4.3.1.5.3 Oxford Knee Score 
 
 
A multivariable analysis suggested that only ASA grade was significantly 
associated with the Oxford Knee Score at 18 months post-surgery.  There were 
no additional significant variables after accounting for this factor. 
4.4 Discussion 
 
4.3.1 Summary 
 
 
This chapter investigated the association between morbidity on POD 3, 5, 8 and 
15 and PROMs (SF-36, WOMAC and Oxford Hip/Knee Scores) at 18 months 
post surgery.  For hip arthroplasty patients, univariable analysis indicated an 
association between morbidity on POD 15 and WOMAC and Oxford Hip 
Scores.  However, multivariable analysis did not support this.  For knee 
arthroplasty patients, no association was found between post-operative 
morbidity and PROMs.  Since POMS has no association with longer-term 
PROMs, POMS should not be used as an early surrogate marker of surgical 
outcome. 
 
The relationship between length of hospital stay and PROMs was also 
investigated.  In the hip arthroplasty group, univariable analysis revealed an 
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association in length of stay and WOMAC and Oxford Hip Scores. In the knee 
arthroplasty group, univariable analysis revealed an association between length 
of stay and WOMAC scores.  Multivariable analysis confirmed these 
associations. 
 
The relationship between patient factors (age, sex, ASA) and PROMs was 
assessed.  There was no association between age and PROMs, or sex and 
PROMs.  Univariable analysis revealed an association between ASA score and 
WOMAC scores in the hip arthroplasty group.  Multivariable analysis confirmed 
this was not statistically significant with other variables taken into account. 
Univariable analysis revealed an association between ASA score and Oxford 
Knee Score in the knee arthroplasty group.  Multivariable analysis confirmed 
this was statistically significant.  
 
The relationship between operating time and PROMs was assessed.  In the hip 
arthroplasty group univariable analysis revealed an association between 
operating time and Oxford Hip Scores.  Multivariable analysis confirmed this 
was not statistically significant when other variables were taken into account.  In 
the knee arthroplasty group no association was found between operation length 
and PROMs. 
4.3.2 Strengths of study  
 
This study involved collecting a large data set.  A dedicated research team 
recorded all POMS data, patient data, length of stay and length of operation.  
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The data was accurate and complete.  A second dedicated research team 
collected the patient-reported outcome scores.  Again, this ensured that full and 
accurate data sets were obtained. 
4.3.3 Limitations of study 
 
 
The main limitation of this study is the small sample size.  This may have lead 
to false negative results.  If a larger sample size had been used, more 
significant associations between post-operative morbidity and long-term patient-
reported outcome may have been found.  This is an area for future research.  A 
further limitation of the study is the fact it was performed at a single centre.  
Thus the results may not be transferable to other centres. 
4.3.4 Comparison to other studies 
 
 
The association between the presence of any type of post-operative morbidity 
and longer term PROMs has not previously been investigated.  Thus it is not 
possible directly to compare this part of the study to previous studies.   
 
Patients with post-operative morbidity could be expected to recover less well 
than patients with no post-operative morbidity, and thus have poorer long-term 
PROM scores.  This was not shown to be the case in this study.  In the hip 
arthroplasty group, univariable analysis showed an association between 
morbidity on POD 15 and poorer WOMAC and Oxford Hip Scores.  This was 
statistically insignificant on multivariable analysis.  If a larger population had 
been used, an association between morbidity on POD 15 and longer-term 
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PROMs may have been found, even using multivariable analysis.  This requires 
further investigation. 
 
Many studies use length of stay as an early surrogate marker of outcome.  Our 
study confirms that this is appropriate.  In the hip arthroplasty group, an 
association was found between length of stay and WOMAC and Oxford Hip 
Scores.  In the knee arthroplasty group, an association was found between 
length of stay and WOMAC scores.  
 
Our study did not find any association between patient age and PROMs.  In the 
knee arthroplasty group, there was a statistically insignificant negative 
correlation between patient age and PROMs.  Most studies report worse 
outcome with increasing age155,156.  Based on our results, arthroplasty surgery 
provides equal long-term benefit to patients of all ages. 
 
The orthopaedic literature is mixed regarding whether sex is associated with 
outcome following arthroplasty158,159.  Our study does not support any difference 
between the sexes.  Several studies report poorer outcome in patients with 
higher ASA grades154.  Our study generally supports this.  A statistically 
significant association was found between ASA grade and WOMAC scores on 
univariable analysis in the hip arthroplasty group.  The association was not 
found to be statistically significant on multivariable analysis but this may be due 
to the small sample size.  A statistically significant association was found 
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between ASA grade and Oxford Knee Scores on both univariable and 
multivariable analysis in the knee arthroplasty group. 
 
There are no previous published studies regarding the association between 
length of arthroplasty surgery and PROMs.  In the hip arthroplasty group, 
univariable analysis found an association between operating time and Oxford 
Hip Scores, with longer operating time resulting in worse Oxford Hip Scores.  
This association was statistically insignificant on multivariable analysis but this 
may be due to a small sample size.  Further investigation using a larger study 
population may prove a true association. 
4.5 Summary 
 
1. There is no association between post-operative morbidity defined by the 
POMS and long-term PROMs.  This study does not support the use of 
POMS as an early surrogate marker of long-term patient outcome. 
2. There was a tendency towards patients with morbidity on POD 15 having 
poorer PROMs but this was not statistically significant. 
3. Length of hospital stay was associated with PROMs in both the hip and 
knee arthroplasty groups.  This justifies the use of length of hospital stay 
as an early marker of outcome. 
4. There was no association between patient age and PROMs. 
5. There was no association between patient sex and PROMs.   
6. Higher ASA grade was associated with worse PROMs in the knee 
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arthroplasty group.  The association was not statistically significant in the 
hip group. 
7. There is no association between length of operation and PROMs. 
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Chapter 5 How reliable is the ‘wound’ item in 
the POMS 
 
5.1 Introduction 
 
 
Surgical site infection (SSI) following arthroplasty is a potentially devastating 
complication.  It can require revision surgery, and in the worst-case scenario, 
can lead to limb amputation.  To avoid these complications, every effort is made 
to keep infection rates to a minimum.  In order to monitor infection rates, a 
reliable and reproducible method of diagnosing infection must be used.  
 
This chapter will examine the accuracy of the wound domain of the POMS.  The 
POMS definition of wound morbidity is ‘wound dehiscence requiring surgical 
exploration or drainage of pus from operative wound with or without isolation of 
organisms’.  The POMS aims to identify morbidity that warrants inpatient 
hospital care.  Therefore, the wound domain of the POMS would be expected to 
identify SSI that requires intravenous antibiotics or surgical treatment.  The 
POMS would not be expected to identify mild superficial wound infections that 
can be treated with oral antibiotics and outpatient monitoring. 
 
In order to test accuracy, the wound domain of POMS needs to be compared to 
a ‘gold standard’.  There are several definitions of wound infection, as 
discussed in chapter one.  These include American Centres for Disease Control 
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(CDC) definition, the English Nosocomial Infection National Surveillance 
Scheme (NINSS) definition and the English ASEPSIS definition (Additional 
treatment, Serous discharge, Erythema, Purulent exudate, Separation of deep 
tissues, Isolation of bacteria and Stay as inpatient prolonged over fourteen 
days), all of which have undergone some psychometric analysis.  Substantial 
gaps exist in the literature regarding the validity of these definitions.  The CDC 
definition is known to be weak since 3 out of the 4 defining criteria are 
subjective.  CDC is also known to be unreliable35.  NINSS evolved in an attempt 
to increase the reliability of CDC but evaluation has confirmed that 
reproducibility remains low36.  The original ASEPSIS method has been shown to 
be both objective and repeatable38 for sternal wounds but a more recent revised 
version has not been psychometrically evaluated.  A recent systematic review 
concluded that ASEPSIS is the ‘gold standard’ for scoring surgical site 
infections168.   It was therefore decided to compare the wound domain of POMS 
to ASEPSIS to test its accuracy. 
 
Patient follow-up is essential to record accurately SSI rates since half of 
infections present after hospital discharge33.   Therefore SSI rates cannot be 
simply defined as a ‘short-term’ outcome measure.  ASEPSIS defines wound 
infection as occurring up to 2 months post-surgery.  This presents a problem 
when comparing it to the wound domain of the POMS.  The POMS only 
identifies wound morbidity during the inpatient episode, where as the ASEPSIS 
considers both the inpatient episode and outpatient follow-up.  Furthermore, the 
POMS only identifies wound morbidity that is sufficiently serious to warrant 
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inpatient care.  ASEPSIS identifies mild wound morbidity that could be treated 
as an outpatient as well more serious morbidity requiring inpatient care.  For 
these two reasons, the incidence of wound morbidity defined by the POMS 
could be expected to be lower than the incidence defined by ASEPSIS. 
 
In an attempt to overcome this problem, and make a fair comparison, the wound 
domain of the POMS was compared to two different ASEPSIS scores: the 
inpatient ASEPSIS score (based on information from the inpatient episode only) 
and the overall ASEPSIS score.  In this way, the wound domain of POMS could 
be directly compared to another inpatient assessment of wound morbidity. 
 
At the time of the POMS study, ASEPSIS scores were routinely collected on all 
patients who remained in the hospital for at least 2 days.  Therefore ASEPSIS 
data was available for all patients in the POMS study. 
5.2 Methods 
 
5.2.1 General methodology 
 
 
The methods used to collect the POMS data are described fully in Chapter 2.  
The patient demographics are also described.  POMS data was collected on 
post-operative days (POD) 3, 5, 8 and 15 if the patient remained in hospital.   
 
ASEPSIS data was collected on the same patients.  A member of a specialist 
wound surveillance team, made up of 4 nurses and a health care assistant, 
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assessed each wound.  The sole role of these five members of staff was to 
collect and record wound infection data, and all received specialist training in 
the diagnosis of surgical site infection.   
 
Each patient was reviewed on 3 separate occasions: once pre-operatively and 
twice post-operatively.  The same standardized data collection sheet was 
completed for each patient.  Details collected pre-operatively included patient 
age, height, weight, clinical team and consultant in charge.  Operative 
information and microbiology results were recorded from a direct interface with 
hospital computer databases.  Microbiology tests, such as wound swabs or 
tissue cultures, were performed according to clinical judgment.  No specific 
microbiology tests were requested for study purposes alone.   
 
Surgical wounds were inspected on POD 2 or 3, and again on POD 4 or 5 (if the 
patient remained in hospital).  The proportion of each wound exhibiting 
erythema, serous discharge, purulent discharge or dehiscence was recorded.  
Wounds were directly inspected by surveillance staff if undressed, but if a 
dressing was present, the relevant information was gained by questioning 
nursing staff.  This was done to avoid an unnecessary increase in the risk of 
infection.  Nurses were encouraged to fill out the data collection sheet at the 
time of dressing change.   
 
At each post-operative visit, patient notes and drug charts were inspected.  The 
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prescription of therapeutic antibiotics and the opening of a wound or drainage of 
an abscess were recorded.   
 
At the time of discharge patients were given a simple ‘yes/no’ questionnaire 
regarding their wound.  They were asked to complete and return the 
questionnaire in a pre-paid envelope 2 months post-surgery.  Patients were 
contacted by telephone if no postal questionnaire was returned.  The 
questionnaire was used to ascertain if a wound infection had been diagnosed 
since discharge, if antibiotics had been prescribed for the wound, if any further 
surgery had been necessary, and if the hospital stay had been longer than 14 
days.    
 
Data was stored on a modified Access 97® database which was only 
accessible to surveillance team members.  A single patient episode was defined 
as an operation with post-operative follow-up of either 3 months or until a further 
operation was performed, whichever was shorter. SSI resulting in readmission 
at any time was recorded in the database.  
5.2.2 Calculation of the ASEPSIS score 
 
 
ASEPSIS is a quantitative wound scoring method.  The score is calculated 
using objective criteria based both on visual characteristics of the wound and 
the consequences of infection.   
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The wound is examined on 2 separate occasions post-operatively and given a 
score of between 0 and 30.  This score is calculated according to the proportion 
of the wound affected by serous exudate, erythema, purulent exudate and 
separation of deep tissues.  The greater the proportion of wound affected, the 
higher the score. There is a maximum score of 5 points for serous exudate and 
erythema, and a maximum score of 10 points for purulent exudate and 
separation of deep tissues.  A detailed breakdown of the point scale for the 
ASEPSIS wound inspection score is provided in Table 5, Page 31, Chapter 1.  
Only the higher of the 2 scores contributes to the overall ASEPSIS score. 
 
The second part of the ASEPSIS score is derived from data concerning the 
consequences of infection.  10 points are given for the prescription of antibiotics 
for the wound, 5 points for drainage of pus under local anaesthetic, 10 points for 
the drainage of pus under general anaesthetic, 10 points for the isolation of 
bacteria and 5 points for a stay in hospital over 14 days.  Full details of this 
points scale are provided in Chapter 1, Page 32, Table 6.  This part of the 
ASEPSIS score is calculated partly from inpatient data and partly from 
questionnaire data collected 2 months post-surgery.  
 
To calculate a final ASEPSIS score, the higher of the two wound scores 
(calculated from data gathered during the inpatient stay) is added to the score 
gained from the consequences of infection (calculated from data gathered 
during the inpatient stay together with data from the questionnaire completed 2 
months post-surgery).  
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5.2.3 Data analysis 
 
In order to calculate the accuracy of the wound domain of the POMS, it was 
compared to the inpatient ASEPSIS score and the overall ASEPSIS score.  The 
sensitivity, specificity, positive predictive value, negative predictive value and 
accuracy of the wound domain of POMS were calculated relative to both the 
inpatient ASEPSIS score and the overall ASEPSIS score.   
5.3 Results 
 
 
The same 529 patients described in Chapter 2 were included in this part of the 
study.  Table 47 shows SSI rates as defined by the wound domain of the POMS 
and the inpatient ASEPSIS score.  Table 48 shows SSI rates as defined by the 
wound domain of the POMS and the total ASEPSIS score.  Out of 529 patients, 
497 (94%) completed the ASEPSIS questionnaire 2 months following surgery.  
For the 32 patients who could not be contacted, only inpatient data was 
available to calculate the second part of the ASEPSIS score (evaluating the 
clinical consequences of infection).  Therefore, the inpatient AEPSIS score and 
overall ASEPSIS score was the same for these 32 patients and the true rate of 
infection may be under-estimated in the overall ASEPSIS score. 
 
 
  
 
 
 
 
 
 
203 
Table 47. Presence of wound infection according to the wound domain of 
POMS and the inpatient ASEPSIS score 
 Wound infection according to POMS 
 
Yes No 
 
Total 
Wound 
infection 
according to 
inpatient 
ASEPSIS 
score 
Yes 
 
10 2 12 
No 
 
49 468 517 
Total 
 
59 470 529 
 
Table 48. Presence of wound infection according to the wound domain of 
POMS and the total ASEPSIS score 
 
 Wound infection according to POMS 
 
Yes No 
 
Total 
Wound 
infection 
according to 
total 
ASEPSIS 
score 
Yes 
 
11 8 19 
No 
 
48 462 510 
Total 
 
59 470 529 
 
The sensitivity, specificity, positive predictive value, negative predictive value 
and overall accuracy of the wound domain of the POMS were calculated and 
compared to (i) the inpatient ASEPSIS score and (ii) the total ASEPSIS score.  
A summary of the estimated values is given in table 49 and 50 respectively. 
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Table 49. Characteristics of the wound domain of POMS compared to the 
inpatient ASEPSIS score 
 
Statistic Number Estimate (95% CI) 
Sensitivity 10/12 0.83 (0.52, 0.98) 
Specificity 468/517 0.91 (0.88, 0.93) 
Positive predictive value 10/59 0.17 (0.08, 0.29) 
Negative predictive value 468/470 0.996 (0.985, 0.999) 
Overall accuracy 478/529 0.90 (0.88, 0.93) 
   
Table 50. Characteristics of the wound domain of POMS compared to the 
total ASEPSIS score 
Statistic Number Estimate (95% CI) 
Sensitivity 11/19 0.58 (0.33, 0.80) 
Specificity 462/510 0.91 (0.88, 0.93) 
Positive predictive value 11/59 0.18 (0.09, 0.30) 
Negative predictive value 462/470 0.98 (0.97, 0.99) 
Overall accuracy 473/529 0.89 (0.86, 0.92) 
 
These results show the wound domain of POMS is reasonably sensitive 
compared to the inpatient ASEPSIS score with a value of 0.83.  Sensitivity of 
the wound domain of POMS is lower (0.58) when compared to the overall 
ASEPSIS score.  Specificity of the wound domain of POMS is high (0.91) when 
compared to both the inpatient and overall ASEPSIS scores. 
  
 
 
 
 
 
 
205 
 
There is a low positive predictive value for the wound domain of the POMS 
compared to both the inpatient ASEPSIS score (0.17) and the total ASEPSIS 
score (0.18).  This suggests that less than one-fifth of patients with a positive 
result according to POMS will have a positive result according to either the 
inpatient or total score of ASEPSIS.  This stems from the wound domain of 
POMS over-predicting the occurrence of a positive result.  The negative 
predictive value is very high with almost all patients with a negative POMS 
result also having a negative ASEPSIS result. 
 
The overall accuracy of the wound domain of POMS is about 90% when 
compared to both the inpatient ASEPSIS and total ASEPSIS scores.  This high 
value is partially due to the majority of patients being negative. 
5.4 Discussion 
 
5.4.1 General conclusions 
 
 
The wound domain of the POMS only assesses wounds during the inpatient 
stay.  For this reason, comparisons between the wound domain of POMS and 
the inpatient ASEPSIS score are more meaningful than comparisons with the 
total ASEPSIS score.  It is known that up to half of wound infections present 
after hospital discharge33.  Thus, the wound domain of POMS is not appropriate 
for monitoring SSI rates.  However, satisfactory wound healing is an important 
factor in determining whether a patient is ready for hospital discharge.  It is 
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important that the wound domain of POMS is highly sensitive and is able to 
recognise wound infections that would be identified by an established definition 
of SSI.  It is important that wound infections receive appropriate treatment to 
avoid potentially catastrophic consequences. 
 
When compared to the inpatient ASEPSIS score, the wound domain of POMS 
has a reasonable sensitivity (0.83), good specificity (0.91), a high negative 
predictive value (0.996) but a poor positive predictive value (0.17).  Overall 
accuracy is 0.90. In other words, the wound domain of POMS is reasonably 
good at identifying infected wounds as defined by ASEPSIS, but over four-fifths 
of the wounds identified as having morbidity by POMS are not infected 
according to ASEPSIS.   
 
The low positive predictive value of the wound domain of POMS in comparison 
to the inpatient ASEPSIS score is surprising considering the two definitions.  
The wound domain of POMS is designed to identify severe wound problems 
(either a dehisced wound requiring surgery or a wound draining pus).  ASEPSIS 
is designed to identify mild, moderate and severe wound infections.  Therefore, 
it follows that ASEPSIS would be expected to identify more wound morbidity 
than the wound domain of POMS, since ASEPSIS would identify mild wound 
infections that the wound domain of POMS would miss.  The study shows the 
opposite is true. 
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The definition of wound morbidity according to POMS includes ‘wound 
dehiscence requiring surgical exploration...with or without isolation of 
organisms’.  The wording of this definition could partially explain the low positive 
predictive value of POMS compared to the inpatient ASEPSIS score.  Most 
wound dehiscence is due to infection.  However, a wound can dehisce for other 
reasons such as trauma, haematoma formation or poor surgical technique.  
Non-infected dehiscence can be repaired on the ward using steristrips or 
interrupted sutures under local anaesthetic. Thus, these cases would be 
positive for wound morbidity defined by POMS but not ASEPSIS.  
 
The personnel used for data collection could also explain the difference in 
wound morbidity according to the POMS and ASEPSIS definitions.  ASEPSIS 
data was collected by study personnel with specific training in the diagnosis of 
wound infection. POMS data was collected by study personnel who did not 
receive training on the evaluation of surgical wounds.  Thus the POMS data 
may be less reliable.  
 
The 2 criteria used to diagnose POMS wound morbidity are very similar to 2 of 
the 4 criteria used to diagnose SSI according to the CDC definition (Table 4, 
Page 31, Chapter 1).  One criterion in the CDC definition is ‘purulent discharge 
from the incision’.  This is the same as one of the POMS criteria.  Another CDC 
criterion is ‘spontaneous dehiscence or deliberate opening of a deep incision, 
following fever or pain or tenderness around the wound (unless cultures are 
negative)’.  This is similar to the other POMS criterion (‘wound dehiscence 
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requiring surgical exploration’).  CDC has been shown to be unreliable35.  Thus, 
the wound domain of POMS may be similarly unreliable and this may partially 
explain the different results between the wound domain of POMS and the 
wound score of ASEPSIS. 
 
The wound domain of POMS identifies over 80% of wounds classified as 
infected by the inpatient ASEPSIS score.  This leaves almost 20% of infected 
wounds undetected by the wound domain of POMS.  This is not necessarily a 
problem since not all wound infections require inpatient care.  As long as 
patients receive appropriate outpatient follow-up and are given information 
regarding wound care and wound infection, it is safe to discharge patients with 
minor wound problems.  There is no method of diagnosing wound infection that 
is 100% sensitive and almost half of SSI presents after hospital discharge.  
Therefore, it is very important that surgical wounds are inspected at least once 
after hospital discharge.  At present, a district nurse or GP practice nurse 
usually does this between 10 and 14 days after surgery.  The wound is usually 
inspected again by a surgeon 6 weeks post surgery in the outpatient clinic.   
 
The wound domain of POMS over-diagnoses wound infection compared to the 
wound score of ASEPSIS.  If the POMS is used to identify morbidity that 
requires inpatient care, patients could be kept in hospital unnecessarily due to 
the mis-diagnosis of wound morbidity.  This would result in higher costs for the 
healthcare provider and greater exposure of patients to hospital-acquired 
infections.   
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It is now mandatory in the UK for all hospitals to collect SSI data.  No definition 
of SSI has been fully validated but some psychometric analysis is available for 
ASEPSIS.  It may be more accurate to use the inpatient ASEPSIS score to 
identify POMS wound morbidity than the definition that exists at present.  This 
data would be readily available if ASEPSIS is used for wound surveillance 
purposes.   
5.4.2 Strengths of study 
 
 
This study has several strengths.  It was performed prospectively and contains 
a large study population.  Standardised data collection sheets were completed 
for both the POMS and ASEPSIS studies.  This ensured complete data sets. 
5.4.3 Weaknesses of study 
 
 
One weakness of this study is that the staff collecting data for the wound 
domain of POMS did not receive specific training with regards the examination 
of surgical wounds and the diagnosis of wound morbidity.  A second weakness 
is that 32/529 patients could not be contacted to complete the second part of 
the ASEPSIS scoring system.  Therefore, the overall ASEPSIS score may be 
under-reported for these patients.  However, this study mainly looked at 
agreement between the wound domain of POMS and the inpatient ASEPSIS 
score.  Therefore, the fact that a proportion of patients did not complete the 
ASEPSIS questionnaire 2 months after surgery will not affect the comparison of 
inpatient diagnoses of wound morbidity.   
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5.4.4 Comparisons with other studies 
 
There are no previous studies examining the accuracy of the wound domain of 
the POMS so no comparisons can be made. 
5.5 Summary 
 
 
1. The wound domain of POMS has a high specificity and reasonable 
sensitivity when compared to the inpatient ASEPSIS score. 
2. The wound domain of POMS has a high negative predictive value but a 
low positive predictive value when compared to the inpatient ASEPSIS 
score. 
3. The wording of the definition of POMS wound morbidity may account in 
part for the low positive predictive value. 
4. The wound domain of the POMS could be replaced by an established 
method of diagnosing SSI.  It is mandatory for all hospitals in the UK to 
collect SSI data so this information is readily available.  
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Chapter 6: How should surgical site 
infection be measured? 
 
6.1 Introduction 
 
 
‘High Quality Care For All7’ is a publication from The Department of Health in 
the UK.  It states that all healthcare providers working for or on behalf of the 
NHS must publish ‘Quality Accounts’.  These ‘accounts’ cover three aspects of 
patient care: safety, patient experience and patient outcome.  As part of the 
safety aspect, surgical site infection prevalence data must be collected and is 
readily available for the general public to review on the ‘NHS Choices’ website. 
  
In the ‘High Quality Care For All’ report, seven steps were described to improve 
quality: 
1) Set standards of high quality  
2) Measure quality 
3) Publish quality performance 
4) Recognise and reward quality 
5) Raise standards 
6) Safeguard quality 
7) Stay ahead by encouraging innovation 
 
The report stated that surgical site infection (SSI) data will be available on the 
NHS Choices website (step 3) but did not state what a ‘good’ SSI rate is (step1) 
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nor did the report describe how SSI rates will be measured (step 2).  There is a 
common misconception that SSIs are easy to define and diagnose.  There are 
several definitions of SSI and diagnosis of infection varies between surgeons. 
 
SSIs were traditionally diagnosed using the examination findings of pain, 
redness, heat, swelling and impairment of function.  More reliable and 
reproducible methods of diagnosing SSI are now available.  Three SSI 
definitions commonly used today are the US Centers for Disease Control (CDC) 
definition, the English Nosocomial Infection National Surveillance Scheme 
(NINSS) definition and the English ASEPSIS definition.   These definitions are 
described in detail in Chapter 1. 
 
In Chapter 5, I looked at the accuracy of the wound domain of POMS compared 
to ASEPSIS.  This led me to consider how reliable and comparable other 
methods of diagnosing wound infection are.  The POMS measures morbidity 
during the inpatient stay only.  A significant proportion of SSIs present following 
hospital discharge and the commonly used definitions of SSI take account of 
this.  The CDC and NINSS definitions define SSI as occurring within 1 year of 
surgery if an implant is present.  ASEPSIS defines SSI as occurring within 2 
months of surgery. 
 
In the last chapter, I compared the wound domain of POMS to inpatient 
ASEPSIS data to ensure that a fair and meaningful comparison was made.  A 
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comparison of the wound domain of POMS to overall ASEPSIS scores (which is 
based on inpatient and out-patient data) would not be meaningful.   
 
For this chapter I will use data collected from inpatient and outpatient episodes.  
Approximately half of SSIs presents after hospital discharge so it important that 
this information is captured when reporting overall SSI rates.  If outpatient data 
was not included, infection rates would be under-reported.  
 
The purpose of this chapter is to assess if three commonly used methods of 
diagnosing SSI (CDC, NINSS and ASEPSIS) report similar rates of infection in 
the same series of patients.  SSI rates are used as a performance indicator and 
are reported for every NHS hospital in England and Wales on the NHS Choices 
website.  Different institutions use different methods to assess SSI.  If published 
SSI rates are to be meaningful, different definitions of SSI must give similar 
values.  This ensures that comparisons between surgeons and hospitals are fair 
and made against the same benchmark.  Alternatively, the same diagnostic 
method must be adopted by all. 
6.2 Methods 
 
6.2.1 General methodology 
 
A wound surveillance program was started in the Department of Trauma and 
Orthopaedics at University College London Hospital in May 2000.   For the first 
two years of the program, due to funding constraints, data was only 
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collected for 6 months of each year, from May till October.  This represented 
35% of total Orthopaedic admissions.  From 2002 onwards, data collection 
became continuous.  This study is part of a hospital audit programme so ethics 
committee approval was not required. 
 
Criteria for inclusion in the wound surveillance program included all trauma and 
elective orthopaedic patients with a minimum 2-night stay in hospital and an 
operation involving the incision of tissue.  Traumatic wounds were not included 
in the study, only incisions made at the time of surgery.   
 
Each patient was reviewed on 3 separate occasions: once pre-operatively and 
twice post-operatively.  Each review was performed by a member of a specialist 
wound surveillance team.  The same standardized data collection sheet was 
completed for each patient.  The methods used to collect the wound data are 
described fully in Chapter 5.  In addition to this, the diagnosis of a wound 
infection by a medical practitioner was noted. 
 
Data was stored on a modified Access 97® database which was only 
accessible to surveillance team members.  A single patient episode was defined 
as an operation with post-operative follow-up of either 3 months or until a further 
operation was performed, whichever was shorter.  At any time point, SSI 
resulting in readmission was recorded in the database.  Sufficient information 
was gathered to allow each wound to be diagnosed according to the CDC, 
NINSS and ASEPSIS definitions of infection.   
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6.2.2 Calculation of SSI rates 
 
 
The ASEPSIS definition of SSI gives every wound a score.  The way in which 
this score is calculated is described in detail in Chapter 5.  A score of 21 or over 
indicates SSI.  Both CDC and NINSS have certain criteria that must be fulfilled 
to diagnose SSI.  There is no score, just a simple dichotomous yes/no result. 
6.2.3 Statistical analysis 
 
 
Crude infection rates were calculated for each definition of infection and 95% 
confidence intervals calculated.  The agreement between crude infection rates 
was calculated using the kappa statistic.  Kendall’s tau b value was used to 
assess correlation between the subdivisions of each definition. 
6.3 Results 
 
 
7448 orthopaedic wounds in 7299 patients were assessed between May 2000 
and October 2008.  The follow-up rate of patients two months following surgery 
was 91%.  Details of patient demographics are shown in table 51.   The 
distribution of age and ASA grade within the study population is shown in 
greater detail in figure 5 and figure 6 respectively.  
 
 
 
 
  
 
 
 
 
 
 
216 
Table 51. Patient demographics of 7299 trauma and orthopaedic patients 
 
Gender  
    M:F 
 
44:56 
Mean age in years (range) 56.4 (0 – 99) 
ASA   I 
          II 
          III  
          IV 
2109 (28.3%) 
3639 (48.9%) 
1595 (21.4%) 
105 (1.4%) 
Type of surgery  
    Elective : Emergency 
 
86:14 
 
Figure 5. Age distribution of study population 
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Figure 6. ASA distribution of study population 
 
 
 
 
 
 
 
 
 
The crude infection rates (together with 95% confidence intervals) according to 
CDC, NINSS and ASEPSIS are shown in table 52.  The incidence of infection 
according to the three definitions over time is shown in figure 7.   
Table 52. Infection rates according to CDC, NINSS and ASEPSIS in the 
same series of 7299 orthopaedic patients 
Definition Number of 
uninfected wounds  
Number of 
infected wounds 
95% CI for 
infection rate 
CDC 6297 (84.55%) 1151 (15.45%) 14.63 – 16.27% 
NINSS 6605 (88.68%) 843 (11.32%) 10.60 – 12.04% 
ASEPSIS 6793 (91.21%) 655 (8.79%) 8.15 – 9.44% 
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Figure 7. Incidence of infection according to CDC, NINSS and ASEPSIS 
from 2000 to 2008 
 
 
 
 
 
 
 
 
 
CDC and NINSS can be divided into ‘no infection’, ‘superficial incisional 
infection’ and ‘deep incisional infection’ (table 53).  ASEPSIS can be divided 
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and ‘severe infection’ (table 54). 
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Table 53.  ‘Superficial’ and ‘deep’ incisional infection rates according to 
CDC and NINSS 
 
Definition Number of wound 
with no infection 
Number of wounds 
with superficial 
incisional infection 
Number of wounds 
with deep incisional 
infection 
CDC 6297 (84.5%) 689 (9.3%) 462 (6.2%) 
NINSS 6605 (88.7%) 663 (8.9%) 180 (2.4%) 
 
Table 54. Grade of infection according to ASEPSIS 
 
 
ASEPSIS grade of infection Number of wounds 
No infection 6110 (82.0%) 
Disturbance in healing 683 (9.2%) 
Minor infection 297 (4.0%) 
Moderate infection 140 (1.9%) 
Severe infection 218 (2.9%) 
 
Tables 55, 56 and 57 show the level of agreement of crude infection rates for 
the three definitions.  The agreement between CDC and ASEPSIS is 88.94% 
(kappa statistic 0.4861, p<0.0001).  The agreement between NINSS and 
ASEPSIS is 89.61% (kappa statistic 0.4266, p<0.0001).  The agreement 
between CDC and NINSS is 95.27% (kappa statistic 0.7969, p<0.0001).   
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Table 55. Agreement between CDC and ASEPSIS infection rates 
 
 CDC  
Total No infection Infection 
 
ASEPSIS 
No infection 6133 
(82.3%) 
660 
(8.9%) 
6793 
(91.2%) 
Infection 164 
(2.2%) 
491 
(6.6%) 
655 
(8.8%) 
 
Total 
6297 
(84.5%) 
1151 
(15.5%) 
 7448 
(100.00%) 
 
Table 56. Agreement between NINSS and ASEPSIS infection rates 
 
 NINSS  
Total No infection Infection 
 
ASEPSIS 
No infection 6312 
(84.7%) 
481 
(6.5%) 
6793 
(91.2%) 
Infection 293 
(3.9%) 
362 
(4.9%) 
655 
(8.8%) 
 
Total 
6605 
(88.6%) 
843 
(11.4%) 
7448 
(100.00%) 
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Table 57. Agreement between NINSS and CDC infection rates 
 
 NINSS  
Total No infection Infection 
 
CDC 
No infection 6275 
(84.2%) 
22 
(0.3%) 
6297 
(84.5%) 
Infection 330 
(4.5%) 
821 
(11.0%) 
1151 
(15.5%) 
 
Total 
6605 
(88.7%) 
843 
(11.3%) 
7448 
(100.00%) 
 
Tables 58, 59 and 60 show the level of agreement between the subgroups of 
the three definitions of SSI.  Kendall’s tau b correlation coefficient between 
ASEPSIS and CDC is 0.5932, between ASEPSIS and NINSS is 0.4493, and 
between NINSS and CDC is 0.7870 (all p<0.0001).   
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Table 58. Agreement between CDC superficial and deep incisional 
infection rates and ASEPSIS scores 
 
 CDC definition  
Total No 
infection 
Superficial 
infection 
Deep 
infection 
 
 
 
 
ASEPSIS 
score 
0-10 5770 
(77.5%) 
304 
(4.1%) 
36 
(0.5%) 
6110 
(82.1%) 
11-20 363 
(4.9%) 
226 
(3.0%) 
94 
(1.3%) 
683 
(9.2%) 
21-30 89 
(1.2%) 
98 
(1.3%) 
110 
(1.5%) 
297 
(4.0%) 
31-40 18 
(0.2%) 
50 
(0.7%) 
72 
(1.0%) 
140 
(1.9%) 
>40 57 
(0.8%) 
11 
(0.1%) 
150 
(2.0%) 
218 
(2.9%) 
 
Total 
6297 
(84.6%) 
689 
(9.2%) 
462 
(6.2%) 
7448 
(100.0%) 
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Table 59. Agreement between NINSS superficial and deep incisional 
infection rates and ASEPSIS scores 
 
 NINSS Definition  
Total No 
infection 
Superficial 
infection 
Deep 
infection 
 
 
 
 
ASEPSIS 
definition 
0-10 5814 
(78.1%) 
281 
(3.8%) 
15 
(0.2%) 
6110 
(82.0%) 
11-20 498 
(6.7%) 
166 
(2.2%) 
19 
(0.3%) 
683 
(9.2%) 
21-30 172 
(2.3%) 
101 
(1.4%) 
24 
(0.3%) 
297 
(4.0%) 
31-40 33 
(0.4%) 
86 
(1.1%) 
21 
(0.3%) 
140 
(1.9%) 
>40 88 
(1.2%) 
29 
(0.4%) 
101 
(1.4%) 
218 
(2.9%) 
 
Total 
6605 
(88.7%) 
663 
(8.9%) 
180 
(2.4%) 
7448 
(100.00%) 
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Table 60. Agreement between NINSS and CDC superficial and deep 
incisional infection rates  
 
 NINSS classification  
Total No 
infection 
Superficial 
infection 
Deep 
infection 
 
 
CDC 
classification 
No 
infection 
6275 
(84.3%) 
22 
(0.3%) 
0 
(0.00%) 
6297 
(84.6%) 
Superficial 
infection 
121 
(1.6%) 
568 
(7.6%) 
0 
(0.00%) 
689 
(9.2%) 
Deep 
infection 
209 
(2.8%) 
73 
(1.0%) 
180 
(2.4%) 
462 
(6.2%) 
 
Total 
6605 
(88.7%) 
663 
(8.9%) 
180 
(2.4%) 
7448 
(100.00%) 
 
6.4 Discussion 
 
6.4.1 Summary 
 
 
Wound surveillance on the same series of patients gives varying rates of SSI 
depending on the definition used.  On this series of 7448 patients, the SSI rate 
according to CDC was 15.45%, according to NINSS was 11.32% and according 
to ASEPSIS was 8.79%.  
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Further breakdown of ASEPSIS scores reveals that 9.17% of patients had 
disturbance of healing (score 11-20).  A score of 11-20 is known to include 
some infected wounds, but is thought to indicate wound breakdown from 
another cause in most cases2.  If these patients were regarded as having ‘true’ 
infections, the SSI rate according to ASEPSIS would be similar to the rate 
according to CDC and NINSS. 
 
A positive correlation was found between an increasing ASEPSIS score and 
deep incisional infection according to CDC and NINSS.  Therefore, the higher 
the ASEPSIS score, the greater the likelihood of a deep incisional SSI.  
 
Wound surveillance in Orthopaedic Surgery became mandatory in the NHS in 
England in 2004.  Reported SSI rates depend on the method used for 
diagnosis, case mix, the thoroughness of surveillance and documentation, and 
the length of patient follow-up.  Post-discharge follow-up is essential in any 
wound surveillance program since more than half of SSIs present after hospital 
discharge33.     
 
Wound surveillance has several advantages.  Firstly, the feedback of infection 
rates to surgeons has been shown to decrease infection rates2.  Secondly, 
outliers can be identified so that good practice can be recognized and 
propagated and, where there is poor practice, remedial assistance can be 
given.  Thirdly, SSI rates can be used as a performance indictor to compare 
surgeons, departments, hospitals and countries.  However, a dedicated 
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programme with full outpatient follow up can result in apparently high rates of 
infection being reported. Comparison should only be made within the institution 
or with hospitals operating to the same standards. 
 
This study illustrates the necessity for one accurate and reproducible definition 
of SSI to allow its use as a performance indicator.  The 3 definitions 
investigated in this study are not directly comparable and there is no good 
evidence at present as to which definition is best to use.  CDC is used 
worldwide but this popularity may be unwarranted since the definition is 
subjective and has been shown to be unreliable35.  The UK NINSS version of 
CDC was devised in an attempt to make CDC more objective, but again NINSS 
is not reproducible35. The difference in reported infection rates according to 
CDC and NINSS in this study shows how a small alteration in the definition of 
CDC has a marked effect on the reported outcome.  Wound scoring methods 
are postulated to be superior to CDC and NINSS since they provide more 
information and are objective.  The original ASEPSIS scoring method is known 
to be repeatable and related to outcome12 but ASEPSIS has now been revised 
and psychometric analysis is awaited. 
 
This study emphasizes the importance of choosing one reliable and 
reproducible method for diagnosing SSI.  This will help to ensure that published 
results are both accurate and meaningful.  At present, institutions choose which 
method they use to assess SSI.  Therefore comparisons are invalid and 
misleading.    
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6.4.2 Strengths of study 
 
 
This study has many strengths.  It is prospective and has a large study 
population.  A dedicated wound surveillance team with specialist training 
collected the data.  This ensured accurate data collection and recording.   
6.4.3 Limitations of study 
 
 
One weakness of this study is that it was performed at a single centre so results 
may not be applicable to other institutions.  However, the study included 
patients following a wide variety of orthopaedic procedures and cared for by 
over 20 different orthopaedic consultants so most sources of variation should be 
represented.  A further weakness is that some wound data was recorded by 
ward nurses.  This may have lead to a decrease in inter-observer reliability.  To 
minimize this problem, each nurse completed a standardized simple results 
table with tick-boxes.  Wound observations were also verified by a member of 
the surveillance team by asking ward nurses specific questions.  Finally, some 
assumptions were used when diagnosing wound infection according to the 
different definitions.  For example, a surgeon’s diagnosis of wound infection was 
assumed when either antibiotics were prescribed or surgical wound 
debridement was performed.  However, since the diagnosis of wound infection 
is known to be poorly recorded in the patient record, we considered this 
assumption to be more accurate than consulting the patient record alone.  
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6.4.4 Comparisons to other studies 
 
 
ASEPSIS has been compared previously to other definitions of SSI36 in surgical 
patients.  In the series of mixed surgical patients there was a wider discrepancy 
between SSI rates according to CDC and ASEPSIS (19.2% and 6.8% 
respectively) than in this series of orthopaedic patients.   The study of mixed 
surgical patients found a significant difference in the SSI rate according to CDC 
and NINSS, despite there being only a slight difference in the two definitions.  
This study of orthopaedic patients alone confirmed the finding.  There have 
been no previous studies comparing ASEPSIS to other scoring methods in 
orthopaedic patients.  
6.5 Summary 
 
 
1. On the same series of orthopaedic patients, surgical site infection rates 
vary widely depending on the definition used. 
2. On this series of 7448 patients, the SSI rate according to CDC was 
15.45%, according to NINSS was 11.32% and according to ASEPSIS 
was 8.79%.  
3. All institutions should use the same definition of surgical site infection to 
make comparisons of infection rates meaningful and fair. 
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Chapter 7 Conclusions and further work 
 
7.1 Summary of thesis 
 
 Outcome measures are used to evaluate the benefits and risks of surgery.  
They are used for both research and audit purposes.  The routine collection and 
reporting of outcome measures started in the UK in 2000 and has gradually 
evolved over time.  Outcomes are now published on the ‘NHS Choices’ website 
to guide patients in their choice of institution and surgeon.   
 
Post-operative outcome measures include mortality rates, morbidity rates and 
patient-reported outcome measures.  The Post-Operative Morbidity Survey 
(POMS) is the only validated measure of post-operative morbidity in the UK.  It 
recognises morbidity of a severity that prevents discharge from hospital. 
 
Morbidity following hip and knee arthroplasty has previously been poorly 
recorded.  This is the first time the POMS has been used for this purpose.   
Infection and renal complications are the most common types of morbidity 
following hip and knee arthroplasty.  Pulmonary, pain and gastro-intestinal 
morbidity are less common.  Cardiovascular, wound, neurological and 
haematological morbidity are the least common.  Most types of morbidity 
decrease with time after surgery. 
 
It is important that medical staff involved with the care of arthroplasty patients 
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are aware of the prevalence of post-operative morbidity in all organ systems.  
This allows prompt diagnosis and treatment of morbidity, minimising its impact.  
Knowing the prevalence of morbidity also allows appropriate pre-operative 
patient education and counselling.  This gives patients realistic expectations 
and goals regarding the recovery period. 
 
There is a statistically significant risk-adjusted difference in the presence of any 
type of post-operative morbidity following primary and revision hip arthroplasty 
on POD 3, 5, 8 and 15. Morbidity is higher in the RTHR group.  There is a 
statistically significant risk-adjusted higher level of infection following RTHR 
than THR on POD 3, 5, 8 and 15.  Following RTHR, there are higher levels of 
renal morbidity on POD 3 than following THR.   
 
There is no difference in post-operative morbidity following primary and revision 
knee arthroplasty. The most likely reason for this is the low number of patients 
in the RTKR group in this study.  After adjusting for POSSUM morbidity scores, 
no difference in post-operative morbidity was found between UKR and TKR, 
and HR and THR.  Thus, newer ‘bone preserving’ arthroplasty procedures do 
not result in less post-operative morbidity than total joint replacements.  After 
adjusting for POSSUM morbidity scores, no difference was found between post-
operative morbidity following hip and knee arthroplasty procedures. 
 
Most levels of post-operative morbidity in this study are higher than in 
previously published studies.  The most likely reason for this discrepancy is 
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the use of different definitions of morbidity. The POMS definitions of morbidity in 
different organ systems are broad and capture more events than narrowly 
defined measures of morbidity.  Different methods of data collection could also 
account for the discrepancy; this study collected data prospectively, which will 
always capture more events than retrospectively collected data.  This study sets 
the benchmark for future audit.  Strategies can be implemented to reduce 
morbidity levels and the audit cycle repeated to evaluate their impact. 
 
Many arthroplasty patients remain in hospital with no identifiable morbidity. 
Two general trends are seen.  Firstly, patients undergoing more ‘invasive’ 
surgery remain in hospital longer with no morbidity than patients undergoing 
less ‘invasive’ surgery.  Secondly, with increasing time after surgery, fewer 
patients with no identifiable morbidity remain in hospital.  The most common 
reason for non-discharge of patients with no apparent morbidity is on-going 
physiotherapy and occupational therapy input. 
 
The use of the POMS as a bed utilisation tool relies on the fact it captures all 
morbidity.  Mobility is an important factor in determining when a patient is ready 
for discharge following arthroplasty surgery.  Addition of a ‘mobility’ domain to 
the POMS may make it more reliable as a bed utilisation tool for orthopaedic 
patients.  The definition of mobility morbidity could be ‘unable to mobilise 10m 
with or without walking aids and/or unable to ascend and descend a single flight 
of stairs’. 
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The use of POMS as a bed utilisation tool also assumes that patients do not 
develop morbidity after a period without morbidity (when they would be 
discharged).  This was generally true, but a small proportion of patients 
developed wound, cardiovascular and neurological morbidity following a period 
without morbidity.  This is not a reason to discount the POMS as a bed 
utilisation tool, but certain precautionary measures need to be taken.  Firstly, 
primary arthroplasty patients should receive regular wound reviews till POD 5 
and revision arthroplasty patients should receive regular wound reviews till POD 
8.  Patients should be aware they could develop wound infection, deep vein 
thrombosis, pulmonary embolus, myocardial infarction or stroke after hospital 
discharge.  They should be given clear written instructions about the symptoms 
of these conditions and what to do if they develop.  
 
Significant savings could be made if bed utilisation were to be improved in the 
UK.  POMS could be used to identify patients remaining in hospital without 
clinically significant morbidity and could be used prospectively as a bed 
utilisation tool.   
 
This study showed no association between post-operative morbidity defined by 
the POMS and longer-term patient-reported outcome measures (PROMs).  
Thus, this study does not support the use of the POMS as an early surrogate 
marker of long-term patient outcome.  There was a tendency towards patients 
with morbidity on POD 15 having poorer PROMs, but this was not statistically 
significant. 
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Longer post-operative stay was associated with poorer PROMs in both the hip 
and knee arthroplasty groups.  This justifies the use of length of hospital stay as 
an early marker of longer-term outcome.  There was no association between 
patient age and PROMs and no association between patient sex and PROMs.  
Higher ASA grades were associated with poorer longer-term PROMs in the 
knee arthroplasty group.  The association was not statistically significant in the 
hip group.  There is no association between length of operation and PROMs. 
 
The wound domain of the POMS has a high specificity, reasonable sensitivity, 
high negative predictive value and low positive predictive value when compared 
to the inpatient ASEPSIS score.  The wording of the definition of POMS wound 
morbidity could account in part for the low positive predictive value.  The wound 
domain of POMS has not been validated.  It may be prudent to replace it with a 
psychometrically evaluated and widely used definition of wound infection such 
as ASEPSIS.  It is mandatory for wound infection data to be collected by all 
hospitals so this data should be readily available. 
 
Assessing the accuracy of the wound domain of POMS compared to the 
inpatients ASEPSIS score lead me to consider the level of agreement between 
other definitions of surgical site infection.  CDC, NINSS and ASEPSIS are all 
definitions of surgical site infection commonly used in the UK.   On the same 
series of orthopaedic patients, surgical site infection rates varied widely 
depending on the definition used.  The SSI rate according to CDC was 15.45%, 
according to NINSS was 11.32% and according to ASEPSIS was 8.79%.  
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This highlights the need for all institutions to use the same definition to make 
comparisons meaningful and fair. 
7.2 Outstanding questions 
 
7.2.1 Use of the POMS as an audit tool 
 
 
Morbidity following hip and knee arthroplasty has now been fully recorded for 
the first time using a validated measure of post-operative morbidity.  This data 
should be presented together with suggestions to improve morbidity rates in 
each of the POMS domains.  Once changes have been implemented, repeat 
POMS data should be collected.  This is an area for further research to assess 
whether the collection and presentation of POMS data ultimately leads to an 
improvement in patient outcome.  Ways by which the morbidity rates in each of 
the POMS domains could be improved are presented in detail in Chapter 2. 
7.2.2 Use of the POMS as a bed utilisation tool 
 
 
This thesis has shown that the POMS can be used as a prospective bed 
utilisation tool.  Several ways were suggested in chapter 3 to improve bed 
utilisation.  These include the provision of physiotherapy at home rather than as 
an inpatient, the delivery of home equipment prior to surgery and the 
arrangement of rehabilitation provision prior to surgery.  Each of these 
suggestions requires further investigation.  Once changes have been 
implemented, POMS data can be recollected to assess if the number of 
inpatients without morbidity has reduced. 
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7.2.3 Addition of a ‘mobility’ domain to the POMS 
 
 
The use of the POMS as a discharge tool relies on the fact that it records all 
morbidity requiring inpatient care.  At present the POMS does not assess 
mobility.  For arthroplasty patients, this is an important factor in determining 
fitness for discharge.  The addition of a ‘mobility’ domain may make the POMS 
more suitable for use as an orthopaedic bed utilisation tool.  The addition of a 
‘mobility’ domain to the POMS requires further investigation and psychometric 
evaluation. 
7.2.4 Does post-operative morbidity lead to poorer 
long-term PROMs? 
 
In Chapter 4, univariable analysis revealed an association between morbidity on 
POD 15 and poorer long-term PROMs.  Multivariable analysis showed the 
association was not statistically significant.  The sample sizes in this chapter 
were small and this may have led to a false negative result.  This requires 
further investigation with a larger sample size.  A true association between 
POMS morbidity on POD 15 and poorer long-term PROMs may be found. 
7.2.5 Which definition of surgical site infection should 
be used? 
 
A systematic review of the commonly used definitions of surgical site infection 
would be valuable.  The modified version of ASEPSIS also needs to be 
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validated for use in orthopaedic patients.  This information could be used to 
decide which definition of surgical site infection is most appropriate for national 
wound surveillance and publication on the ‘NHS Choices’ website. 
7.3 Conclusions  
 
 
Morbidity following lower limb arthroplasty has previously been poorly recorded.  
The POMS reveals that infection and renal complications are the most common 
types of morbidity following hip and knee replacement.  Pulmonary, pain and 
gastro-intestinal morbidity are less common.  Cardiovascular, wound, 
neurological and haematological morbidity are the least common.  Most types of 
morbidity decrease with time after surgery. 
 
Many patients remain in hospital with no identifiable morbidity.  The POMS can 
be used prospectively to identify these patients.  The use of POMS as a bed 
utilisation tool is based on the assumption that it identifies all patients with 
clinically significant morbidity.  The most common reason for non-discharge of 
patients without morbidity in this study was on-going physiotherapy and 
occupational therapy input.  This raises the possibility that patients were not 
sufficiently mobile for safe discharge.  The addition of a ‘mobility’ domain to the 
POMS may improve its utility as a bed utilisation tool for orthopaedic patients. 
 
This study found no association between the POMS and PROMs at 18 months 
post-surgery.  There was a tendency towards an association between the 
presence of morbidity on POD 15 and poorer PROMs at 18-months post-
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surgery, but this was not statistically significant on multivariable analysis.  Thus, 
this study does not support the use of the POMS as an early surrogate marker 
of longer-term PROMS in orthopaedic patients.  An association was found to 
exist between longer inpatient stay and PROMs at 18 months post-surgery.  
Thus, this study supports the use of length of inpatient stay as an early 
surrogate marker of longer-term patient-reported outcome.  
 
The wound domain of POMS has high specificity, reasonable sensitivity, high 
negative predictive value and low positive predictive value compared to the 
inpatient ASEPSIS score.  It may be prudent to consider replacing the wound 
domain of the POMS with a validated definition of surgical site infection.   
 
On the same series of orthopaedic patients, surgical site infection rates varied 
widely depending on the definition used.  According to the CDC definition the 
infection rate was 15.45%, according to the NINSS definition it was 11.32% and 
according to the ASEPSIS definition it was 8.79%.  When comparing surgical 
site infection rates between institutions, the same definition should be used to 
ensure comparisons are valid.  
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How will surgical site infection be measured 
to ensure “high quality care for all”? 
 
 
 
As	of	April	2010	all	NHS	institutions	in	the	United	Kingdom	are	required	to	publish	data	on	
surgical	site	infection,	but	the	method	for	collecting	this	has	not	been	decided.	We	
examined	7448	trauma	and	orthopaedic	surgical	wounds	made	in	patients	staying	for	at	
least	two	nights	between	2000	and	2008	at	our	institution	and	calculated	the	rate	of	surgical	
site	infection	using	three	definitions:	the	US	Centers	for	Disease	Control,	the	United	
Kingdom	Nosocomial	Infection	National	Surveillance	Scheme	and	the	ASEPSIS	system.	On	
the	same	series	of	wounds,	the	infection	rate	with	outpatient	follow-up	according	to	Centre	
for	Disease	Control	was	15.45%,	according	to	the	UK	Nosocomial	infection	surveillance	was	
11.32%,	and	according	to	ASEPSIS	was	8.79%.	These	figures	highlight	the	necessity	for	all	
institutions	to	use	the	same	method	for	diagnosing	surgical	site	infection.	
If	different	methods	are	used,	direct	comparisons	will	be	invalid	and	published	rates	of	
infection	will	be	misleading.	
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In	 June	 2008	 the	 Department	 of	 	 Health	 	 in	
the	United	Kingdom	published	 a	 report	 enti-	
tled	 “High Quality  Care  For  All”.1	 	 This	
stated	 that	by	April	2010,	healthcare	provid-	
ers	 working	 for	 or	 on	 behalf	 of	 the	 NHS	
must	 publish	 ‘quality	 accounts’.	 These	 will	
cover	 three	 aspects	 of	 patient	 care:	 safety,	
patient	 experience	 and	 patient	 outcome.	 As	
part	of	the	safety	aspect,	rates	of	surgical	site	
infection	(SSI)	will	be	published.	
SSI	 is	 a	 major	 risk	 in	 all	 orthopaedic	 sur-	
gery.	 It	 causes	 pain	 and	 can	 lead	 to	 wound	
dehiscence,	 deep	 infection	 and	 generalised	
sepsis.	 Further	 surgery	 and	 admission	 to	
intensive	 care	 may	 be	 necessary.	 	 A	 patient	
with	an	SSI	spends	twice	as	 long	 in	hospital.2	
It	 is	 therefore	 not	 only	 distressing	 for	 the	
patient	but	also	an	economic	burden.	
In	the	report	“High Quality Care For All” 
report,	 seven	 steps	 were	 described	 to	
improve	 quality.	 These	 are	 to	 set	 standards	
of	 high	 quality;	 measure	 quality;	 publish	
quality	 performance;	 recognise	 and	 reward	
quality;	 raise	 standards;	 safeguard	 quality;	
and	 stay	 ahead	 by	 encouraging	 innovation.	
The	 report	 stated	 that	 data	 on	 SSI	 will	 soon	
be	 available	 on	 the	 NHS	 Choices	 website	
(step	 3)	 but	 did	 not	 state	what	 a	 ‘good’	 rate	
of	SSI	is	(step	1),	nor	did	it	describe	how	such	
rates	 will	 be	 measured	 (step	 2).	 This	 paper	
concentrates	 on	 step	 2	 and	 examines	 the	
methods	commonly	used	to	measure	SSI.	
	
There	 is	a	misconception	 that	SSIs	are	easy	
to	define	and	diagnose.	There	are	several	defi-	
nitions	 of	 SSI	 	 and	 the	 diagnosis	 of	 infection	
varies	between	surgeons.	They	were	tradition-	
ally	diagnosed	using	 the	 findings	on	examina-	
tion	 of	 pain,	 redness,	 heat,	 swelling	 and	
impairment	 of	 function.	 As	 surgeons	 became	
increasingly	 accountable	 for	 	 their	 practice,	
more	 reliable	 and	 reproducible	 methods	 of	
diagnosing	 SSI	 became	 necessary.	 There	 are	
three	definitions	in	use	today	(i)	the	US	Centers	
for	 Disease	 Control	 (CDC),	 (ii)	 the	 English	
Nosocomial	 Infection	 National	 Surveillance	
Scheme	 (NINSS)	 and	 (iii)	 an	 English	 system	
which	 combines	 scores	 for	 additional	 treat-	
ment,	 serous	 discharge,	 erythema,	 purulent	
exudate,	separatin	of	deep	tissues,	isolation	of	
bacteria	and	stay	as	an	in-patient	(ASEPSIS).	
The	CDC	definition3		is	used	 throughout	 the	
world	 and	 divides	 SSIs	 into	 incisional	 and	
organ/space	infections.	Incisional	SSIs	are	fur-	
ther	 divided	 into	 superficial	 and	 deep	 infec-	
tions	 (Table	 I).	 Several	 of	 the	CDC	criteria	 are	
subjective,	 and	 on	 psychometric	 evaluation	
have	been	shown	to	be	unrealiable.4	
The	 United	 Kingdom	 NINSS	 definition	 	 of	
SSI	 is	 based	 on	 the	 CDC,	 with	 two	 significant	
modifications.	Firstly,	pus	cells	must	be	present	
for	a	wound	culture	to	be	classified	as	positive	
and	secondly,	a	surgeon’s	diagnosis	of	infection	
is	excluded	as	a	sufficient	criterion	to	diagnose	
SSI.			These			changes			were			 implemented			to	
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!
$
Table&I.&The!Center!for!Disease!Control!definition!of!surgical!site!infection!
Superficial&infection!
(involving&skin&and&superficial&tissues)!
Deep&infection!
(involving&the&fascial&and&muscle&layers)!
&
!
Time!period! Occurs!within!30!days!of!surgery! Occurs!within!30!days!of!surgery!or!
within!one!year!if!implant!present!
!
Site! Involves!only!the!skin!and!superficial!tissue! Related!to!the!surgical!site!and!involves!
deep!tissues!
!
Further!criteria! !Must!fulfil!one!of!the!following:! Must! fulfil!one!of!the!following:!
Purulent!discharge!from!superficial!incision! Purulent!discharge! from!deep!
incision!
Organisms!isolated!from!incision.!
Pain,!tenderness,!swelling,!redness!or!heat!around!
the!incision!AND!the!incision!deliberately!opened!by!
a!surgeon!(unless!cultures!are!negative)!
Spontaneous!dehiscence!or!deliberate!
opening!of!a!deep!incision,!following!
fever!or!pain!or!tenderness!around!the!
wound!(unless!cultures!are!negative)!
Diagnosis!by!a!surgeon!or!physician! Abscess!involving!a!deep!incision!
Diagnosis!by!a!surgeon!or!physician!
!
!
!
!
!
Table&II.&Points!scale!used!to!calculate!total!ASEPSIS!score!
Criterion& Points!
Table&III.&Points!scale!for!ASEPSIS!daily!wound!inspection!
!
!
Proportion&of&wound&affected&(%)!
&
Additional!treatment! ! ! ! 0! >&0&to&19! 20&to&39! 40&to&59! 60&to&79! 80&to&100!
Antibiotics!
Drainage!of!pus!under!local!anaesth!
10!
etic! 5!
! Serous!
exudate!
0 1 2 3 4 5 
Debridement!of!wound!under!general!anaesthetic! 10! ! Erythema! 0 1 2 3 4 5 
! ! ! Purulent! 0 2 4 6 8 10 
Serous!discharge! 0!to!5!! exudates! ! ! ! ! ! !
Erythema! 0!to!5!! Separation!of! 0 2 4 6 8 10 
Purulent!!exudate! 0!to10!
Separation!of!deep!tissues! 0!to!10!
Isolation!of!bacteria! 10!
Stay!in!hospital!over!14!days! 5!
deep!tissues!
!
!
!
!
!
!
!
!
Table&IV.&Breakdown!of!ASEPSIS!scores!
!
!
Score& Meaning!
&
!
• to10!No!infection!Normal!healing!
• to!20! Disturbance!of!healing!
21!to!30! Minor! infection!
31!to!40! Moderate!infection!
³ 41! Severe!infection!
!
!
!
!
improve$the$objectivity$of$CDC,$but$the$reproducibility$of$
NINSS$remains$low.5$
ASEPSIS$is$a$quantitative$wound$scoring$method.6$The$
score$is$calculated$using$objective$criteria$based$both$on$
visual$characteristics$of$the$wound$and$the$consequences$of$
infection$(Tables$II$and$III).$A$score$of$>$10$indicates$an$
increasing$probability$and$severity$of$infection$(Table$IV).$
The$original$ASEPSIS$method$has$been$shown$to$be$both$
objective$and$repeatable,7$but$a$more$recent$revised$version$$
$$has$not$been$psychometrically$evaluated.$
&
&
&
&
&
&
Table&V.&Patient!demographics!Gender!
!
$
M:F! 44:56!
Mean!age!in!years!(range)! 56.4!(0!to!99)!
ASA*14!!!(%)!
I! 2109!!(28.3)!
II! 3639!!(48.9)!
III! 1595!!(21.4)!
IV! 105!(1.4)!
!
Type!of!surgery!
Elective:!emergency! 86:14!
!
*!ASA,!american!society!of!anesthesiologists!
!
!
!
!
!
!
Scoring$methods$provide$more$detailed$ information$
than$the$CDC$and$NINSS$but$are$more$complicated$to$
perform,$more$time c^onsuming$and$more$costly.$It$takes$
an$average$of$59$minutes$to$collect$the$data$and$calculate$
an$ASEPSIS$score.8$
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Table	VI.	Infection	rates	according	to	CDC,	NINSS	and	ASEPSIS	
	
Definition*	
	
Number	of	uninfected	wounds	
(%)	
Number	of	infected	wounds	
(%)	 95%	CI†		for	infection	rate	
	
	
CDC	 6297		(84.55)	 1151		(15.45)	 14.63 to	16.27 
NINSS	 6605	(88.68)	 843	(11.32)	 10.60 to	12.04 
ASEPSIS	 6793	(91.21)	 655	(8.79)	 8.15 to	9.44 
 
*	CDC,	center	for	disease	control;	NINSS,	nosocomial	infection	national	surveillance	scheme	
†	CI,	confidence	interval	
	
	
	
 
 
The	purpose	of	this	prospective	observational	study	was	
to	assess	the	rate	of	SSI	in	orthopaedics	according	to	these	
three	common	definitions.	
	
Patients	and	Methods	
In	May	2000	a	wound	surveillance	programme	began	in	the	
Department	 of	 Trauma	 and	 Orthopaedics	 at	 University	
College	Hospital,	 London.	 For	 the	 first	 two	 years,	 because	
of	funding	restraints,	data	were	collected	for	six	months	of	
each	 year,	 from	May	 to	 October.	 This	 represented	 35%	 of	
total	orthopaedic	 admissions.	From	2002	onwards,	 collec-	
tion	of	data	became	continuous.	This	study	is	part	of	a	hos-	
pital	audit	programme	and	so	 formal	ethical	approval	was	
not	required.	
All	trauma	and	elective	orthopaedic	patients	with	a	min-	
imum	 of	 two-nights	 stay	 in	 hospital	 and	 an	 operation	
involving	 the	 incision	 of	 tissue	 were	 included	 in	 the	 pro-	
gramme.	 Traumatic	 wounds	 were	 not	 included,	 only	 inci-	
sions	made	at	the	time	of	surgery.	
Wounds	were	assessed	by	a	member	of	a	specialist	team,	
made	up	of	four	nurses	and	a	healthcare	assistant.	The	sole	
role	of	this	team	was	to	collect	and	record	data	on	wound	
infection,	and	all	members	received	specialist	training	in	the	
different	definitions	and	diagnosis	of	surgical	site	infection.	
Each	patient	was	reviewed	on	three	separate	occasions,	
once	pre-operatively	and	twice	post-operatively.	The	same	
standardised	data	collection	sheet	was	completed	for	each	
patient.	 The	 information	 collected	 pre-operatively	
included	patient	demographics	 and	 the	name	of	 the	 con-	
sultant			in			charge.			Operative			information			and			micro-	
biology	 results	 came	 from	 a	 direct	 interface	 with	 other	
hospital	 computer	databases.	Microbiology	 tests,	 such	 as	
wound	swabs	or	tissue	cultures,	were	performed	accord-	
ing	 to	 clinical	 judgement.	 No	 specific	 microbiology	 tests	
were	requested	for	study	purposes	alone.	
Surgical	wounds	were	inspected	two	or	three	days	after	
operation	 and	 again	 on	 days	 four	 or	 five	 if	 the	 patient	
remained	 in	 hospital.	 The	 proportion	 of	 each	 wound	
exhibiting	erythema,	serous	discharge,	purulent	discharge	
or	 dehiscence	 was	 recorded.	 Wounds	 were	 inspected	
directly	if	visible,	but	if	a	dressing	was	present	the	relevant	
information	was	gained	by	questioning	nursing	staff.	This	
was	 done	 to	 avoid	 an	 unnecessary	 increase	 in	 the	 risk	 of	
infection.	 The	 nurses	 were	 encouraged	 to	 fill	 in	 the	 data	
collection	sheet	at	the	time	of	dressing	change.	
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Fig.	1	
	
Graph	showing	infection	rates	(CDC,	center	for	disease	control;	NINSS,	
nosocomial	infection	national	surveillance	scheme).	
	
	
	
At	each	post-operative	visit	the	notes	and	drug	charts	of	
the	 patient	 were	 inspected.	 The	 diagnosis	 of	 a	 wound	
infection	 by	 a	 medical	 practitioner,	 the	 prescription	 of	
prophylactic	or	therapeutic	antibiotics	and	the	opening	of	
a	wound	or	drainage	of	an	abscess	were	recorded.	
At	the	time	of	discharge	patients	were	given	a	simple	‘yes/	
no’	questionnaire	regarding	their	wound,	which	they	were	
asked	 to	 complete	 and	 return	 in	 a	pre-paid	 envelope	 two	
months	later.	They	were	contacted	by	telephone	if	no	postal	
questionnaire	was	returned.	The	questionnaire	was	used	to	
ascertain	 whether	 a	 wound	 infection	 had	 been	 diagnosed	
since	discharge,	whether	antibiotics	had	been	prescribed	for	
the	wound.	whether	any	further	surgery	had	been	necessary	
and	whether	the	hospital	stay	had	been	longer	than	14	days.	
The	data	were	stored	on	a	modified	Access	97	database	
which	was	only	accessible	to	members	of	 the	surveillance	
team.	A	single	patient	episode	was	defined	as	an	operation	
with	 follow-up	 of	 either	 three	 months	 or	 until	 a	 further	
operation	was	 performed,	 whichever	was	 shorter.	 At	 any	
time	point,	SSI	resulting	in	readmission	was	recorded	in	the	
database.		 Sufficient		 information		was		 gathered		 to		 allow	
each	wound	to	be	diagnosed	according	 to	 the	CDC,	NINSS	
and	ASEPSIS	definitions.	
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Table	VII.	‘Superficial’	and	‘deep’	incisional	infection	rates	according	to	CDC	and	NINSS	
	
Definition*	
	
Number	of	wounds	with	no	
infection	(%)	
	
Number	of	wounds	with	superficial	
incisional	infection	(%)	
	
Number	of	wounds	with	
deep	incisional	infection	(%)	
CDC	 6297		(84.5)	 689		(9.3)	 462		6.2 
NINSS	 6605	(88.7)	 663		(8.9)	 180		2.4 
*	CDC,	center	for	disease	control;	NINSS,	nosocomial	infection	national	surveillance	scheme	
Table	VIII.	Grade	of	infection	according	to	ASEPSIS	 Table	IX.	Agreement	between	CDC*	and	ASEPSIS	infection	rates	
Grade	of	infection	
Number	of	wounds	
(%)	
CDC	
No	infection	(%)	 Infection	(%)		Total	(%)	
No	infection	 6110	(82.0)	
Disturbance	in	healing	 683	(9.2)	
	
Infection	
	
	
ASEPSIS	
No	infection	
Infection	
	
Total	 6297	(84.5)	 1151	(15.5)				7448	(100.0)	
	
*	CDC,	center	for	disease	control	
	
	
	
Table	X.	Agreement	between	NINSS*	and	ASEPSIS	infection	rates	
	
	
NINSS	
	
	
No	infection	(%)	 Infection	(%)				Total	(%)	
	
	
ASEPSIS	
	
No	infection	 6312		(84.7)	 481		(6.5)	 6793		(91.2)	
Infection	 293		(3.9)	 362		(4.9)	 655		(8.8)	
	
Total	 6605	(88.6)	 843	(11.4)	 7448	(100.0)	
	
*	NINSS,	nosocomial	infection	national	surveillance	scheme	
	
Table	XI.	Agreement	between	NINSS*	and	CDC†	infection	rates	
	
	
NINSS	
	
	
No	infection	(%)	 Infection	(%)				Total	(%)	
	
	
CDC	
No	infection	 6275	(84.2)	 22	(0.3)	 6297	(84.5)	
Infection	 330	(4.5)	 821	(11.0)	 1151	(15.5)	
	
Total	 6605	(88.7)	 843	(11.3)	 7448	(10 0.0)	
* NINSS,	nosocimial	infection	national	surveillance	scheme	
†	CDC,	center	for	disease	control	
	
	
6133		(82.3)	 660		(8.9)	 6793		(91.2)	
164		(2.2)	 491		(6.6)	 655		(8.8)	
	
Minor	 297		(4.0)	
Moderate	 140		(1.9)	
Severe	 218		(2.9)	
	
Statistical	analysis.	Crude	 infection	 rates	 were	 	 calculated	
for	 each	 definition	 of	 infection	 and	95%	 confidence	 inter-	
vals	 calculated.	 The	 agreement	 between	 crude	 infection	
rates	was		calculated		using		the		k  statistic.		Kendall’s		tau	
b	value	was	used	to	assess	correlation	between	the	subdivi-	
sions	of	each	definition.	
	
Results	
Between	May	 2000	 and	 October	 2008,	 7448	 orthopaedic	
wounds	were	assessed	in	7299	patients.	The	patient	demo-	
graphics	 are	 shown	 in	 Table	 V.	 The	 rate	 of	 follow-up	 of	
patients	two	months	after	surgery	was	91%.	
The	 crude	 infection	 rates	 according	 to	 	 CDC,	 	 NINSS	
and	 ASEPSIS	 are	 shown	 in	 Table	 VI	 and	 the	 incidence	 of	
infection	 according	 to	 the	 three	 definitions	 over	 time	 is	
shown	 in	 Figure	 1.	 CDC	 and	 NINSS	 can	 be	 divided	 into	
‘no	 infection’,	 ‘superficial	 incisional	 infection’	 and	 ‘deep	
incisional	 infection’	 (Table	 VII).	 ASEPSIS	 can	 be	 divided	
into	 ‘no	 infection’,	 ‘disturbance	 of	 healing’,	 ‘mild	 infec-	
tion’,	 	 	 ‘moderate	 	 	 infection’	 	 	 and	 	 	 ‘severe	 	 	 infection’	
(Table		VIII).	
Tables	IX,	X	and	XI	show	the	level	of	agreement	of	crude	
infection	rates	for	the	three	definitions.	The	agreement	
between	CDC	and	ASEPSIS	is	88.94%	(k statistic	0.4861,	
p	<	0.0001),	that	between	NINSS	and	ASEPSIS	is	89.61%	(k 
statistic	 0.4266,	 p	 <	 0.0001)	 and	 that	 between	 CDC	 and	
NINSS	is	95.27%	(k statistic	0.7969,	p	<	0.0001).	
Tables	 XII,	 XIII	 and	 XIV	 show	 the	 level	 of	 agreement	
between	 the	 subgroups	 of	 the	 three	 definitions	 of	 SSI.	
Kendall’s	 tau	b	 correlation	 coefficient	 between	ASEPSIS	 and	
CDC	 is	 0.5932,	 between	 ASEPSIS	 and	 NINSS	 is	 0.4493,	 and	
between	NINSS	 and	CDC	 is	0.7870	 (all	 p	 <	 0.0001).	
	
Discussion	
Wound	 surveillance	 in	 the	 same	 series	 of	 patients	 gives	
varying	rates	of	SSI	depending	on	the	definition	used.	On	
this	series	of	7448	patients,	 the	SSI	rate	according	 to	 the	
CDC	 was	 15.45%,	 according	 to	 the	 NINSS	 was	 11.32%	
and	 according	 to	 ASEPSIS	 was	 8.79%.	 The	 latter	 has	
previously	been	 compared	with	other	definitions	 of	 SSI,9	
but	never	 in	a	 series	of	 trauma	and	orthopaedic	patients	
only.	
Further	 breakdown	 of	 ASEPSIS	 scores	 reveals	 	 that	
9.17%	of	patients	had	disturbance	of	healing	 (score	11	 to	
20).	A	score	of	11	to	20	is	known	to	include	some	infected	
wounds,	 but	 in	 most	 cases	 is	 thought	 to	 indicate	 wound	
breakdown	 from	 another	 cause.10	 If	 these	 patients	 were	
regarded	as	having	 ‘true’	 infections,	 the	SSI	 rate	according	
to	ASEPSIS	would	be	 similar	 to	 the	 rate	 according	 to	CDC	
and		 NINSS.	  
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Table	XII.	Agreement	between	CDC*		superficial	and	deep	incisional	infection	rates	and	ASEPSIS	
scores	
	
	 CDC	definition	 	
No	infection	(%)	 Superficial	infection	(%)	Deep	infection	(%)	 Total	
ASEPSIS	score	 	 	 	 	
0	to	10	 5770		(77.5)	 304		(4.1)	 36		(0.5)	 6110		(82.1)	
11	to	20	 363		(4.9)	 226		(3.0)	 94		(1.3)	 683		(9.2)	
21	to	30	 89		(1.2)	 98		(1.3)	 110		(1.5)	 297		(4.0)	
31	to	40	 18		(0.2)	 50		(0.7)	 72		(1.0)	 140		(1.9)	
>	40	 57		(0.8)	 11		(0.1)	 150		(2.0)	 218		(2.9)	
	
Total	 6297	(84.6)	 689	(9.2)	 462	(6.2)	 7448	(100.0)	
	
* CDC,	center	for	disease	control	
	
	
	
	
Table	XIII.	Agreement	between	NINSS*		superficial	and	deep	incisional	infection	rates	and	ASEP-	
SIS	scores	
	
	 NINSS	definition		
No	infection	(%)	 Superficial	infection	(%)	 Deep	infection	(%)	 Total	
	
ASEPSIS		score	
0	to	10	
	
	
5814		(78.1)	
	
	
281		(3.8)	
	
	
15		(0.2)	
	
	
6110		(82.0)	
11	to	20	 498		(6.7)	 166		(2.2)	 19		(0.3)	 683		(9.2)	
21	to	30	 172		(2.3)	 101		(1.4)	 24		(0.3)	 297		(4.0)	
31	to	40	 33		(0.4)	 86		(1.1)	 21		(0.3)	 140		(1.9)	
>	40	 88		(1.2)	 29		(0.4)	 101		(1.4)	 218		(2.9)	
Total	 6605		(88.7)	 663		(8.9)	 180		(2.4)	 7448		(100.0)	
* NINSS,	nosocomial	infection	national	surveillance	scheme	
	
	
	
	
Table	XIV.	Agreement	between	NINSS*		and	Center	for	Disease	Control	(CDC)	superficial	and	deep	
incisional	infection	rates	
	
	
	
	
CDC	classification	
	
NINSS	definition	
	
	
No	infection	(%)			Superficial	infection	(%)	Deep	infection	(%)			Total	
No	infection	 6275	(84.3)	 22	(0.3)	 0	(0.0)	 6297	(84.6)	
	
Superficial	infection			121	(1.6)	 568		(7.6)	 0		(0.0)	 689		(9.2)	
Deep	infection	 209	(2.8)	 73		(1.0)	 180		(2.4)	 462		(6.2)	
	
Total	 6605	(88.7)	 663	(8.9)	 180	(2.4)	 7448	(100.0)	
	
*	NINSS,	nosocomial	infection	national	surveillance	scheme	
	
	  
A	positive	correlation	was	found	between	an	 increasing	
ASEPSIS	 score	 and	 deep	 	 incisional	 	 infection	 	 according	
to	 the	 CDC	 and	 the	 NINSS.	 Therefore,	 the	 higher	 the	
ASEPSIS	 score,	 the	 greater	 the	 likelihood	 of	 a	 deep	
incisional	SSI.	
The	strengths	of	this	study	are	that	it	is	prospective,	there	is	
a	large	study	population	and	a	dedicated	wound	surveillance	
team	with	specialist	training	who	collected	and	recorded	the	
data.	One	weakness	is	that	some	of	the	data	was	recorded	by	
ward	nurses,	leading	to	a	possible	decrease	in	inter-observer	
reliability.	In	order	to	minimise	this	problem,	each	nurse	com-	
pleted	a	standardised	simple	results	table	with	tick-boxes,	and	
all	wound	observations	were	verified	by	the	surveillance	team	
asking	the	ward	nurses	specific	questions.	
Wound	surveillance	in	orthopaedic	surgery	became	man-	
datory	 in	 the	 NHS	 in	 England	 in	 2004.	 Reported	 rates	 of	
SSI	depend	on	the	method	used	for	diagnosis,	the	case	mix,	
the	 thoroughness	 of	 surveillance	 and	 documentation,	 and	
the	 duration	 of	 patient	 follow-up.	 Follow-up	 after	 dis-	
charge	 is	essential	 in	any	wound	surveillance	programme,	
as	more	than	half	of	SSIs	present	after	discharge.11	
Wound	 surveillance	 has	 several	 advantages.	 Firstly,	 the	
feedback	of	rates	of	 infection	to	surgeons	has	been	shown	
to	reduce	them.10	Secondly,	outliers	can	be	identified	so	that	
good	practice	can	be	recognised	and	propagated,	and	poor	
practice	can	be	highlighted	and	improved.	Thirdly,	rates	of	
SSI	can	be	used	as	a	performance	indicator	to	compare	sur-	
geons,	 departments,	 hospitals	 and	 countries.	 However,	 a	  
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dedicated	 programme	 with	 full	 outpatient	 follow-up	 can	
result	in	apparently	high	rates	of	infection	being	reported.	
Comparison	should	only	be	made	within	the	 institution	or	
with	hospitals	operating	to	the	same	standards.	
This	study	illustrates	the	need	for	a	single	accurate	and	
reproducible	definition	of	SSI	to	allow	its	use	as	a	reliable	
Supplementary material 
A	further	opinion	by	Professor	S.	Hughes	is	available	
with	the	online	version	of	this	article	on	our	website	
at		www.jbjs.org.uk	
APR	Wilson	was	part	funded	by	the	UCLH/UCL	comprehensive	biomedical	cen-	
tre.	
performance	 indicator.	 The	 three	 definitions	 investigated	
here	are	not	directly	comparable,	and	at	present	there	is	no	
good	evidence	as	 to	which	 is	best	 to	use.	The	CDC	 is	used	
worldwide,	but	this	popularity	may	be	unwarranted	as	the	
definition	 is	 subjective	 and	 has	 been	 shown	 to	 be	 unreli-	
able.4	 The	 United	 Kingdom	 NINSS	 version	 of	 CDC	 was	
devised	 in	 an	 attempt	 to	 make	 CDC	 more	 objective,	 but	
again	 NINSS	 is	 not	 reproducible.4	 The	 difference	 in	
reported	 infection	 rates	 according	 to	 CDC	 and	 NINSS	 in	
this	study	shows	how	a	small	alteration	in	the	definition	of	
the	 former	 has	 a	marked	 effect	 on	 the	 reported	 outcome.	
Methods	 of	 wound	 scoring	 are	 claimed	 to	 be	 superior	 to	
those	 of	 the	 CDC	 and	 NINSS,	 because	 they	 provide	 more	
information	and	are	objective.	
From	2010,	hospitals	will	no	longer	be	paid	a	fixed	tariff	for	
each	procedure:	 instead,	 they	will	 receive	 a	 variable	 amount	
according	 to	 ‘outcome’.	 Therefore,	 hospitals	 with	 lower	 SSI	
rates	will	receive	higher	tariffs.	In	order	for	this	to	be	fair,	the	
rates	must	be	reported	in	a	reliable	and	accurate	fashion.	
We	recommend	 the	use	of	 the	ASEPSIS	scoring	method.	
Both	 CDC4	and	 NINSS5	have	 been	 shown	 to	 be	 unreliable.	
The	original	ASEPSIS	method	 is	objective	and	repeatable,7	
but	a	more	recent	revised	version	has	not	been	psychomet-	
rically	evaluated	and	this	must	be	promptly	addressed.	
Before	the	publication	of	SSI	rates	within	the	profession	
and	 to	 the	 general	 public,	 the	Department	of	Health	must	
clearly	define	it.	If	different	diagnostic	methods	are	used	by	
different	 institutions,	 any	 comparison	will	 be	meaningless	
and	misleading.	
No	benefits	in	any	form	have	been	received	or	will	be	received	from	a	com-	
mercial	party	related	directly	or	indirectly	to	the	subject	of	this	article.	
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Abstract 
 
Appropriately timed patient discharge is essential for optimal patient care and efficient 
hospital functioning.  The Post-Operative Morbidity Survey (POMS) is the only 
validated prospective method of measuring short-term post-operative morbidity.  It has 
not been used previously as a bed utilisation tool.  We collected POMS data from 529 
consecutive lower limb arthroplasty patients over a one-year period and recorded the 
number of patients remaining in hospital without morbidity, together with alternative 
reasons for remaining in hospital.  On post-operative day 5, 53% of all hip arthroplasty 
patients and 47% of all knee arthroplasty patients remained in hospital with no 
identifiable morbidity.  The most common reason for inappropriate bed occupancy was 
on-going physiotherapy and occupational therapy.  We believe that the Post Operative 
Morbidity Survey is able to identify patients remaining in hospital with no significant 
morbidity and has utility as a prospective bed utilisation tool.  Addition of a mobility 
measure to the POMS may improve the utility of this survey in detecting morbidity 
requiring hospitalisation, particularly following lower limb joint replacement surgery. 
 
Introduction 
 
Appropriately timed discharge of patients following surgery is essential for optimal 
patient care and efficient hospital functioning.  A patient discharged early is at risk of 
under-diagnosis of medical complications with consequent adverse outcome.  A patient 
whose discharge is delayed is at risk of developing a hospital-associated complication 
(e.g. hospital-acquired infection) and incurs an unnecessary cost to the health-care 
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provider.  Post-operative patients should be discharged at the earliest safe opportunity to 
reduce the rate of hospital-associated complications and the cost of each inpatient 
episode.  Appropriate discharge timing should increase the throughput of patients and 
reduce waiting times.    
 
Historically, hospitals in the UK have been paid according to contracts with no financial 
incentive to treat increased numbers of patients.  This changed in 2000 when the NHS 
Plan1 announced that hospital incomes would be directly linked to activity.  Payment by 
Results2 began in 2003 and now every healthcare provider is paid a sum (tariff) for each 
procedure undertaken.  In the UK, many patients remain in hospital with no medical 
indication3.  One study showed that 31% of post-operative patients remained in hospital 
inappropriately 4.  Payment by Results aims to reduce this figure by rewarding 
efficiency and encouraging increased activity. 
 
In order to improve efficiency, hospitals must first recognise inappropriate bed 
occupancy.  The Post-Operative Morbidity Survey (POMS)5 is the only validated 
prospective method of measuring short-term post-operative morbidity in the literature.  
The POMS was designed to identify morbidity of a type and severity that could delay 
discharge from hospital.  The survey focuses on indicators of organ systems dysfunction 
(e.g. inability to tolerate enteral diet) rather than traditional diagnostic categories (e.g. 
deep vein thrombosis).  The POMS assesses 9 domains of morbidity (Table 1).  Data is 
obtained from observation charts, medication charts, patient notes, routine blood test 
results and direct patient questioning and observation.  No additional investigations are 
required.  The data collection process is simple to allow routine screening of large 
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numbers of patients.  The POMS has been shown to be reliable, valid and acceptable to 
patients6.  The POMS has been used in outcomes research7 and in effectiveness 
research8.   
 
In the US, over 98% of post-operative inpatients had morbidity defined by the POMS5.  
This implies that patients with a POMS score of zero are fit for discharge.   
Therefore, as well as providing useful clinical research and audit data, the POMS may 
have utility for assessing and improving hospital bed utilisation. 
 
The aim of this study is to identify inappropriate bed occupancy following lower limb 
arthroplasty using the POMS.  We report the reasons for delayed discharge and suggest 
ways to improve bed utilisation. 
 
Methods 
 
Ethics Committee approval was sort prior to commencement of the study.  The 
requirement for consent was waived as collection of the POMS has become a routine 
part of service evaluation within our institution.  All patients aged 18 or over 
undergoing elective lower limb arthroplasty at University College Hospitals NHS Trust 
over a 12 month period were eligible for inclusion into this prospective cohort study.  
There were no exclusion criteria ensuring a consecutive sample was taken.  Elective 
lower limb arthroplasty procedures included unicompartmental knee replacement 
(UKR), total knee replacement (TKR), revision total knee replacement, hip resurfacing 
(HR), total hip replacement (THR) and revision total hip replacement.   
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Data was collected by one of two study nurses.  The age, sex, ASA and length of 
inpatient stay for each patient was recorded.   POMS data were collected on post-
operative days (POD) 3, 5, 8 and 15 if the patient remained in hospital.  Presence of 
morbidity was defined as occurring in any patient meeting POMS criteria, in one or 
more domain of the survey, on the day of data collection.   For patients remaining in 
hospital without morbidity on POD 8 and POD 15, the reason was recorded.  The use of 
mobility aids on these days was also noted.   
 
The number and percentage of patients with no identifiable morbidity according to the 
POMS was calculated for POD 3, 5, 8 and 15.  The number of days each patient 
remained in hospital with no morbidity was calculated by distracting the day on which 
the patient first had a POMS score of zero from their total length of stay.  An overall 
estimated cost saving was calculated by multiplying this figure by the average cost for 
one orthopaedic inpatient night. 
 
The number of patients developing post-operative morbidity after a period free of 
morbidity was recorded.  The number of readmissions to the same hospital in the first 
year following discharge was also recorded. 
 
Results 
 
Data collection was completed on 529 patients.  Patient characteristics of the study 
population are shown in table 2.  The mean age of all study patients was 68.9 years, 
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the median ASA was 2 and 62% of patients were female.  The median length of stay 
was 7 days and the overall inpatient mortality rate was 0.4%. 
 
A) Hip arthroplasty patients 
 
The location of hip arthroplasty patients on POD 3, 5, 8 and 15 is shown in table 3.  
Many patients undergoing HR remained in hospital with no identified morbidity on 
POD 3 (75%), 5 (78%) and 8 (16%). All HR patients were discharged by POD 15.  
 
Many THR patients remained in hospital with no identifiable morbidity on POD 3 
(46%), 5 (54%), 8(34%) and 15 (7%).  Patients undergoing revision THR patients also 
remained in hospital with no identifiable morbidity on POD 3 (11%), 5 (29%), 8 (31%) 
and 15 (3%).  Discharge status and prevalence of morbidity for all hip arthroplasty 
patients combined are presented in figure 1.   
 
B) Knee arthroplasty patients 
 
The location of knee arthroplasty patients on POD 3, 5, 8 and 15 is shown in table 4.  
Many patients undergoing UKR remained in hospital with no identified morbidity on 
POD 3 (63%), 5 (39%) and 8 (6%). All UKR patients had been discharged by POD 15.  
 
Many TKR patients remained in hospital with no identifiable morbidity on POD 3 
(50%), 5 (50%), 8 (19%) and 15 (4%).  Revision TKR patients also remained in hospital 
with no identifiable morbidity on POD 3 (52%), 5 (47%), 8 (17%) and 15 (3%).  
  
 
 
 
 
 
 
258 
Discharge status and prevalence of morbidity for all knee arthroplasty patients 
combined are presented in figure 2.   
 
C) Overall inappropriate bed occupancy days  
 
Table 5 and figure 3 show the average number of days that post-operative patients 
remained in hospital with no identifiable morbidity.   HR patients stayed an average of 
2.36 days, THR patients 4.19 days, and revision THR patients 10.37 days.  UKR 
patients stayed an average of 1.76 days with no identifiable morbidity, TKR patients 
2.73 days, and revision TKR patients 14.38 days.   
 
D)  Cost of inappropriate bed occupancy days 
 
Overall, 529 patients undergoing lower limb arthroplasty were included in this study.  
These patients remained in hospital for a total of 1965 days with no morbidity as 
defined by the POMS.  A surgical inpatient bed costs up to £400 per night9.  If these 
patients had been discharged when their POMS score was zero, a saving of up to 
£786,000 could have been made. 
 
E) Reasons for patients with no morbidity remaining in hospital 
 
Of the 529 patients participating in this study, 120 remained in hospital with no 
morbidity defined by the POMS on POD 8 and 20 patients remained with no 
identifiable morbidity on POD 15.  The reasons for non-discharge are shown in 
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figure 4.  The most common reason is continuing physiotherapy and occupational 
therapy input.  Other reasons include waiting for home equipment, waiting for a 
rehabilitation bed, waiting for a social services package of care and patients feeling 
unwell with negative investigations.   
 
Of the patients remaining in hospital with no morbidity identified by the POMS, 24% 
were mobilising with a zimmer frame, 55% were mobilising with two crutches, 14% 
with a single crutch and 7% were mobilising unaided.  This study did not record how far 
patients could mobilise or whether they could climb stairs. 
 
F New morbidity and readmission 
 
38 out of 529 patients developed morbidity as an inpatient following a period without 
morbidity.  5 of these patients underwent a second surgical procedure and developed 
morbidity in the second post-operative period.  33 patients (6.2%) developed morbidity 
following a period without morbidity.  25 of these patients developed wound morbidity, 
6 developed cardiovascular morbidity, 1 developed neurological morbidity and 1 patient 
developed neurological morbidity.   
 
24 patients developed wound morbidity by POD 5 having had no morbidity on POD 3.  
One revision arthroplasty patient developed wound morbidity by POD 8 having had no 
morbidity on POD 5.  Of the 6 patients that developed cardiovascular morbidity, 5 were 
prescribed new anticoagulation (two for pulmonary embolus and three for deep vein 
thrombosis) and 1 patient had a myocardial infarction.  1 THR patient developed a 
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CVA and another THR patient developed infectious morbidity (an infected peripheral 
cannula site) after a period with no morbidity.  
 
No patient in this study was readmitted to the same hospital in the first year following 
discharge for any reason relating to their surgery. 
 
Discussion 
 
This study identifies many patients remaining in hospital with no identifiable morbidity 
following lower limb arthroplasty in a UK teaching hospital.  The rate of inappropriate 
bed occupancy varies with time after surgery and type of arthroplasty.   
 
The most common reason for patients remaining in hospital with no identifiable 
morbidity was on-going physiotherapy and occupational therapy.  This suggests that 
improving pre- and post-operative planning could reduce inappropriate bed occupancy.  
Prior to surgery patients could be taught post-operative physiotherapy exercises in 
group classes.  Occupational therapists could assess each patient’s home environment 
and ensure necessary modifications are made.  In the post-operative period ‘fast-track’ 
pathways could be used to ensure maximum therapy in-put at the earliest possible 
opportunity.   Some physiotherapy and occupational therapy could be provided post-
operatively at the patient’s home rather than in hospital.  This would require safety and 
cost evaluation prior to implementation.   
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Three of the top five reasons for patients remaining in hospital with no identifiable 
morbidity relate to ‘social’ issues (awaiting home equipment, awaiting a rehabilitation 
bed, awaiting a package of care from social services).  Pre-operative clinics could 
identify and address these problems prior to admission.  Such clinics could also be used 
to manage patient expectation so they are aware of the difficulties they may encounter 
in the post-operative period and the expected timing of discharge.   
 
This study has several strengths.  A large consecutive dataset was collected 
prospectively using a validated methodology for measuring post-operative morbidity.  
This is the first published study to prospectively evaluate the appropriateness of 
discharge following lower limb joint replacement surgery specifically. 
 
The weaknesses of this study are that it was conducted in a single centre, the POMS is 
not validated as a bed utilisation tool, there was not daily recording of data so the 
calculation of excess days are an approximation, and patient mobility was not fully 
assessed.  Data was collected regarding mobility aids, but the distance each patient 
could mobilise was not recorded. 
 
This is the first time the POMS has been used as a bed utilisation tool.  It has not been 
validated for this purpose but has previously been used to identify patients in hospital 
without morbidity5,6.  In the US over 98% of inpatients had morbidity defined by the 
POMS5 suggesting that patients with a POMS score of zero were rapidly discharged. In 
a previous UK study 63% of orthopaedic patients remained in hospital with no 
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morbidity on POD 3 and 42% on POD 5 suggesting that discharge efficiency was lower 
in the UK institution.   
 
Use of the POMS as a bed utilisation tool relies on the assumption that it captures all 
reasons for remaining in hospital.  In this study, the main reason for remaining in 
hospital with no identifiable morbidity was ‘on-going physiotherapy and occupational 
therapy input’.  A specific concern in this patient group is that these patients may not 
have adequate mobility to be discharged safely.  Including a specific domain for 
mobility may improve the sensitivity of the POMS for morbidity requiring 
hospitalisation following orthopaedic surgery.  Criteria for a positive result could 
include inability to mobilise 10 metres or climb a single flight of stairs.   Whilst this 
domain could be especially relevant for orthopaedic patients, this requires further 
investigation.   
 
Use of the POMS as a “fitness for discharge” tool rests on the assumption that patients 
do not develop new morbidity after they have become free from morbidity, either in 
hospital or following discharge.  No patients were readmitted to the study hospital in the 
first post-operative year for complications linked to surgery.  However, 38 patients 
developed “new” morbidity following a period without morbidity whilst in hospital.  
This highlights a limitation of prospectively using the POMS as a “fitness for 
discharge” tool.  To overcome this potential problem primary arthroplasty patients 
should have regular would reviews until POD 5 and revision arthroplasty patients until 
POD 8.  This could be done on an out-patient basis.  Patients should be aware of the risk 
of deep vein thrombosis, pulmonary embolus, myocardial infarction and cerebro-
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vascular accident following discharge and receive clear written instructions regarding 
symptoms and management.  As long as these precautionary measures are in place, 
POMS has potential as a bed utilisation tool.   
    
The most commonly used tool to assess appropriate bed utilisation in the literature is the 
Appropriateness Evaluation Protocol (AEP)10.  The AEP is a retrospective tool that 
relies on data from the inpatient record.  It has been shown to be valid and reliable in 
some studies10 but not in others11.  The POMS is a prospective tool that could be used in 
real time to assist with appropriate patient discharge.  The AEP is a retrospective tool 
that can only be used to evaluate past events.  Data for the POMS is collected directly 
from contemporary data sources whilst the patient is in hospital; the AEP relies solely 
on past patient records and is therefore dependent on completeness and accuracy of 
record keeping for reliable functioning. 
 
The AEP has been used in several European countries to examine bed utilization.  In 
Portugal 50% of inpatient days were deemed inappropriate12, in Italy 37.3%13, in 
Germany 28%14, in Switzerland 8-15%15 and in France 7%16.  This study indicates bed 
utilisation in the UK is comparable to that seen in Portugal and Italy but such a direct 
comparison may have limited validity since different bed utilisation tools have been 
used.   
 
The finding that many fewer patients remain in hospital with no morbidity (as defined 
by the POMS) in the US when compared with the UK suggests that bed utilisation in 
the US is superior to that seen in the UK.  The implementation of ‘payment by 
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results’ in the UK aims to improve appropriate bed occupancy to optimise patient care 
and improve efficiency.  If the patients in this study had been discharged when they first 
had no morbidity defined by the POMS, a saving of over £750,000 could have been 
made in one year (based on a cost of £400 per bed-day). 
 
We believe that the POMS is able to identify patients remaining in hospital without 
clinically significant morbidity and may be used prospectively as a bed utilisation tool.  
To use the survey for this purpose, it may be useful to add an additional measure to 
assess mobility.   
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Table 1: Criteria for a positive POMS score 
Variable Criteria for positive result 
Pulmonary Requires supplementary oxygen or ventilatory support 
Infection Currently on antibiotics or temperature >38°C in the last 24 
hours 
Renal Oliguria (<500ml/day), elevated creatinine (>30% pre-op 
level), catheter in-situ (for non-surgical reason) 
Gastrointestinal Unable to tolerate enteral diet for any reason 
Cardiovascular Diagnostic tests or treatment within the last 24 hours for: 
myocardial infarction, hypotension (requiring pharmacological 
therapy or fluids >200ml/hour), atrial/ventricular arrhythmia or 
cardiogenic pulmonary oedema  
Central nervous 
system 
Presence of new focal deficit, coma, confusion, delirium 
Wound 
complications 
Wound dehiscence requiring surgical exploration or drainage 
of pus from operative wound with or without isolation of 
organisms 
Haematological Requirement of blood transfusion, platelets, fresh frozen 
plasma or cryoprecipitate within the last 24 hours  
Pain Wound pain requiring parenteral opioids or regional 
anaesthesia 
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Table 2 Demographics of study population  
 
 Number 
performed 
Mortality 
rate / % 
Age / years ASA % 
Female  
Length of stay / 
days 
Mean Range Median Range Median Range 
UKR 66 1 66.1 45-87 2 1-3 45 5 2-52 
TKR  226 0 70.3 23-90 2 1-3 36 6 3-37 
RTKR 8 0 71.6 46-88 2 1-3 25 13 3-102 
BHR 32 0 51.6 22-70 1 1-3 50 6 4-13 
THR 162 0 70.7 21-89 2 1-3 36 8 3-51 
RTHR 35 3 72.2 26-88 2 1-3 36 14 6-93 
TOTAL 529 0.4 68.9 21-90 2 1-3 38 7 2-102 
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Table 3 – Location of patients following hip arthroplasty procedures 
  POD 3 POD 5 POD 8 POD 15 
 
 
 
Procedure 
BHR Patients 
discharged 
0/32 
(0%) 
2/32 
(6%) 
27/32  
(84%) 
32/32 
(100%) 
Inpatients 
POMS >0 
8/32 
(25%) 
5/32 
(16%) 
0/32 
(0%) 
0/32 
(0%) 
Inpatients 
POMS = 0 
24/32 
(75%) 
25/32 
(78%) 
5/32 
(16%) 
0/32 
(0%) 
THR Patients 
discharged 
0/162 
(0%) 
13/162  
(8%) 
78/162  
(48%) 
138/162 
(85%) 
Inpatients 
POMS >0 
87/162 
(54%) 
62/162 
(38%) 
29/162 
(18%) 
13/162 
(8%) 
Inpatients 
POMS = 0 
75/162  
 
(46%) 
 
87/162 
 
(54%) 
55/162 
 
(34%) 
11/162 
 
(7%) 
Revision 
THR 
Patients 
discharged 
0/35 
(0%) 
0/35 
(0%) 
3/35 
(9%) 
20/35 
(57%) 
Inpatients 
POMS >0 
31/35 
(89%) 
25/35 
(71%) 
21/35 
(60%) 
14/35 
(40%) 
Inpatients 
POMS = 0 
4/35 
(11%) 
10/35 
(29%) 
11/35 
(31%) 
1/35 
(3%) 
TOTAL Patients 
discharged 
0/230 
(0%) 
16/230 
(7%) 
109/230 
(47%) 
191/230 
(83%) 
Inpatients 
POMS >0 
127/230 
(55%) 
92/230 
(40%) 
50/230 
(22%) 
27/230 
(12%) 
Inpatients 
POMS = 0 
103/230 
(45%) 
122/230 
(53%) 
71/230 
(31%) 
12/230 
(5%) 
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Table 4 – Location of patients following knee arthroplasty procedures 
  POD 3 POD 5 POD 8 POD 15 
 
 
 
Procedure 
UKR Patients 
discharged 
7/66 
(11%) 
33/66 
(50%) 
59/66 
(89%) 
65/66 
(98%) 
Inpatients 
POMS >0 
17/66 
(26%) 
7/66 
(11%) 
3/66 
(5%) 
1/66 
(2%) 
Inpatients 
POMS = 0 
42/66 
(63%) 
26/66 
(39%) 
4/66 
(6%) 
0/66 
(0%) 
TKR Patients 
discharged 
0/226 
(0%) 
22/226 
(10%) 
145/226 
(64%) 
211/226 
(93%) 
Inpatients 
POMS >0 
114/226 
(50%) 
90/226 
(40%) 
38/226 
(17%) 
7/22 
(3%) 
Inpatients 
POMS = 0 
112/226 
 
(50%) 
 
114/226 
 
(50%) 
43/226 
 
(19%) 
8/226 
 
(4%) 
Revision 
TKR 
Patients 
discharged 
0/8 
(0%) 
1/8 
(13%) 
1/8 
(13%) 
6/8 
(75%) 
Inpatients 
POMS >0 
6/8 
(75%) 
4/8 
(50%) 
5/8 
(62%) 
1/8 
(12.5%) 
Inpatients 
POMS = 0 
2/8 
(25%) 
3/8 
(37%) 
2/8 
(25%) 
1/8 
(12.5%) 
TOTAL Patients 
discharged 
7/300 
(2%) 
56/300 
(19%) 
205/300 
(68%) 
282/300 
(94%) 
Inpatients 
POMS >0 
137/300 
(46%) 
101/300 
(34%) 
46/300 
(15%) 
9/300 
(3%) 
Inpatients 
POMS = 0 
156/300 
(52%) 
143/300 
(47%) 
49/300 
(17%) 
9/300 
(3%) 
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Table 5 - Number of inappropriate inpatient days classified by type of arthroplasty 
 Total number of 
patients 
Total number of 
inappropriate 
inpatient days 
Average number of 
inappropriate 
inpatient days per 
patient 
BHR 33 78 2.36 
THR 162 678 4.19 
Revision THR 35 363 10.37 
UKR 63 111 1.76 
TKR 227 620 2.73 
Revision TKR 8 115 14.38 
Total 528 1965 3.72 
 
Figure 1 – Discharge status and prevalence of morbidity following all types of hip 
arthroplasty 
 
 
 
 
 
 
 
 
All hip arthroplasty patients
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
3 5 8 15
Post-operative day
P
e
rc
e
n
ta
g
e
 o
f 
p
a
ti
e
n
ts
Discharged
No morbidity
Morbidity
  
 
 
 
 
 
 
272 
Figure 2 – Discharge status and prevalence of morbidity following all types of knee 
arthroplasty 
 
 
 
 
 
 
 
 
 
 
Figure 3 – Average number of inappropriate inpatient days classified by type of 
arthroplasty 
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Figure 4 – Reasons lower limb arthroplasty patients with no morbidity remained 
in hospital on post-operative days 8 and 15 
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